University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2015

Biomaterial-Mediated Reprogramming of the Wound Interface to
Enhance Meniscal Repair
Feini Qu
University of Pennsylvania, feini@vet.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Biomedical Commons

Recommended Citation
Qu, Feini, "Biomaterial-Mediated Reprogramming of the Wound Interface to Enhance Meniscal Repair"
(2015). Publicly Accessible Penn Dissertations. 1961.
https://repository.upenn.edu/edissertations/1961

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1961
For more information, please contact repository@pobox.upenn.edu.

Biomaterial-Mediated Reprogramming of the Wound Interface to Enhance
Meniscal Repair
Abstract
Endogenous repair of fibrous connective tissues is limited, and there exist few successful strategies to
improve healing after injury. As such, new methods that advance repair by enhancing cell migration to the
wound interface, extracellular matrix (ECM) production, and tissue integration would represent a marked
clinical advance. Using the adult meniscus as a test platform, we hypothesized that ECM density and
stiffness increase throughout tissue maturation, and that these age-related changes present biophysical
barriers to interstitial cell migration during wound healing. We further posited that modulating the matrix
could remove these impediments, enabling endogenous cells to reach the injury site. To test our
hypotheses, we compared the microenvironment of fetal and adult meniscal ECM via atomic force
microscopy (AFM) indentation and second harmonic generation (SHG) imaging of the collagenous
matrix. We also explored interstitial cell mobility through fetal and adult native tissue environments using
a three-dimensional ex vivo system. We further investigated strategies that might expedite cell migration,
including enzymatic degradation of the ECM with collagenase to reduce matrix stiffness and increase
porosity. To restrict these biological manipulations to the wound interface, we fabricated a delivery
system in which selected biofactors were stored inside composite electrospun nanofibrous scaffolds and
released upon hydration. The ability for bioactive scaffolds to enhance the cellularity and integration of
meniscal injuries was evaluated in vivo using tissue explants in a subcutaneous implantation model, as
well as an orthotopic meniscal injury model. Our findings suggest that matrix stiffness, density, and
organization increase with meniscal development at the expense of cell mobility. Our results also indicate
that partial digestion of the wound interface with collagenase improves repair by creating a more
compliant and porous microenvironment that facilitates cell migration. Furthermore, when scaffolds
containing collagenase-releasing fibers were placed inside meniscal defects, enzymatic digestion was
localized and resulted in improved cellular colonization and closure of the wound site, similar to treatment
with aqueous collagenase. This innovative approach of targeted delivery may aid the many patients that
exhibit meniscal tears by promoting integrative repair, thereby circumventing the pathologic
consequences of partial meniscus removal, and may find widespread application in the treatment of
injuries to a variety of dense connective tissues.
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ABSTRACT

BIOMATERIAL-MEDIATED REPROGRAMMING OF THE WOUND INTERFACE
TO ENHANCE MENISCAL REPAIR

Feini Qu
Robert L. Mauck

Endogenous repair of fibrous connective tissues is limited, and there exist few successful
strategies to improve healing after injury. As such, new methods that advance repair by
enhancing cell migration to the wound interface, extracellular matrix (ECM) production,
and tissue integration would represent a marked clinical advance. Using the adult
meniscus as a test platform, we hypothesized that ECM density and stiffness increase
throughout tissue maturation, and that these age-related changes present biophysical
barriers to interstitial cell migration during wound healing. We further posited that
modulating the matrix could remove these impediments, enabling endogenous cells to
reach the injury site. To test our hypotheses, we compared the microenvironment of fetal
and adult meniscal ECM via atomic force microscopy (AFM) indentation and second
harmonic generation (SHG) imaging of the collagenous matrix. We also explored
interstitial cell mobility through fetal and adult native tissue environments using a threedimensional ex vivo system. We further investigated strategies that might expedite cell
migration, including enzymatic degradation of the ECM with collagenase to reduce matrix
stiffness and increase porosity. To restrict these biological manipulations to the wound
interface, we fabricated a delivery system in which selected biofactors were stored inside
composite electrospun nanofibrous scaffolds and released upon hydration. The ability for
bioactive scaffolds to enhance the cellularity and integration of meniscal injuries was
vi

evaluated in vivo using tissue explants in a subcutaneous implantation model, as well as
an orthotopic meniscal injury model. Our findings suggest that matrix stiffness, density,
and organization increase with meniscal development at the expense of cell mobility. Our
results also indicate that partial digestion of the wound interface with collagenase
improves repair by creating a more compliant and porous microenvironment that facilitates
cell migration. Furthermore, when scaffolds containing collagenase-releasing fibers were
placed inside meniscal defects, enzymatic digestion was localized and resulted in
improved cellular colonization and closure of the wound site, similar to treatment with
aqueous collagenase. This innovative approach of targeted delivery may aid the many
patients that exhibit meniscal tears by promoting integrative repair, thereby circumventing
the pathologic consequences of partial meniscus removal, and may find widespread
application in the treatment of injuries to a variety of dense connective tissues.
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GM6001 group. Adapted from (Wolf et al. 2013). (C) Confocal cross-sections show cells migrating
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the annulus fibrosus of the intervertebral disc, (B) knee meniscus, and (C) ligament. (D) Top down
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within the ECM. (F) Transverse view of the circumferential collagen fibrils of the knee meniscus.
Scale = (A) 200 µm, (B) 500 µm, (C) 100 µm, and (D and F) 2 µm. Adapted from (A) (Iatridis et al.
2004), (B) (Petersen et al. 1998), (C) (Provenzano et al. 2002), and (E) (Chevrier et al. 2009).
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cells, (B) immunostaining for type I collagen (green) with DAPI nuclear counterstain (blue), and (C)
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menisci stained with Picrosirius Red (collagen) and Alcian Blue (proteoglycans). Adult tissue
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Micromechanics (elastic modulus normalized to fetal tissue, measured via AFM indentation) and
bulk mechanics (compressive equilibrium modulus) of fetal, juvenile, and adult bovine meniscus.
Tissue becomes stiffer on both length scales with age. Adapted from (Ionescu et al. 2011). ....... 46
Figure 3-8: Nuclear stiffness and lamin A content increase with cell age. (A) Schematic showing
relative nuclear stiffness of stem cells as they differentiate over time. Adapted from (Swift et al.
2014). (B) Nuclear modulus and (C) lamin A content (normalized to β-actin) of fetal (Fet), juvenile
(Juv), and adult (Adu) bovine meniscal fibrochondrocytes, and juvenile bovine mesenchymal stem
cells (MSCs). Data courtesy of Claire McLeod (B) and Tristan Driscoll (C). ................................. 47
Figure 3-9: MMP-degradable hydrogels enhance cell invasion, matrix remodeling, and matrix
synthesis. (A) H&E staining of soft and stiff MMP-degradable and MMP-insensitive (Nondegradable) poly(ethylene glycol) (PEG) hydrogels implanted within rat calvarial defects. After 2
weeks, endogenous cells invade, degrade, and remodel MMP-degradable matrices in a stiffnessdependent manner. Cell invasion is homogenous in soft gels and becomes less regular in stiff gels,
and fewer cells invade Non-degradable gels. Adapted from (Ehrbar et al. 2011). (B) Schematic
showing encapsulation of human mesenchymal stem cells (hMSCs) in hyaluronic acid (HA)
hydrogels using either MMP-degradable peptides or MMP-insensitive (Non-degradable)
crosslinkers. (C) Glycosaminoglycan (GAG) and collagen content (normalized to the DNA content)
of hMSC-laden HA hydrogels after 4 weeks of in vitro culture. Adapted from (Feng et al. 2014). 51
Figure 3-10: Nanofibrous topography organizes cells and matrix. (A) Scanning electron
micrographs of aligned (top) and non-aligned (bottom) PCL scaffolds. Scale = 50 µm. (B)
Mesenchymal stem cells cultured on nanofibrous scaffolds for 7 days (green = actin, blue = nuclei).
Cells are oriented with the primary fiber axis on the aligned scaffold. Scale = 50 µm. (C) En face
section of scaffold stained after 10 weeks of in vitro culture with Picrosirius Red (collagen) and
Alcian Blue (proteoglycans). Deposited collagen is aligned with the fiber direction. Scale = 100 µm.
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Figure 3-11: Fast-degrading nanofibers in a composite scaffold increase scaffold porosity, cell
infiltration, and integration with native tissue. (A) Schematic illustrating composite PCL/PEO
scaffold with fast-degrading PEO fibers (green) and slow-degrading PCL fibers (red) before and
after removal of PEO. (B) Scanning electron micrographs of scaffold with 0% or 60% PEO content
removed. Scale = 50 µm. (C) DAPI staining showing nuclei of cell-seeded scaffolds after 12 weeks
of in vitro culture indicates enhanced cell colonization of 60% PEO scaffold. Scale = 0.5 mm. (D)
Percent of nuclei in the center of the scaffold after 12 weeks of in vitro culture. (A–D) Adapted from
(Baker et al. 2012). (E) Integration strength of PCL/PEO scaffold with native meniscus after 4 and
8 weeks of in vitro culture shows enhanced scaffold-tissue integration with 60% PEO scaffold at 8
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Figure 4-1: Aqueous collagenase treatment reduces matrix density and increases cellularity in the
adult meniscus, producing a more fetal-like tissue state. (A) Schematic of annulus and core
meniscal repair constructs. (B) H&E (left) and DAPI (right) staining of constructs after 4 weeks of
culture, where the dashed line indicates the wound interface (n=1–2/group). Scale = 0.25 mm. . 70
Figure 4-2: Improved integration and interface cellularity of adult meniscus after low- (LC) and highdose (HC) collagenase treatment, compared to controls (BM). (A) Left: 1 week µCT scans showing
low (red) and high (yellow) signal intensity correlating to matrix loss at the wound interface
(n=4/group). Scale = 1 mm. Right: 8 week PSR staining of the interface imaged under polarized
light showing improved integration with treatment (n=4/group). Scale = 0.25 mm. (B) Quantification
of % integration normalized to core perimeter (n=3–4/group), (C) cell density at the interface
(n=4/group), and (D) total DNA content per dry weight (n=6–7/group). * = p≤0.05 vs. BM. + = p≤0.05
vs. BM and LC. Line = p≤0.05 between 4 and 8 weeks. ............................................................... 71
Figure 4-3: Sacrificial PEO nanofibers deliver functional enzymes upon hydration. (A) Morphology
of cell monolayers treated with eluant from fibers containing trypsin for 60 minutes as a function of
fiber mass (n=2/group). Scale = 0.2 mm. (B) Proteoglycan removal from cartilage cylinders after 6
hours of incubation with BM or HBSS (controls) or eluant from PEO or PEO-T nanofibers
(n=3/group). Scale = 0.5 mm. (C) % AB staining of proteoglycan in cartilage cylinders as a function
of treatment group and time, normalized to BM controls (n=3/group). Dashed line indicates
treatment with 1.25% w/v trypsin for 20 minutes as a positive control. * = p≤0.05 vs. other groups
at 3 hours. ** = p≤0.05 vs. all other groups and time points. ......................................................... 72
Figure 4-4: Fabrication of enzyme-delivering nanofibrous composites. (A) SEM micrographs of
PEO (left) and PEO-HC (right) nanofibers. Scale = 5 μm. (B) Schematic of electrospinning setup
and (C) composite scaffolds produced with PEO fiber fractions that deliver enzyme. .................. 73
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Figure 4-5: Release of active collagenase from PEO fibers. (A) Combined AB and PSR staining of
cartilage cylinders after 6 hours of exposure to BM, PEO, PEO-C, or aqueous collagenase (aqC,
0.1% w/v) solution (n=4/group). Scale = 0.5 mm. (B) GAG content of cartilage cylinders as a
function of treatment and time (n=4/group). Dashed line indicates treatment with aqC for 3 hours.
* = p≤0.05 compared to other groups at 3 hours. ** = p≤0.05 compared to all other groups at 6
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Figure 4-6: Integrative repair of juvenile meniscus treated with collagenase-releasing scaffolds. (A)
Schematic of repair construct with scaffold placed inside a horizontal meniscal tear. (B) AB staining
of meniscus on day 7 with insertion of control and of collagenase-releasing composite scaffolds
(n=3/group). Scale = 5 mm. (C) DAPI staining of wound interface after 50 days of culture with
PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC scaffolds (n=2/group). Scale = 0.25 mm. (D)
Integration strength as a function of culture duration. Inset shows mechanical testing setup (n=5–
6/group). * = p≤0.05 compared to PCL/PEO-HC. Line = p≤0.05 between 25 and 50 days. ......... 75
Figure 4-7: Improved repair of adult meniscus with collagenase-releasing composite scaffolds. (A)
Repair construct schematic with annular scaffold insert. (B) AB and (C) H&E staining of constructs
containing annular PCL/PEO-LC scaffolds on day 7. Scale = 1 mm. (D) Magnified areas from (C).
Left: lack of integration at the edge occupied by the scaffold (asterisk). Right: bridging tissue in the
interior after collagenase delivery. Scale = 0.25 mm. .................................................................... 76
Figure 5-1: Partial enzymatic digestion with collagenase enhances cellular egress from meniscal
explants in vitro. (A) Alcian Blue (AB) and Picrosirius Red (PSR) staining for proteoglycans (PGs)
and collagen, respectively. Collagenase digestion removes PGs and collagens from the tissue
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staining of axial sections show cell nuclei at the interface (dashed line) after 1 week. Scale = 100
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culture. (A) Schematic of AFM nanoindentation measurements of matrix stiffness across the wound
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implantation. (A) Schematic of repair construct assembly. Scaffold is fenestrated to allow tissue-totissue contact. (B) Quantification of histological integration normalized to defect length (n=3–4
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model. (A) Schematic and photograph of surgical approach, longitudinal meniscal injury, and suture
repair with scaffold. Asterisk indicates the bone block. (B) Radial sections of the repaired meniscus
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Experimental schematic. (B) Top: SHG signal (green) of fECM and aECM. Scale = 50 µm. Bottom:
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modulus measured via AFM indentation and normalized to fECM (n=50 indentations/group, mean
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depth with schematic inset (n=15 cells/group, mean ± standard error of the mean). (D) Cumulative
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Figure 8-3: Micromechanical heterogeneity and anisotropy of fetal and adult meniscal tissues. (A)
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xxv

term delivery may require entrapment within a slow-degrading polymer shell. (C) Schematic
showing the proposed biological role of each biofactor and their time course of delivery. .......... 177
Figure 8-7. Magnet-based system for quantifying joint kinematics. (A) Experimental schematic. (B)
Magnetic field strength as a function of flexion angle (n=3–4/group, mean ± standard deviation). *
= p≤0.05 vs. all other angles. (C) Average flexion angle and (D) angular velocity for a human knee
during a gait cycle (n=10 steps, mean ± standard error of the mean). ........................................ 183
Figure 8-8: Unsupervised activity monitoring demonstrates time course of recovery in a porcine
model. (A) Distribution of activity intensity pre- and post-surgery. (B) Non-Rest Activity normalized
to the pre-operative Baseline value (red dashed line) and animal weight over 12 weeks........... 184
Figure 8-9: Dynamic range of motion during unprovoked ambulation. (A) Image of animal wearing
the device. (B) Sensor and magnet positions during gait cycle. (C) Magnetic field as a function of
flexion angle (n=3–4/group, mean ± standard deviation). * = p≤0.05 vs. all other angles. (D) Average
flexion angle during a gait cycle at Week 11 (n=10 steps, mean ± standard error of the mean). Red
line indicates neutral stance. ........................................................................................................ 185

xxvi

CHAPTER 1: INTRODUCTION

The musculoskeletal system is the fundamental scaffold that provides support for body
infrastructure and allows for physical movement. As such, orthopaedic injuries significantly
impact both quality of life and life expectancy. While some tissues, such as bone, can
remodel to pre-injury equivalence after damage, dense connective tissues, including the
knee meniscus, annulus fibrosus of the intervertebral disc, tendon, and ligament, exhibit
poor healing capacity in adults. The microstructure of these tissues (at the cell level) is
dominated by aligned collagen bundles, which provide mechanical anisotropy and greater
tensile strength in the loading direction, allowing function in mechanically demanding
environments. For example, the meniscus promotes stifle joint congruency and stability
by distributing load over a large surface area. It is mainly comprised of circumferentially
arranged collagen bundles that serve to resist tensile hoop stresses in the knee. Tears
that disrupt this collagen architecture predispose the joint to altered biomechanics and
eventually osteoarthritis. Despite the common occurrence of such injuries, there are
limited restorative strategies available (e.g. allograft replacement), and in many cases
damage culminates in a total joint replacement. An ideal alternative would be to
reestablish native tissue function by promoting cell growth, organized extracellular matrix
(ECM) production, and, most importantly, integration of the newly formed tissue via the
creation of an instructive regenerative microenvironment.

The overall goal of this thesis is to expedite dense connective tissue repair by identifying
and manipulating the cellular and ECM impediments to wound healing. This body of work
focuses on the knee meniscus, but the principles outlined within are applicable to other
fiber-reinforced soft tissues. Chapter 2 will introduce meniscus structure and function,
describe the biological limitations to intrinsic repair, and review strategies to augment the
1

healing response. Interestingly, the meniscus exhibits a robust repair capacity early in
development, but this potential declines with aging. To overcome the restricted blood
supply and sparse cell population of the mature meniscus, most experimental therapies
attempt to directly boost the vascularity and cellularity at the defect. Others strategies seek
to increase the anabolic activity of resident cells via the provision of biochemical and
mechanical cues.

While several of these studies appear promising, few address the biophysical barrier of
the ECM itself, which may affect the interstitial migration of endogenous cells to the injury
site and subsequent repair. The cellular and extracellular determinants of 3D migration, a
complex set of interdependent factors absent from 2D migration, will be detailed in
Chapter 3. This chapter begins by discussing the basic mechanisms of cell locomotion in
confined 3D environments and constraints to mobility posed by the cell and its
environment. The remaining sections explore the implication of 3D migration in fibrous
tissue repair and tissue engineering, processes that rely on a sufficient population of cells
to produce, remodel, and maintain the ECM. While tissues and scaffolds are optimized for
mechanical function, their dense and stiff microenvironments may hinder cell mobility and
infiltration. Recent advances in biomaterial design that mitigate these issues are also
highlighted.

Building on these concepts, we hypothesized that the density and stiffness of the adult
meniscal ECM prevent cell migration to the wound margin, and that removing these
inhibitions will facilitate cell migration and tissue repair. To achieve this, we developed a
novel electrospun polymer nanofiber system from which bioactive factors are released to
initiate and enhance repair. The challenges of this project are two-fold: first, to create a
local wound environment favorable to cell migration by delivering a matrix-degrading
2

enzyme, and second, to enforce and instruct matrix deposition in the regenerate tissue
that bridges the wound interface with a structural scaffold. Chapter 4 investigates the effect
of partial digestion of the wound interface with the enzyme collagenase on meniscal repair
using a tissue explant model. Additionally, a technique to fabricate bioactive, enzymedelivering nanofibers that can modulate tissue properties is presented. Chapter 5, which
continues this work in vivo, assesses the use of composite collagenase-releasing
scaffolds to enhance meniscal repair in a subcutaneous implantation model (rat) and an
orthotopic meniscal defect model (sheep). These studies demonstrate that partial
degradation of the wound margin leads to local micromechanical and microstructural
changes in the ECM, which becomes more compliant and porous. A targeted burst release
of collagenase from nanofibrous scaffolds localizes this effect to the tissue margin.
Importantly, enzyme treatment results in higher cell density and physical integration of the
meniscal wound interface, suggesting that endogenous cells are capable of repair when
the steric impediments of the ECM are reduced.

To better comprehend this mechanism on the microscale, a method to visualize and
quantify interstitial cell migration through native tissue is developed in Chapter 6. Here,
the influence of the tissue microenvironment on migratory efficacy is investigated using
fetal, adult, and adult meniscal tissue substrates with and without pre-digestion with
collagenase.

Results

suggest

that

age-related

biophysical

changes

to

the

microenvironment affect cell migration, which may partly explain the differential repair
capacity of fetal and adult tissues. This work confirms that cell mobility is extremely limited
in the adult meniscus, but can be enhanced by modulating tissue stiffness and density via
enzymatic digestion.
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In addition to enabling cell mobility, scaffolds may be further functionalized to deliver
biochemical signals that guide native cells to the injury site. Chapter 7 explores the
application of a soluble chemoattractant to trigger directed cell migration to the wound site
after matrix degradation. A novel tissue-based migration chamber to study interstitial
chemotaxis is designed for this purpose. To determine whether aging also changes a cell’s
intrinsic mobility, the ability of fetal and adult meniscal cells to translocate through
increasingly small pores is evaluated, along with other biophysical features of the cell.
Platelet-derived growth factor-AB (PDGF-AB) is identified as a chemoattractant for cells
of both ages, as well as its dose-dependent and pore-size dependent impact on cell
migration. Further, fetal cells appear more mobile than adult cells, potentially due to their
smaller and more deformable nuclei. Finally, this chapter details the development of a tricomponent nanofibrous scaffold that delivers collagenase, PDGF-AB, or both biofactors
in a temporally controlled manner. Cell infiltration into these nanofibrous composites is
assessed in vitro prior to their evaluation in a subcutaneous implantation model. As
expected, cell migration into scaffolds is limited by nanofiber density and inter-fiber pore
size. In vivo results indicate that local PDGF-AB delivery alone can enhance cellularity at
the wound interface in the short-term, but that collagenase-mediated reprogramming of
the ECM may be essential for cell invasion of the scaffold in the long-term. Taken together,
these findings illustrate the importance of biophysical barriers to interstitial migration, as
well as the feasibility of delivering multiple agents in a staged fashion to prime the wound
microenvironment for repair.

Finally, Chapter 8 provides a summary of the findings herein and describes their impact
on dense connective tissue repair and the current understanding of cell behavior in
physiologic 3D environments. The limitations and future directions of this research are
also discussed, a testament to the exploratory nature of this work.
4

CHAPTER 2: BASIC SCIENCE OF MENISCUS REPAIR: LIMITATIONS AND
EMERGING STRATEGIES

2.1

Abstract

Meniscal tears, especially in the inner avascular zone, have limited healing capacity and
a high failure rate when repair is attempted. Endogenous repair, characterized by cell
proliferation and matrix deposition at the injury site, is hindered by a lack of vascular
supply, low cell density, and a catabolic state induced by inflammation. To biologically
augment the healing response, experimental methods have focused on directly
addressing these issues by enhancing vascularity, increasing cellularity, and providing an
instructive extracellular environment via biochemical and mechanical cues. With further
clinical development, these emerging regenerative strategies have potential to render
meniscal repair a favorable operation in patients who would otherwise undergo partial
meniscectomy (removal of the damaged segment).

2.2

Introduction

The meniscus, a semilunar fibrocartilaginous tissue located between the femur and tibia,
is essential to the mechanical functionality of the knee (Figure 2-1). Besides contributing
to joint congruency, stability, shock absorption, and lubrication (Ghosh et al. 1987), it plays
a significant role in tibiofemoral load bearing (Shrive et al. 1978). The meniscal
extracellular matrix (ECM) contains 85–95% dry weight collagen, of which over 90% is
fibrillar type I collagen (Eyre et al. 1983). The remaining dry weight components include
types II, III, V, and VI collagens (1–2%) (McDevitt et al. 1992) and proteoglycans (<2–3%)
(Adams et al. 1992), with water making up 72–77% of the tissue wet weight (Adams et al.
1992). A sparse population of resident cells, collectively known as meniscal
fibrochondrocytes (MFCs), maintains and remodels the ECM via a balance of matrix
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synthesis and catabolism by matrix metalloproteinases (Upton et al. 2003, Verdonk et al.
2005).

Figure 2-1: Anatomy of the knee meniscus. Anterior (left) and top-down (right) views of the
medial and lateral menisci within the knee joint. Adapted from www.aaos.org (left) and
(Pagnani et al. 1995) (right).

The ultrastructure and biochemical content of the meniscus vary with anatomical location
and illustrate the tissue’s adaptations to regional mechanical demands. A meshwork of
thin fibrils cover the superficial surface, underneath which lies a lamellar layer of radially
distributed fibers (Petersen et al. 1998). Within the tissue center, the circumferentially
aligned type I collagen fibers, the primary component of the ECM, give rise to anisotropic
(direction dependent) mechanical properties that allow the meniscus to bear greater
tensile forces along the fiber direction (Fithian et al. 1990) (Figure 2-2B). During axial
loading, the meniscus is displaced radially and converts compressive stresses from the
femur to tensile hoop stresses that are transmitted to the circumferential collagen fibers
and the horn attachments to the tibial plateau (Shrive et al. 1978) (Figure 2-2A). A small
fraction of interdigitating radial ‘tie’ fibers constrains the main fiber bundles (Skaggs et al.
1994) and may aid in local strain transmission (Lai et al. 2010) (Figure 2-2B). During
normal physiological loading conditions, bulk tensile strains are in the range of 2–6%
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(Jones et al. 1996, Richards et al. 2003), with the tissue transmitting 50% of the load in
the knee at full extension and 85% of the load at 90º flexion (Ahmed et al. 1983). The
circumferential tensile modulus ranges from 48–259 MPa, whereas the radial modulus is
much lower (3–70 MPa) (Bullough et al. 1970, LeRoux et al. 2002, Proctor et al. 1989)
(Figure 2-2C). Consequently, the meniscus offers less resistance to radial shear forces
and is predisposed to longitudinal tears (Kawamura et al. 2003).

Figure 2-2: Anisotropic collagen organization of the extracellular matrix enhances
mechanical functionality of the knee meniscus. (A) During axial loading, the meniscus is
displaced radially and converts compressive stresses from the femur to tensile hoop
stresses (Fc) born by the circumferential collagen fibers and the horn attachments to the
tibial plateau. However, lower tensile modulus in the radial direction results in poor
resistance to radial shear forces (Fr). Adapted from (Kawamura et al. 2003). (B) Schematic
showing the dominant circumferential collagen fiber organization of the meniscus, with an
interspersion of radial ‘tie’ fibers. (C) Schematic of circumferential (Circ) and radial (Rad)
meniscal samples for tensile testing. Circ samples have >3x higher tensile modulus than
Rad samples, demonstrating mechanical anisotropy. Adapted from (LeRoux et al. 2002).
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Load-bearing

capability

decreases when

the fiber-reinforced microstructure is

compromised, consequently increasing tibiofemoral contact pressures and predisposing
the joint to degenerative osteoarthritis (OA). The incidence of meniscal tears is reported
to be 60–70 per 100,000 persons (Hede et al. 1992, Nielsen et al. 1991) and accounts for
over 1 million arthroscopic procedures each year (Hasan et al. 2014). While repair success
ranges from 63% to 91% for simple peripheral tears (Boyd et al. 2003, DeHaven 1999,
Eggli et al. 1995, Hanks et al. 1991, Miller 1988, Morgan et al. 1991), tears in the inner
avascular zone of the meniscus have a much poorer prognosis, with up to 75% failing to
heal completely and 20% requiring repeat surgery (Rubman et al. 1998).

Figure 2-3: Surgical approaches to meniscal injuries. (A) Arthroscopic image of a suture
repair. Repairs stabilize simple tears but rarely result in tissue integration. (B) Illustration of
partial resection of damaged tissue. Tissue removal alters joint loading and causes cartilage
degradation (C) Replacement options such as allografts or engineered implants restore
function in the short-term, but their long-term benefits are unclear. Images courtesy of (A)
www.tarlowknee.com, (B) www.cartilagerestoration.org, and (C) www.medimagery.net and
www.ivysportsmed.com.
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Partial meniscectomy is the standard treatment after repair failure (Figure 2-3), yet tissue
resection also leads to osteoarthritic changes in the affected knee compartment (Aagaard
et al. 1999, Englund 2004, Fairbank 1948). Furthermore it appears that degenerative
changes positively correlate with amount of meniscal resection. When the tissue is
damaged beyond repair, it is completely removed (total meniscectomy). Current
replacement strategies include meniscal allograft transplants or engineered substitutes
(e.g., collagen or polyurethane scaffolds) (Figure 2-3), although the long-term outcome
of these relatively new therapies is unclear (Rongen et al. 2015, Smith et al. 2015,
Vrancken et al. 2012). As such, methods that improve meniscal repair or salvage would
be a marked advance to the treatment of this common injury.
This chapter will begin by reviewing the basic science understanding of the limited
endogenous healing capacity of the meniscus, with an emphasis on the implications of
hypovascularity, hypocellularity, and inflammation at the tear site. Following this
discussion, we will describe extant and emerging regenerative medicine approaches that
are designed to directly address these issues. This section will include a review of repair
strategies and experimental methods that are aimed at 1) enhancing vascularity, 2)
increasing cellularity, and 3) promoting matrix deposition and new tissue formation via
biochemical and/or mechanical cues at the wound site.

2.3

Endogenous Limitations to Meniscal Repair

Multiple factors influence the intrinsic healing capacity of meniscus, the most significant
being zonal differences in vascularity, alterations in matrix composition and density,
insufficient cellular density, and other soluble and mechanical factors (Figure 2-4). Each
of these factors is described below as they relate to compromised endogenous healing in
the adult meniscus.
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Figure 2-4: Schematic of a horizontal meniscal tear highlighting the limitations to repair
(hypovascularity, hypocellularity, and inflammation) and pro-repair strategies, including
enhancing vascularity (angiogenesis, fibrin clot, vascularized graft or conduit), improving
cellularity (recruitment or delivery), and generating an instructive environment via
biochemical (inflammatory inhibitors and anabolic growth factors) and mechanical cues
(dynamic loading).

2.3.1

Vascular Supply

Healing is characterized by cellular invasion into the defect, with subsequent proliferation,
ECM remodeling, and synthesis of new matrix proteins to bridge the wound gap. Thus,
the availability of a vascular supply that can deliver regenerative cells, nutrients, and
growth factors, is likely to be crucial to a successful repair response. The region-specific
healing that is seen clinically is largely attributed to degrees of vascularity, where limited
vascularization precludes the formation of a fibrin clot that stimulates cellular infiltration
and matrix remodeling in the inner, avascular zones of the tissue. Since vessels from the
perimeniscal capillary plexus fail to penetrate past the peripheral one-third of the meniscus
in the adult (red-red zone) (Arnoczky et al. 1982, Day et al. 1985) (Figure 2-6A), this
10

results in an inner avascular zone (white-white zone) with poor healing capacity (Arnoczky
et al. 1983, Ghadially et al. 1986, Heatley 1980, King 1936). Junctional tears (red-white
zone), as expected, possess intermediate healing capacity. Thus, attempted repair of an
avascular tear has a high failure rate and is generally not recommended despite the
pathological consequences of partial meniscus removal (Greis et al. 2002, Noyes et al.
2012).

2.3.2

Cell and Matrix Density

The presence of a sufficient number of cells at the wound interface is also critical in the
healing response. Meniscal cells normally are responsible for maintaining tissue structure,
an active process wherein the ECM is continuously being remodeled due to physiologic
loading. These same cells can respond to injury or altered loading by upregulating
production of matrix proteins and/or enzymes to affect repair. However, cellularity
decreases progressively with maturation until a low cell density is reached in the adult
(Figure 2-5A) (Clark et al. 1983, Ionescu et al. 2011). Along with a loss in cellularity,
collagen and proteoglycan content increase with age, increasing the overall ECM density
and compressive modulus (Figure 2-5A and Figure 2-5B). The lack of viable cell density
in older patients renders them more susceptible to meniscal degeneration and re-tear after
repair (Mesiha et al. 2007) (Figure 2-5C and Figure 2-5D). Furthermore, the increased
ECM density likely reduces the capacity of endogenous cells to migrate and remodel the
tissue after injury (Clark et al. 1983, Ionescu et al. 2011).
In addition to changes that occur with maturation, there are also zonal differences of the
cells within the meniscus itself. A superior healing response is often seen in the peripheral
region, even after eliminating contributions from the microvasculature and synovium,
indicating that there may be intrinsic zonal cellular differences that influence repair
(Kobayashi et al. 2004). Cell morphology and gene expression vary with meniscal region,
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with fusiform cells located superficially, fibroblast-like cells in the fibrous periphery, and
chondrocyte-like cells in the inner fibrocartilage (Fuller et al. 2012, Hellio Le Graverand et
al. 2001, McDevitt et al. 2002, Upton et al. 2006a). ECM components also differ by region,
where the outer portion consists mainly of type I collagen to resist tensile stresses and the
inner portion has a greater percentage of type II collagen and proteoglycans, which are
more resistant to compressive forces (McDevitt et al. 1992) (Figure 2-5A). As a result,
there are zonal differences in regenerative mechanisms, sensitivity to cytokines, and
response to growth factors (Fuller et al. 2012).

Figure 2-5: Meniscal properties change with age, contributing to a reduced integrative
potential in mature patients. (A) Matrix proteoglycan content and collagen density increase
in the adult meniscus (arrow indicates the inner zone’s concentration of proteoglycans)
while cellularity decreases compared to fetal meniscus (dashed line indicates wound
interface). Adapted from (Ionescu et al. 2011) and (Qu et al. 2013). (B) The compressive
modulus of adult bovine meniscus is greater than that of fetal meniscus. Adapted from
(Ionescu et al. 2011). (C) Integration is tested by pushing a cylindrical core out from a
surrounding annulus. (D) Integration strength for adult meniscus is lower than fetal
meniscus and does not improve with time in culture. Adapted from (Ionescu et al. 2011).
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2.3.3

Soluble and Mechanical Factors

Meniscal healing is also affected by soluble and mechanical cues. Inflammatory cytokines
that are up-regulated post-injury, especially interleukin-1β (IL-1β) and tumor necrosis
factor α (TNFα), inhibit integrative repair (McNulty et al. 2007). Specifically, IL-1β
increases the expression of matrix metalloproteinases (MMPs), catabolic enzymes that
cleave collagens and other ECM components (McNulty et al. 2009). On the other hand,
cells are stimulated to proliferate and produce matrix when exposed to anabolic growth
factors. Mechanical loading, such as static or dynamic compression, can also alter gene
expression and modulate inflammation (McNulty et al. 2010, Upton et al. 2003). Thus,
introduction of bioactive factors that reduce inflammation and potentiate anabolism and/or
loading of the extracellular milieu has the potential to create a matrix-forming environment
more conducive to repair.

2.4

Emerging Strategies to Promote Meniscal Repair

Numerous techniques have been investigated to address the biologic issues of suboptimal
meniscal healing and to improve repair (Figure 2-4). One approach is to enhance
vascularity by increasing access to pre-existing vasculature or promoting neovascularization to improve delivery of nutrients, reparative cells, and growth factors to the
wound site (Figure 2-6). Another method is to improve the cellularity of the interface by
recruiting endogenous cells or introducing exogenous cells (Figure 2-7). A related
approach is to then encourage the cell population to proliferate and increase matrix
synthesis by introducing soluble factors and/or mechanical stimulation that promote
anabolic activity and inhibit inflammation (Figure 2-8). These experimental strategies to
enhance integrative repair will be discussed in the following sections.
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2.4.1

Methods to Enhance Vascularity

Inability of the avascular, inner portion of the meniscus to heal has driven the impetus to
investigate means to enhance vascularity via surgical approaches (Figure 2-6). These
approaches include mechanical rasping, trephination, and the introduction of vascularized
grafts to the wound site. Partial removal of the wound interface by abrasion has been
shown to encourage vascularization by inducing production and release of growth factors
and cytokines beneficial to healing (Ochi et al. 2001, Okuda et al. 1999). This technique
has been used experimentally to repair longitudinal meniscal tears of the avascular zone
in rabbits and humans, although it was reported that success was dependent on the
distance of the joint capsule to the tear site as well as the size and stability of the tear,
indicating that proximity of a vascularized source was still necessary (Uchio et al. 2003).
This problem can be addressed by creating vascular ‘access’ channels that connect the
inner zone to the peripheral vasculature (Figure 2-6B). The provision of a such a vascular
conduit was pioneered separately by Gershuni et al. (Gershuni et al. 1989) and Zhang et
al. (Zhang et al. 1995, Zhang et al. 1988) in animal models. However, trephined channels
are prone to collapse during normal physiologic loading, and the removal of meniscal
cores can disrupt the aligned collagen fibers and further destabilize meniscal architecture.
In a prospective study, Zhang et al. found that symptomatic re-tear rates decreased after
combining arthroscopic trephination with suturing to ensure stability, but healing was not
evaluated (Zhang et al. 1996). To maintain biomechanical integrity after core removal,
Cook et al. developed a bioabsorbable conduit composed of poly(l-lactic) acid that allowed
for fibrovascular tissue ingrowth, which proved superior to trephination alone in a canine
model (Cook et al. 2007) (Figure 2-6C).
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Figure 2-6: Lack of vasculature in the inner meniscus (white-white zone) results in limited
healing after injury. (A) Vascular perfusion shows the perimeniscal capillary plexus (PCP)
of the medial meniscus. Adapted from (Arnoczky et al. 1982). Strategies to enhance
vascularity include increasing vascular access via a trephine/conduit or synovial graft,
promoting angiogenesis, and introducing vascular elements. (B) Trephine/conduit
schematic. (C) Tissue and vascular ingrowth using bioabsorbable conduit. Adapted from
(Cook et al. 2007). (D) Synovial graft placed above meniscal allograft results in
vascularization after 8 weeks as seen by microangiography. Adapted from (Yamazaki et al.
2003). (E) Factor VIII immunostaining indicates early vessel formation in meniscus repaired
with VEGF-coated sutures. Adapted from (Petersen et al. 2007). (F) Fibrin clot placed into
meniscal tear with sutures. Adapted from (Sethi et al. 2003).

Alternatively, parameniscal synovial abrasion can be applied to increase vascularity and
provide chemotactic factors up to 5 mm from the outer meniscal rim (Henning et al. 1987).
Vascularized synovial flaps can also be placed within the meniscal defect to provide both
a blood supply and a source of synoviocytes that can infiltrate the wound site and lay down
matrix to bridge the gap (Gershuni et al. 1989, Ghadially et al. 1986, Jitsuiki et al. 1994,
Ochi et al. 1996) (Figure 2-6D). Indeed, interpositional free synovial autografts can
improve integration in vitro despite these grafts lacking connections to the systemic
vasculature in this model. This indicates that the mechanism of action may be in provision
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of an added source of regenerative cells or by the graft itself acting as a scaffold for cell
migration (Ochi et al. 1996, Yamazaki et al. 2003). In fact, it is thought that superficial cells
of the meniscus originated from the synovium and that these cells may be implicated in
meniscal healing (Hu et al. 2001, Kambic et al. 2000).
To enhance vascularity without surgically removing or introducing tissue, angiogenic
factors such as vascular endothelial growth factor (VEGF) (Kopf et al. 2010, Petersen et
al. 2007) and angiogenin (King et al. 1991) have been utilized to promote neovascularization (new vessel formation) at the site of repair. VEGF is a potent endothelial
cell chemokine and mitogen that induces formation of new capillaries when delivered at
high concentrations (Phillips et al. 1994), whereas angiogenin interacts with both
endothelial and smooth muscle cells to promote formation of vascular structures (Gao et
al. 2008). Although angiogenin was found to promote neo-vascularization of the avascular
zone in rabbits, two sheep studies investigating the application of VEGF released through
poly(d,l-lactide) acid suture coatings concluded that local treatment with VEGF did not
enhance meniscal angiogenesis or healing in either the vascular or avascular zone (Kopf
et al. 2010, Petersen et al. 2007) (Figure 2-6E). In these latter studies, the authors
speculated that a longer duration of growth factor delivery, using a combination of several
angiogenic factors involved in vessel wall assembly, may be necessary. These issues
could be addressed by using a composite scaffold, where discrete components can be
incorporated to release multiple bioactive factors with differing temporal release profiles
(Richardson et al. 2001). For instance, Ionescu et al. recently developed an electrospun
scaffold for fibrous connective tissue engineering that releases VEGF rapidly from watersoluble poly(ethylene oxide) nanofibers and gradually from embedded poly(lactic-coglycolic acid) microspheres (Ionescu et al. 2012a). Using this versatile platform of gradual
elution, a combination of VEGF, angiogenin, platelet-derived growth factor, and/or
angiopoietin may be used to promote neovascularization.
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Endogenous cells can also be acquired from the vasculature to increase cellularity and
stimulate healing at the wound site, either via the introduction of a fibrin clot or through
microfracture of the underlying bone. It has been argued that it is the hematoma and
consequent clotting, rather than the continuous bloody supply, that are critical to the
induction of a repair response (Webber et al. 1985). Acting as a source of reparative cells,
growth factors, and temporary matrix, exogenous fibrin clots can be precipitated and
inserted into meniscal defects to stimulate a healing response (Arnoczky et al. 1988,
Henning et al. 1990, Henning et al. 1991, Nakhostine et al. 1991, van Trommel et al.
1998). In a canine model, Arnockzy et al. found that meniscal defects filled with fibrin clots
remodeled into fibrocartilage with chondroid cells after six months, although the reparative
tissue could still be histologically distinguished from native tissue (Arnoczky et al. 1988).
Clinical repair of acute, isolated meniscal tears, including complete radial tears that cross
avascular regions, were also improved after clot injection (Henning et al. 1990, Ra et al.
2012, van Trommel et al. 1998). Despite some experimental success, fibrin clots have not
been widely adopted because they are difficult to place arthroscopically and are often
destroyed or lost during the insertion process. To prevent loss after placement, the fibrin
clot can be covered by a fascia sheath (Henning et al. 1991) or secured by a suture (Jang
et al. 2011) (Figure 2-6F). A minimally invasive intra-articular method to create a fibrin clot
in situ was also developed to bypass the difficulty of clot acquisition and placement (Sethi
et al. 2003). Similarly, an artificial hematoma that releases marrow elements into the joint
space via microfracture of the intercondylar notch can expedite early recovery (Driscoll et
al. 2012, Freedman et al. 2003). To attract and protect endogenous fibrin clots and other
host elements after hemarthrosis, small intestine submucosal grafts may be used to
promote cellular attachment and expedite regeneration (Bradley et al. 2007, Cook et al.
2006, Fox et al. 2004, Gastel et al. 2001).
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2.4.2

Methods to Improve Cellularity

While strategies for enhancing vascularization are promising, a more established
approach is to harvest and deliver therapeutic cells to the wound site, independent of the
blood supply (Figure 2-7). Cells can be recruited from adjacent tissues, injected directly
into the lesion, or delivered via a scaffold to improve the intrinsically low cellularity of the
native tissue. Ideally, cells should be autologous and abundant, easily acquired and
expanded in vitro, and able to produce fibrocartilaginous matrix (Hoben et al. 2006). The
success of autologous chondrocyte implantation (ACI) for cartilage repair demonstrates
that cell therapy is clinically feasible and could be adapted to improve meniscal repair. Of
particular interest for such applications are synoviocytes, chondrocytes, and meniscal
cells, as well as multipotent mesenchymal stem cells (MSCs) that can differentiate into a
meniscal-like cell phenotype.
Located just adjacent to the meniscus, fibroblast-like type B synoviocytes produce matrix
proteins such as collagen and hyaluronan for the intimal interstitium (Iwanaga et al. 2000).
Studies by Arnoczky et al. have demonstrated that these cells can cross the synoviomeniscal boundary to reach the wound site and contribute to the repair process (Arnoczky
et al. 1985). It is also likely that cells of synovial origin play a role in integrating free synovial
grafts (Ochi et al. 1996, Yamazaki et al. 2003) as well as repopulating meniscal allografts
(Arnoczky et al. 1992, Rodeo et al. 2000). To that end, parameniscal abrasion of the
synovial intima may liberate these cells and expedite their migration to the defect
(Nakhostine et al. 1990).
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Figure 2-7: Cellularity can be increased by (A) direct injection of cells into the lesion or (B)
delivery via a scaffold. (C) Bone marrow-derived mesenchymal stem cells seeded onto a
hyaluronan-collagen composite scaffold improved matrix production and integration in
rabbits compared to untreated and acellular groups. Adapted from (Zellner et al. 2010). SEM
image shows the integrated interface of the tissue (white arrow) and pre-cultured scaffold
(black arrow).

On the other hand, chondrocytes are typically harvested from articular cartilage, expanded
in vitro, and delivered to the lesion site seeded inside a biocompatible scaffold. When
inserted into a defect, allogenic chondrocytes improved bonding of the meniscal margins
by depositing cartilaginous matrix that integrated the scaffold, in this case devitalized
meniscus, with the native tissue (Peretti et al. 2004). In a more recent integration study,
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Weinand et al. found that auricular chondrocytes seeded onto Vicryl meshes may provide
more healing capacity than articular chondrocytes due to increased production of elastin
(Weinand et al. 2006). Unlike synoviocytes and chondrocytes, meniscal cells have been
evaluated more for their use in engineering replacement tissue than for their role in directly
modulating repair. Nevertheless, due to their ability to deposit fibrocartilage when seeded
onto 3D scaffolds, meniscal cells have potential to be used in the same way as
chondrocytes for integrative repair (Baker et al. 2009a, Freymann et al. 2012, Ibarra et al.
2000, Mueller et al. 1999, Nakata et al. 2001). Interestingly, the ability of meniscal cells to
produce ECM in vitro does not decrease with age, making meniscal surgical debris a
potential source of viable cells for implantation (Baker et al. 2009a).
Another source of regenerative cells for meniscal repair applications is undifferentiated
MSCs. These cells are capable of differentiating into chondrocytes or cells of other
mesodermal lineage if provided the appropriate biochemical and mechanical cues. MSCs
can be obtained from several sources, including bone marrow, synovium, and adipose
tissue, thus bypassing the need to harvest meniscal or chondral tissue to isolate
autologous cells. The most common technique for MSC delivery is injection either into the
joint space or directly into the tear site, which is then often closed with sutures (Figure
2-7A). Abdel-Hamid et al. found that injection of bone marrow MSCs into a meniscal tear
in a canine model improved healing by promoting angiogenesis, chondrogenesis, and
collagen fiber deposition (Abdel-Hamid et al. 2005). In rat and rabbit models, fluorescently
labeled synovium-derived MSCs injected into the joint space filled meniscal defects and
differentiated into chondrocytes that produced type II collagen (Horie et al. 2009, Horie et
al. 2012, Mizuno et al. 2008). Adipose-derived MSCs produced similar regenerative
effects when injected directly into avascular meniscal lesions in rabbits (Ruiz-Iban et al.
2011). The first human case of autologous MSC transplantation for meniscal cartilage
regeneration was done via percutaneous intra-articular injection (Centeno et al. 2008).
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Bone marrow-derived MSCs were harvested from the iliac crest, expanded in vitro, and
injected into the joint space of an osteoarthritic knee. Analysis via MRI showed evidence
of increased meniscal volume after 3 months, although a biopsy was not performed to
determine the composition of the new tissue.
Despite the promise of cell therapy, it is often difficult to localize or retain cells at the lesion
using injection alone. A study by Agung et al. tracking intra-articular injected bone marrow
MSCs with green fluorescent protein (GFP) found that MSCs must be delivered in high
numbers (1 x 107) for them to actively mobilize to the meniscus and generate extracellular
matrix at the site of injury. However, this high concentration of cells also caused the
formation of unwanted scar tissue (Agung et al. 2006) and may result in the undesirable
colonization of surrounding structures. Consequently, it may be more effective to localize
cell delivery to the region of interest with the use of a pre-seeded biodegradable scaffold
(Figure 2-7B). For example, fluorescent tracking of transplanted MSCs that were
embedded in fibrin glue demonstrated retention of cells inside the meniscal defect (Dutton
et al. 2010, Izuta et al. 2005). Other successful biomaterials that have been used include
collagen scaffolds (Pabbruwe et al. 2010) and hyaluronan-collagen composites (Zellner
et al. 2010) (Figure 2-7C). It is important to note that while pre-culture of cells may
generate fibrocartilage and thus improve mechanical properties, formation of new tissue
also could inhibit integration of the scaffold in vivo (Ionescu et al. 2013, Zellner et al. 2010).
Thus, while there are still many factors to optimize for cell-based treatments, there is
strong evidence that viable autologous cells, and MSCs in particular, can significantly
augment meniscal healing.

2.4.3

Influence of Soluble Factors

The mere presence of viable cells at the wound site does not in and of itself guarantee a
robust repair response. To expedite the healing process, cells should be in a non21

inflammatory, instructive environment that encourages proliferation and synthesis of
extracellular matrix. McNulty et al. demonstrated that inhibition of inflammatory cytokines
IL-1 and TNFα with IL-1 receptor antagonist (IL-1ra) and anti-TNFα monocolonal antibody
(TNFα mAB), respectively, as well as inhibition of matrix metalloproteinase (MMP) activity
improved the integration strength of meniscal explants in vitro (McNulty et al. 2007,
McNulty et al. 2009) (Figure 2-8A and Table 2-1). MMP inhibitors, such as tetracycline,
hold promise as agents that may potentiate meniscal healing.
Conversely, growth factors such as transforming growth factor-beta (TGF-β) (Collier et al.
1995, Esparza et al. 2012, Imler et al. 2004, Ionescu et al. 2012b, Kasemkijwattana et al.
2000, McNulty et al. 2008), platelet-derived growth factor-AB (PDGF-AB) (Bhargava et al.
1999, Imler et al. 2004, Kasemkijwattana et al. 2000, Lietman et al. 2003, Spindler et al.
1995, Tumia et al. 2009), insulin-like growth factor-1 (IGF-1) (Bhargava et al. 1999,
Esparza et al. 2012, Imler et al. 2004, Kasemkijwattana et al. 2000, Tumia et al. 2004b),
and basic fibroblast growth factor (bFGF) (Esparza et al. 2012, Imler et al. 2004, Narita et
al. 2009, Tumia et al. 2004a, Webber et al. 1985), have been investigated for their
mitogenic and anabolic effects on meniscal cells (Table 2-1). Since integrative strength is
correlated with collagen deposition and crosslinking (DiMicco et al. 2002), the most
significant improvement occurs when ECM synthesis increases as a result of growth factor
stimulation. Throughout the literature, the most successful growth factor for increasing cell
division and proteoglycan and collagen production in cell cultures and tissue explants in
vitro is TGF-β1 (Imler et al. 2004). McNulty et al. found that TGF-β1 supplementation
increases the interfacial shear strength of meniscal explants enough to overcome the
catabolic effects of IL-1-mediated MMP activity (McNulty et al. 2008). TGF-β3 has also
been investigated for its pro-matrix effects and has been shown to improve the integration
of juvenile and adult meniscal explants when delivered continuously over time in vitro
(Ionescu et al. 2012b) (Figure 2-8C).
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Growth
factor

TGF-β

Cellular effect

Potent stimulator of
matrix deposition

Integrative
potential

Method(s)

Increased

Monolayer (Collier et al.
1995, Esparza et al. 2012,
Kasemkijwattana et al.
2000), Explant (Collier et al.
1995) (Ionescu et al.
2012b) (Imler et al. 2004,
McNulty et al. 2008),
Scaffold (Ionescu et al.
2012b)

PDGF-AB
Intermediate stimulator
of matrix deposition,
proliferation, and
migration

No data

Monolayer (Bhargava et al.
1999, Kasemkijwattana et
al. 2000, Tumia et al. 2009),
Explant (Imler et al. 2004,
Lietman et al. 2003,
Spindler et al. 1995)

IGF-1

Monolayer (Bhargava et al.
1999, Esparza et al. 2012,
Kasemkijwattana et al.
2000, Tumia et al. 2004b),
Explant (Imler et al. 2004)

bFGF

No effect

Monolayer (Esparza et al.
2012, Kasemkijwattana et
al. 2000, Tumia et al.
2004a, Webber et al. 1985),
Explant (Imler et al. 2004,
Ionescu et al. 2012b, Narita
et al. 2009), Scaffold
(Ionescu et al. 2012b)

Integrative
potential

Method(s)

Potent stimulator of
proliferation

Inflammatory Cellular and/or
inhibitor
environmental effect
IL-1ra

Receptor antagonist
competitively blocks IL1 receptor

Increased

Explant (McNulty et al.
2007)

Anti-TNF
mAB

Monoclonal antibody
binds and inhibits TNFα

Increased

Explant (McNulty et al.
2007)

MMP inhibitor
GM 6001

Broad-spectrum MMP
inhibitor

Increased

Explant (McNulty et al.
2009)

Table 2-1: Biologic factors of interest for meniscal repair and their effect on meniscal cell
behavior and impact on integrative potential.
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Growth factors of intermediate efficacy include PDGF-AB and IGF-1 (Imler et al. 2004).
PDGF-AB also induces meniscal cell migration (Bhargava et al. 1999) as well as
proteoglycan production (Imler et al. 2004, Lietman et al. 2003), making it an attractive
agent for recruiting endogenous cells to the wound margin. However, region-specific
response to PDGF-AB has been reported, where proliferation increased within meniscal
explants from peripheral zone but not so in central region, possibly due to local variation
in growth factor receptors (Spindler et al. 1995). Subsequent studies found that meniscal
cells from all zones show a proliferative response in monolayer culture, suggesting that
regional matrix sequestration of soluble factors may be the cause instead (Bhargava et al.
1999, Tumia et al. 2009). IGF-1 supplementation similarly enhances cellularity and ECM
synthesis, and is especially stimulatory for cells in the inner avascular zone (Tumia et al.
2004b). Less successful have been growth factors that stimulate proliferation but little to
no increase in matrix protein production, such as bFGF (Esparza et al. 2012, Imler et al.
2004, Ionescu et al. 2012b, Kasemkijwattana et al. 2000, Tumia et al. 2004a, Webber et
al. 1985), perhaps because less resources are devoted to repair when cells are in a mitotic
state (Figure 2-8C). In this case, it may be beneficial to deliver a mitogen over the shortterm, coupled with sustained delivery of a pro-matrix growth factor either via drugreleasing scaffolds or sutures, or gene transfer to ensure long-term stability.

2.4.4

Influence of Mechanical Factors

Inflammation and matrix production, and therefore the repair outcome, is also mechanoresponsive. Meniscal cell gene expression controlling the balance of structural protein
synthesis and degradation can be altered by mechanical stimuli, such as tensile and
compressive loading. Meniscal cells in monolayer respond to cyclic biaxial stretch by
increasing matrix protein biosynthesis (Upton et al. 2006b). MSCs cultured in nanofibrous
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scaffolds respond similarly to dynamic tensile loading, with improvements in matrix
production and tensile modulus in engineered fibrocartilage (Baker et al. 2011). In studies
done with meniscal explants, static but not dynamic compression increased MMP activity
and inhibited matrix production, even in the presence of anabolic growth factors (Imler et
al. 2004, Upton et al. 2003). In fact, cyclic loading was required for meniscal homeostasis
(Natsu-Ume et al. 2005) and treatment with dynamic compression antagonized the
catabolic effects of IL-1-mediated MMP degradation and consequent glycosaminoglycan
release in meniscal explants (McNulty et al. 2010) (Figure 2-8C). Nonetheless,
overloading the meniscus at high strains (10–20%) (Zielinska et al. 2009) or high strain
rates (50%/s) may cause cell lysis and tissue damage that is physically undetectable
(Nishimuta et al. 2012). These studies clearly show that the mechanical environment can
synergize with the biochemical environment to promote (or delay) repair, depending on
the duration and degree of loading applied.
These effects of mechanical forces on meniscal repair are also seen in vivo. For instance,
prolonged cast immobilization prevented collagen production in a canine model, indicating
that normal joint mobility is essential to encourage meniscal healing (Dowdy et al. 1995).
Furthermore, immobilization significantly reduced blood flow post-injury in rabbits and
promoted menisci degeneration (Bray et al. 2001, Huang et al. 1991, Ochi et al. 1997). A
sheep study yielded similar findings, where weight-bearing menisci supported more load
than those that were immobilized after suture repair (Guisasola et al. 2002). Collectively,
these results suggest that controlled mobilization should be initiated as soon as possible
after repair to encourage long-term healing of isolated lesions, although rehabilitation
should be passive or at a low, controlled intensity to prevent tear destabilization and intraarticular damage in the immediate post-operative period.
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Figure 2-8: Modification of the environment via biochemical and mechanical cues can
augment integration. (A) The addition of IL-1 receptor antagonist (IL-1ra) in the presence of
inflammatory cytokine IL-1 increases integrative shear strength of porcine meniscus in
vitro. Adapted from (McNulty et al. 2007). (B) The application of dynamic loading increases
integrative shear strength of porcine meniscus in vitro, overriding the catabolic effects of
IL-1. Adapted from (McNulty et al. 2010). (C) Supplementation with the pro-matrix growth
factor TGF-β3 improves integration strength of juvenile bovine meniscus in vitro, while
addition of pro-mitotic bFGF does not enhance repair, even when applied in conjunction
with TGF-β3. Adapted from (Ionescu et al. 2012b).

2.5

Summary and Future Directions

As the negative sequelae of meniscectomy become clearer, development of novel
methods aimed at the biologic augmentation of meniscal healing has increased
tremendously in recent years. Other emerging approaches that aim to enhance repair
include high frequency stimulation (Pavlovich 1998), partial enzymatic degradation of the
wound margin (Qu et al. 2013), and pro-matrix gene therapy (Kasemkijwattana et al. 2000,
Zhang et al. 2009). The advancement of biocompatible scaffolds, either as a vehicle for
delivering cells and/or bioactive molecules or as engineered meniscal replacements, is

26

also highly promising. Such tissue engineered constructs could be used to replace large
portions of resected degenerate tissue injured beyond physical repair. Already, two
synthetic implants have been clinically approved for use in Europe, one composed of
collagen (Collagen Meniscus Implant (CMI), Ivy Sports Medicine LLC) and the other
polyurethane (Actifit®, Orteq Ltd) (Vrancken et al. 2012). However, these implants are not
tailored to match individual patient dimensions, nor do their microstructure replicate the
mechanical anisotropy seen in native meniscus. Novel approaches to generate
anatomically correct structures have recently emerged, including the use of image-guided
injection molding to replicate meniscus geometry (Ballyns et al. 2008) and the
electrospinning of circumferentially oriented nanofibers to mimic collagen alignment and
mechanical properties (Fisher et al. 2013). These engineered constructs offer promise for
replacement when endogenous repair cannot resolve the meniscal injury.
Regardless of the specific technique or application (improvement of repair or replacement
of damaged tissue), future directions will increasingly focus on combining minimally
invasive surgical stabilization with cell therapy and stimulatory environmental cues to
encourage vascularization and integration at the lesion site. As these experimental
methods for avascular tear repair become clinically available, the current standard of
partial meniscal removal will be shifted towards a paradigm of preservation and
regeneration. This transition towards regeneration and/or functional replacement has the
potential to dramatically improve long-term joint health in the many thousands of patients
who suffer from the sequelae of acute and degenerative meniscus pathology.
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CHAPTER 3: CELL MIGRATION IN 3D ENVIRONMENTS: IMPLICATIONS FOR
FIBROUS WOUND REPAIR AND TISSUE ENGINEERING

3.1

Abstract

Cell migration in physiologic 3D microenvironments is considerably different than
migration on 2D substrates. Steric hindrances force cells to adapt to the shape of its
confines, deform past biophysical barriers, and/or remodel their pericellular matrix in order
to migrate. These issues are especially important for dense connective tissue repair,
where endogenous cells must navigate through a dense and stiff collagenous matrix to
reach the wound site. Cells infiltrating into biomimetic scaffolds face similar challenges.
This chapter will address the complexities of the 3D microenvironment from three separate
but interdependent perspectives: basic science, physiology, and tissue engineering. By
appreciating the fundamental mechanisms governing interstitial cell migration, improved
methods may emerge that maximize endogenous cell-mediated repair and regeneration.

3.2

Introduction

Cell migration plays a pivotal role in numerous physiological and pathophysiological
processes, including embryogenesis, tissue morphogenesis, immune surveillance and
inflammation, wound healing, and cancer metastasis (Franz et al. 2002). The efficacy and
mode of migration is governed by a multifaceted set of biophysical and biochemical factors
that are dependent on both cellular and extracellular matrix (ECM) properties. In the most
general sense, a net protrusive force generated by cytoskeletal contraction allows the cell
to overcome the frictional resistance from the environment and move forward (Friedl et al.
2000a). First, actin assembly at the leading edge of the cell results in cell polarization and
the formation of actin-rich protrusions, orienting it in the direction of intended movement.
Transmembrane adhesion receptors mediate interaction with the surrounding ECM,
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allowing the cell to form focal adhesions upon which to generate traction at the leading
edge. Actomyosin cytoskeletal contraction then produces tension between the leading and
trailing edges, resulting in the detachment of adhesions in the trailing edge and at last,
forward sliding of the cell rear.
While the mechanisms of migration have been probed extensively on planar substrates,
these 2D systems are not reflective of the in vivo environment, where most cells exist
within a complex and physically restrictive 3D matrix. Cells moving on 2D surfaces are not
constrained in the horizontal plane and consequently exhibit flat, well-spread
morphologies with adhesions limited to the basal surface, with their movement guided by
broad, leading lamellipodia (Friedl et al. 2000b, Friedl et al. 2010). In contrast, cells in 3D
tend to assume stellate or spindle shapes, with adhesions distributed in all directions and
cylindrical protrusions known as pseudopodia (Cukierman et al. 2001, Pathak et al. 2011).
This extra dimensionality introduces ECM density, stiffness, organization, and biochemical
composition as determinants of cell locomotion. Cells may dynamically respond to these
factors by adapting their shape, actomyosin machinery, and migration strategy (Friedl et
al. 2010). Furthermore, cells are sensitive to mechanical and chemical gradients in their
environment, which can potentiate motility and directed movement.
Understanding how cells migrate in native tissue environments is key to optimizing tissue
repair and regeneration. In the first two sections of this chapter, the different cellular and
environmental factors influencing 3D migration will be independently considered. The third
section will describe the role of interstitial migration in dense connective tissue repair and
the changes that occur during aging. Finally, current methods to enhance cell migration
into artificial scaffolds will be discussed, with an emphasis on the implications for fibrous
tissue engineering.
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3.3

Cellular Factors Affecting 3D Migration

Interstitial migration is a coordinated dance of adhesion, cytoskeletal dynamics,
deformation of the cell body and its intracellular constituents, and/or matrix remodeling.
The mode of migration is primarily dependent on the cell type. Leukocytes are ellipsoid,
deformable, and move rapidly in an ‘amoeboid’ mode, which is characterized by transient
adhesion and low contractility (Friedl et al. 2010). In contrast, spindle-shaped fibroblasts
move in a slower ‘mesenchymal’ mode, which involves the formation of focal adhesions
and contractile stress fibers. Single-cell migration is also different from collective
migration, where cellular aggregates move in a coordinated stream or sheet, relying in
part on their adhesion to one another to influence mobility (Friedl et al. 2010). Although
the rest of this chapter will focus on single-cell ‘mesenchymal’ migration, the basic
principles covered apply to all migrating cells.

3.3.1

Cell Adhesion and Mechanotransduction

Cell-matrix adhesion occurs when transmembrane receptors known as integrins engage
with ECM components. Integrins are heterodimeric proteins that consist of α and β
subunits, which bind to various ligands via specific peptide sequences (Walters et al.
2015). When integrins bind to their respective ligands, both structural and signaling
molecules are recruited to the cell membrane to form focal adhesions that join with actin
filaments to mechanically link the ECM and cytoskeleton. Focal adhesions anchor the cell
to its substrate, enabling transmission of mechanical information as the actomyosin
machinery contracts via the sliding of nonmuscle myosin II and actin filament stress fibers
(Figure 3-1A). This increase in cytoskeletal tension is transmitted back to the ECM to pull
the cell forward. Force sensation by stress fibers can also feed back to alter the focal
adhesions themselves, activating the RhoA/ROCK (Rho associated protein kinase)
pathway to increase contractility (Petrie et al. 2012). Blocking integrin-mediated adhesion,
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as well as ROCK phosphorylation of its downstream effector, myosin light chain (MLC),
reduces migration speed in a dose-dependent manner (Wolf et al. 2013) (Figure 3-1B
and Figure 3-1C).

Figure 3-1: Cell adhesion and contractility are required for 3D migration. (A)
Mechanosensing matrix rigidity via the RhoA/ROCK/myosin II axis. Adapted from (Petrie et
al. 2012). (B) Blocking cell adhesion via an anti-β1 integrin antibody (4B4, top) and
contractility via the ROCK inhibitor Y-27632 (bottom) reduces cell migration speed in
collagen gels. Cell-produced MMPs are inhibited in the GM6001 group. Adapted from (Wolf
et al. 2013).

Several studies report that migration occurs most rapidly at an intermediate adhesive
ligand density (Lautscham et al. 2015, Singh et al. 2014), similar to migration in 2D
(Palecek et al. 1997). Interestingly, focal adhesion proteins that normally form aggregates
on 2D surfaces (e.g., vinculin, paxillin, talin, α‑ actinin) remain diffuse in cells moving within
3D environments. Fraley and colleagues found that, rather than producing a single
prolonged protrusion, focal adhesions in 3D were associated with increased protrusive
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activity and matrix deformation, suggesting that cells actively engage with their
environment before selecting a route for migration (Fraley et al. 2010).

3.3.2

Nuclear Mechanics

In confined passages, cells must physically deform to move forward (Figure 3-2A). The
nucleus is considered the rate-limiting organelle in migration due to its large size and
stiffness, which is 2–4 times higher than the surrounding cytoplasm (Guilak et al. 2000).
When the nuclear cross-sectional area is >4 times the area of the constriction, cells stall
at the channel entrance and migration speed significantly declines as they enter (Friedl et
al. 2011, Lautscham et al. 2015) (Figure 3-2B). As the nucleus exits the constriction, its
velocity increases due to the dissipation of stored elastic energy. Indeed, nuclear
deformation of most cells is limited to a diameter of 3–4 μm (Wolf et al. 2013). This
limitation is partly a function of the chromatin structure, such that higher degrees of
chromatin condensation reduce nuclear plasticity and increase stiffness (Friedl et al. 2011,
Pajerowski et al. 2007). Of equal importance are type V intermediate filament proteins
called lamins that provide structure and stability to the nuclear envelope, with lamins A
and C (lamin A/C) being the major contributors to nuclear mechanics (Lammerding et al.
2006). While cells with stiff nuclei display limited migratory capacity inside dense collagen
gels, cells with compliant nuclei that lack lamin A/C, such as leukocytes and certain cancer
cells, remain highly mobile (Friedl et al. 2011, Rowat et al. 2013, Wolf et al. 2013).
Restoring nuclear plasticity by reducing lamin A/C enhances 3D migration through small
pores (Greiner et al. 2014, Harada et al. 2014), whereas overexpressing lamin A reduces
migratory capacity (Booth-Gauthier et al. 2013, Lautscham et al. 2015, Rowat et al. 2013)
(Figure 3-2C–E). Since nuclear deformation also relies on actomyosin-generated
contractility and nuclear-cytoskeletal force transmission (Driscoll et al. 2015), disrupting
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linkers of the nucleoskeleton to the cytoskeleton likewise reduces migration (Khatau et al.
2012). Alternatively, the nucleus may also act as a piston that physically
compartmentalizes the cytoplasm, such that increasing hydrostatic pressure between the
nucleus and the forward elements of the cell can act to push the cell forward (Petrie et al.
2014). It should be recognized that while the nucleus is a steric barrier to migration,
depletion of lamin beyond certain levels can make them susceptible to stress-induced cell
death, where the act of squeezing the nucleus through a small pore results in nuclear
fragmentation (Harada et al. 2014).

Figure 3-2: Nuclear stiffness is a physical impediment to interstitial cell migration. (A)
Schematic showing a cell migrating through a fibrous matrix, deforming the cell body and
nucleus as it passes through a constriction. (B) Phases of nuclear deformation: (1)
resistance, (2) local prolapse, (3) compression and gliding, and (4) rear release. Plot
illustrating nuclear velocity over time for the phases above. Scale = 5 µm. Adapted from
(Friedl et al. 2011). (C) Plot illustrating cell migration speed as a function of lamin A
expression (Knockout (KO), Wild Type (WT), Overexpression (OE)). Migration efficiency is
highest with a moderate level of lamin A KO. Adapted from (Swift et al. 2014). (D) Lamin A
KO enhances cell migration through porous barriers. Adapted from (Greiner et al. 2013). (E)
Lamin A OE reduces cell migration through microporous membranes. Adapted from (Rowat
et al. 2013).
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3.3.3

Cell-Mediated Matrix Degradation

Interstitial migration through dense or impenetrable matrices is often aided by cellproduced matrix metalloproteinases (MMPs), which cleave ECM molecules at specific
peptide sequences to generate a gap wide enough to allow for cell passage (Lu et al.
2011) (Figure 3-3). MMP expression is also mechanosensitive: it is enhanced on stiff
substrates (Haage et al. 2014, Nukuda et al. 2015) via increased focal adhesion kinase
(FAK) activity that is triggered by integrin clustering (Wu et al. 2005, Zhao et al. 2015).
Cells can likewise remodel the matrix by contact-dependent, membrane-bound MMPs or
by secretion of MMPs into the pericellular space (Friedl et al. 2000a). Cell surface binding
of MMPs, which includes MMP-2, MMP-9, and membrane-type (MT)-MMPs, localizes
proteolysis to the cell periphery, such that tube-like trails are generated behind the
migrating cell (Friedl et al. 2009). Normal fibroblasts use this method, as do malignant
neoplastic cells during metastatic invasion (Friedl et al. 2000a). In contrast, protease
secretion results in a diffuse proteolysis that reduces biophysical matrix resistance at
distances further than the cell membrane, acting to soften the tissue around pre-existing
gaps in the ECM so as to make it easier to deform during passage. This method is
commonly used in large-scale tissue remodeling events, such as morphogenesis and
wound healing, although deregulated expression of matrix-degrading enzymes can result
in collective tumor invasion (Lu et al. 2011). If cell-produced MMPs are inhibited, cells
migrate (where they can) by adapting their shape to squeeze through pre-existing pores
and by locally deforming the ECM network (Friedl et al. 2010), significantly reducing
migration speed (Raeber et al. 2007, Wolf et al. 2013, Zaman et al. 2006). However, when
pore dimensions are below the lower limit of nuclear deformation, cells become
immobilized (Wolf et al. 2013).
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Figure 3-3: Stages of interstitial migration with or without matrix remodeling. (1) Initial cell
polarization with rotation of the nucleus, (2) cellular adhesion of integrins, (3) cytoskeletal
contraction of stress fibers (red), (4a) surface localization and secretion of matrix-degrading
enzymes (green) to enlarge the matrix pores allowing for cell passage without deformation,
and (4b) non-proteolytic migration requiring deformation of the cell and nucleus. Adapted
from (Friedl et al. 2011).

3.4

Extracellular Matrix Factors Affecting 3D Migration

Synthesized by resident cells, the ECM provides shape and structure to tissues, offers
binding sites for cells and growth factors, and regulates cell behavior, intercellular
communication, and mechanical load transmission (Mouw et al. 2014). Besides water,
major

ECM

molecules

include

fibrillar

and

non-fibrillar

collagens,

elastin,

glycosaminoglycans (GAGs) (e.g., hyaluronan, chondroitin sulfate), proteoglycans (PGs)
(e.g., decorin, biglycan, aggrecan), and glycoproteins (e.g., fibronectin, laminin) (Halper
et al. 2014). Collagen and elastin fibers are the primary structural proteins in the ECM and
are important for tensile load bearing and tissue elasticity. Of note, fibrillar collagens
(especially type I collagen) are the most abundant component of connective tissues.
Single collagen molecules (tropocollagen) are organized into increasingly larger rope-like
aggregates (fibrils, fibers, fiber bundles) via covalent crosslinks and/or interactions with
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other ECM components, and are highly aligned and tightly packed in dense connective
tissues. GAGs and PGs contain hydrophilic polysaccharides with a high density of
negative charges, resulting in osmotic swelling of the tissue that imparts resistance to
compressive forces. Small leucine-rich PGs (SLRPs), including decorin and biglycan, are
also implicated in collagen fibrillogenesis, assembly, and organization (Connizzo et al.
2013). Glycoproteins reinforce the structural ECM network, as well as facilitate
connections between cells and the ECM via binding to cellular integrins (Halper et al.
2014). Within this intricate 3D environment, cells must translate extracellular stimuli into
intracellular signals that ultimately influence downstream behaviors, including migration.
Three major ECM determinants of migration will be discussed in the following sections.
These include: matrix micromechanics, matrix microstructure (fiber alignment and
density), and insoluble and soluble biochemical cues (adhesive and chemoattractive
signals).

3.4.1

Matrix Micromechanics

Variations in the biochemical composition and organization of ECM molecules give rise to
the biophysical and biological functions of different tissues (Figure 3-4). For example, the
ECM can be classified as loose connective tissue (e.g., adipose, lymphoid organs), dense
irregular connective tissue (e.g., joint capsule, fascia, dermis), or dense regular connective
tissue (e.g., meniscus, tendon/ligament) (Figure 3-4B). The mechanical properties of
biological tissues vary by length scale due to the heterogeneity and hierarchical nature of
its building blocks. To understand cellular interactions with its microenvironment, tissue
mechanics are examined on the microscale (micromechanics) rather than on the
macroscale (bulk mechanics). This is typically accomplished by indentation via atomic
force microscopy (AFM) (Kwok et al. 2014, Qu et al. 2015, Sanchez-Adams et al. 2013),
local strain tracking (Szczesny et al. 2014), or shear rheometry (Chan et al. 2008). As a
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rule of thumb, tissue collagen content, density, and alignment increase with load-bearing
capacity, resulting in higher ECM mechanical properties (i.e., Young’s modulus) (Figure
3-4C), which are often referred to colloquially as the tissue ‘stiffness’ or ‘rigidity’, although
these last two terms are actually structural properties (depend on sample size/shape) and
not inherent mechanical properties (independent of a tissue size/shape).

Figure 3-4: Collagen content and organization of native tissues. (A) Collagen content (µg/mg
wet weight) of various mouse and bovine tissues. Data adapted from QuickZyme
Biosciences (www.quickzyme.com). (B) Matrix density and organization of loose connective
tissue (lymph gland, Methenamine Silver/Mallory Trichome), dense irregular connective
tissue (dermis, H&E), and dense regular connective tissue (tendon, H&E). Adapted from
Histology Guide, University of Leeds (www.histology.leeds.ac.uk). (C) Type I collagen
content and corresponding stiffness of various mouse tissues. Adapted from (Swift et al.
2013). (D) Pore size (top) and storage modulus (bottom) of collagen gels commonly used in
migration studies, as a function of collagen gel concentration. Adapted from (MironMendoza et al. 2010).

Cells sense matrix stiffness via integrin-mediated adhesions, recruiting focal adhesion
proteins

that

activate

downstream

mechanotransduction
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pathways

(e.g.,

RhoA/ROCK/myosin II), which ultimate feed back to reinforce the adhesions (Petrie et al.
2012) (Figure 3-1A). In stiff environments, this signaling feedback loop results in the
generation of high traction forces by the actomyosin contractile machinery and cell
spreading. However, when the matrix stiffness is too high, cells in confined spaces cannot
deform their surroundings to pass through. On the other hand, although focal adhesions
are not reinforced on compliant substrates, cells may physically enlarge pre-existing gaps.
Ulrich and colleagues found that increasing the gel stiffness induced a mesenchymal-toamoeboid transition in glioma cell motility (Ulrich et al. 2010). Ehrbar et al. found that while
migration was inhibited with high gel stiffness, introduction of MMP-degradable linkages
into the gel rescued migration (Ehrbar et al. 2011) (Figure 3-5A). These results indicate
that cells can partly overcome the steric hindrance of stiff environments via extreme cell
body deformation and/or matrix degradation. Similar to findings in 2D (Peyton et al. 2005),
there appears to be a bimodal relationship between matrix stiffness and migration in 3D,
such that there is an intermediate stiffness that maximizes migration speed (Pathak et al.
2012, Peyton et al. 2011, Singh et al. 2014, Zaman et al. 2006), although this is
significantly influenced by the level of cell-ECM adhesion (Singh et al. 2014, Zaman et al.
2006) and matrix pore size (Pathak et al. 2012, Peyton et al. 2011). In addition, cells sense
and respond to mechanical gradients in 2D by preferentially migrating towards regions of
higher rigidity, a phenomenon known as durotaxis (Lo et al. 2000, Raab et al. 2012,
Vincent et al. 2013). Due to the difficulty of fabricating and encapsulating cells inside
graded 3D environments, most migration studies have been conducted with collagenembedded cells that are laid over graded substrates via a two-stage casting process
(Hadjipanayi et al. 2009, Raab et al. 2012). While cells do migrate from soft to stiff regions
in these systems, migration occurs parallel to the stiffness gradient axis of the underlying
substrate. Thus, the role of durotaxis in 3D remains unclear. In all cases, it is difficult to
decouple the effect of stiffness from that of pore size and/or adhesivity because hydrogel
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mechanics are often directly related to matrix density (and in the case of ECM-derived
materials, adhesive ligand concentration). Moreover, since the collagen concentration,
stiffness, and fibril organization of most gels used in these 3D assays are extremely low
(~100X lower concentration than that of connective tissues, Figure 3-4A and Figure
3-4D), it is unknown to what extent these findings apply to migration in dense connective
tissues.

3.4.2

Matrix Microstructure

The microstructure of connective tissues is dependent on collagen content, fiber
alignment, and inter-fiber porosity and pore size. Cells in a loose ECM with large pores
are rounded, whereas cells in a dense ECM with small pores are elongated and spindleshaped, due to a reduction in cell diameter. Wolf et al. found that migration speed through
collagen gels decreased with pore size, an effect that was accentuated with MMP
inhibition (Wolf et al. 2013) (Figure 3-5B). Using a lattice Monte Carlo simulation to
independently evaluate the effects of matrix deformability, pore size, and MMP
degradation, Zaman et al. demonstrated that even a high level of cell-mediated matrix
deformation (50%) cannot compensate for decreased pore size below a certain limit
(Zaman et al. 2007). The number of cells translocating through microporous membranes
also decreases with pore size (Wolf et al. 2013) (Figure 3-5C). Together, these results
suggest that pore size, and not stiffness, is the true limiting physical factor. As with ECM
stiffness, a bimodal relationship exists between pore size and migration speed (Kim et al.
2012b, Lautscham et al. 2015, Pathak et al. 2012, Peyton et al. 2011, Singh et al. 2014,
Zaman et al. 2007), although this also depends on adhesion ligand concentration (Kim et
al. 2012b, Lautscham et al. 2015, Peyton et al. 2011). Since contact guidance (response
to topographic cues) is diminished in wide channels, migration is optimal at pore diameters
that match or are slightly less than the diameter of migrating cells (Friedl et al. 2010).
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Figure 3-5: Cell migration is impaired in stiff and dense matrices. (A) Cell migration through
RGD-modified PEG hydrogels decreases with increasing gel stiffness. Addition of MMPdegradable linkages partially rescues migration. Adapted from (Ehrbar et al. 2011). (B)
Migration speed through collagen gels decreases as a function of pore size. Cell-produced
MMPs are inhibited in the GM6001 group. Adapted from (Wolf et al. 2013). (C) Confocal
cross-sections show cells migrating though polycarbonate pores of increasing size (red =
cytoplasm, green = nucleus). Cells are immobilized by 1 µm diameter pores. Scale = 10 µm.
Adapted from (Wolf et al. 2013).

Migrating cells adapt to the spatial confinement of their environment by traveling along a
path of least resistance (Friedl et al. 2010). For example, T-cells avoid areas of dense
ECM, preferring to travel along fibrillar strands (Friedl et al. 1998). Due to the fibrous,
interconnected nature of ECMs, contact guidance can play a central role in interstitial
migration. Indeed, cells preferentially align and migrate along fibers in collagen gels, and
migration speed increases with collagen alignment (Fraley et al. 2015, Petrie et al. 2009,
Provenzano et al. 2008). This directional migration is mediated by Rho/ROCK-mediated
contractility, which preferentially aligns new cellular protrusions along the fiber axis,
increasing migration persistence (Petrie et al. 2009). Conversely, migration orthogonal to
the fiber direction is suppressed (Dickinson et al. 1994, Riching et al. 2014).
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3.4.3

Biochemical Signals

The ECM provides a wealth of signaling molecules. Of the insoluble signals, the most
important are ECM ligands, which enable direct coupling of the cytoskeleton to the
environment by binding to cellular integrins. In general, higher ECM ligand density
increases cell adhesion and contractility, but reduces 3D migration speed compared to an
intermediate density (Lautscham et al. 2015, Singh et al. 2014). On the other hand, a low
ECM ligand density promotes cell detachment and does not support contractile force
generation, leading to even slower migration. The most prevalent adhesive peptide motif
within the ECM is Arginine-Glycine-Aspartic acid (RGD) (Walters et al. 2015). This
sequence is present in fibronectin, laminin, vitronectin, fibrinogen, and various other ECM
proteins, and binds with high affinity to 8 types of integrin heterodimers. Another common
motif, glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER), is
found on collagen types I, II, and III. Different integrins bind to fibronectin and collagen,
resulting in disparate downstream signaling and behavior (Seong et al. 2013, Walters et
al. 2015).
Fibronectin also functions to sequester a host of growth factors, including latent
transforming growth factor-β1 (TGF-β1), platelet-derived growth factor (PDGF),
hepatocyte growth factor (HGF), and fibroblast growth factor 2 (FGF2) (Hinz 2015). While
TGF-β1 is kept in a latent form, it can be activated by cellular contraction to stimulate
migration in some cell types, notably epithelial cells (Giehl et al. 2006). PDGF, HGF, and
FGF2 are all known chemoattractants, which stimulate directional migration of cells (the
ability to move in a persistent direction) (Vorotnikov et al. 2014). The rapid release of
soluble growth factors from the ECM during matrix degradation and/or after injury may
induce chemotaxis, defined as the directed movement of cells towards the source of a
soluble gradient. Directional sensing is accomplished via binding of the chemoattractant
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to cell surface receptors, which activates signaling pathways that promote cell polarization
and the formation of protrusions, adhesions, and contractile forces. Similarly, cells may
migrate towards a substrate-bound gradient, such as that of fibronectin (Wu et al. 2012).

3.5

Role of Cell Migration in Dense Connective Tissue Repair

Dense connective tissues include the knee and temporomandibular menisci, tendons and
ligaments, and the annulus fibrosus of the intervertebral disc (Figure 3-6). These tissues
are characterized by densely packed and highly organized collagen fibers, which impart
tensile strength along the fiber direction. Given that this structure-function relationship is
essential for resisting forces within the musculoskeletal system, injuries that disrupt the
fibrous architecture significantly reduce the mechanical functionality of these tissues.

Figure 3-6: Collagen organization of fiber-reinforced tissues. (A) Scanning electron
micrographs of the annulus fibrosus of the intervertebral disc, (B) knee meniscus, and (C)
ligament. (D) Top down view of the aligned circumferential collagen fibrils in the knee
meniscus. (E) Fibrochondrocytes within the ECM. (F) Transverse view of the circumferential
collagen fibrils of the knee meniscus. Scale = (A) 200 µm, (B) 500 µm, (C) 100 µm, and (D and
F) 2 µm. Adapted from (A) (Iatridis et al. 2004), (B) (Petersen et al. 1998), (C) (Provenzano et
al. 2002), and (E) (Chevrier et al. 2009). Images (D) and (F) courtesy of Qing Li.
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3.5.1

Phases of Wound Repair

In the case of fibrous wound repair, effective migration is critical for the initial inflammatory
phase (hours to days), during which immune cells clear dead cells, pathogens, and debris,
and for the later proliferative phase, during which reparative cells actively divide and
migrate into the wound bed to deposit new tissue and contract the wound (days to weeks)
(Yang et al. 2013). This is followed by a period of matrix remodeling (weeks to months),
where the scar tissue is organized into mature, crosslinked type I collagen fibers that
become aligned along the direction of stress to restore biomechanical function. While
tissues with a well-established vascular supply may depend in part on circulating
mesenchymal stem cells to promote repair, most dense connective tissues in the mature
state are hypovascular (Arnoczky et al. 1983, Hiraki et al. 2005) and thus must rely on
cells intrinsic to the tissue and/or from extrinsic sources to affect repair.
For example, in tendon injuries, both tenocytes from the endotenon and epitenon and
fibroblasts from the tendon sheath and synovium contribute to the proliferative and
remodeling phases (Manske et al. 1985). While intrinsic repair by native tenocytes results
in superior functional outcomes (Fujita et al. 1992), exogenous cells often dominate the
repair process, leading to scar tissue and adhesion formation (Lo et al. 2002, Sharma et
al. 2006). Cadby et al. recently demonstrated that cells derived from the peritenon migrate
faster than those derived from the tendon core, suggesting that enhanced ability to reach
the wound site may increase the propensity for extrinsic repair (Cadby et al. 2014). This
suggests therapeutic potential for regulating the ability of endogenous and extrinsic cells
to reach the wound interface.
In addition to endogenous primary cells, the adult knee meniscus harbors a stem cell-like
population that is capable of migration and fibrochondrogensis in vitro (Mauck et al. 2007,
Shen et al. 2014). However, lesions in the inner avascular portion remain hypocellular and
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fail to self-repair in the long-term (Mesiha et al. 2007). While a fibrovascular scar may
eventually physically bridge the wound gap, it is mechanically inferior and prone to reinjury (Newman et al. 1989). Moreover, cells fail to colonize the central core of devitalized
meniscal autografts after 6 months in a canine model (Arnoczky et al. 1992), and
repopulation of meniscal allografts remain incomplete after 16 months in human patients
(Rodeo et al. 2000). Overall, these studies indicate that impeded interstitial migration may
contribute to poor meniscal wound healing.

3.5.2

Cellular and Extracellular Changes with Age

Unlike adult dense connective tissues, many fetal tissues, including meniscus (Ionescu et
al. 2011), tendon (Beredjiklian et al. 2003), ligament (Provenzano et al. 2002), and
intervertebral disc (Roughley 2004), exhibit a robust healing capacity. This regenerative
capacity is independent of the fetal environment. For example, when fetal sheep tendons
are injured, removed, and implanted into the subcutaneous space of adult immunedeficient mice, healing proceeds in a manner comparable to that in the fetus (Favata et al.
2006). Furthermore, fetal bovine meniscal explants (in the absence of vasculature) still
exhibit superior integration in vitro compared to adult specimens, suggesting that there
are intrinsic age-related differences that influence repair (Ionescu et al. 2011). Since cells
make up a significantly higher proportion of the fetal tissue mass compared to adult tissues
(Russo et al. 2015) (Figure 3-7C), it is not surprising that the intrinsic repair potential is
much greater for fetal tissues.
Several age-related factors may exacerbate the impaired healing of adult tissues. During
development, ECM collagen content and alignment increase with load bearing while cell
density declines (Clark et al. 1983, Marturano et al. 2013, Russo et al. 2015) (Figure
3-7A–C), resulting in higher mechanical properties on the microscale (Marturano et al.
2013) and bulk tissue levels (Ionescu et al. 2011) (Figure 3-7E). Compressive forces on
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the inner meniscus also lead to substantial proteoglycan accumulation (Figure 3-7D),
most notably aggrecan (Di Giancamillo et al. 2014, Ionescu et al. 2011, Melrose et al.
2005). It is likely that the dense network of aligned collagen bundles of the mature
meniscal ECM, coupled with a highly pressurized, proteoglycan-rich inner zone, prevent
a sufficient population of endogenous progenitor cells from migrating to the defect to
initiate repair (Morales 2007).

Figure 3-7: Dense connective tissues become denser, stiffer, and less cellular with age.
Tendons from fetal and adult sheep illustrate changes with maturation. (A) H&E staining
showing ECM and cells, (B) immunostaining for type I collagen (green) with DAPI nuclear
counterstain (blue), and (C) DAPI staining for cell nuclei. Cells in fetal tendon are numerous
and ellipsoid, whereas the few cells in adult tendon are elongated along the fiber direction.
Collagen content and organization increase with tendon age. § = tendon tissue proper, * =
endotenon. Scale = (A) 50 µm, (B) 25 µm, and (C) 10 µm. Adapted from (Russo et al. 2015).
(D) Radial sections from fetal, juvenile, and adult bovine menisci stained with Picrosirius
Red (collagen) and Alcian Blue (proteoglycans). Adult tissue contains more proteoglycans
in the inner zone than fetal and juvenile tissues. Scale = 10 mm. (E) Micromechanics (elastic
modulus normalized to fetal tissue, measured via AFM indentation) and bulk mechanics
(compressive equilibrium modulus) of fetal, juvenile, and adult bovine meniscus. Tissue
becomes stiffer on both length scales with age. Adapted from (Ionescu et al. 2011).
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As the ECM becomes stiffer and denser, cells become deformed within the narrow spaces
between adjacent collagen bundles (Figure 3-7C) and must establish narrow cytoplasmic
projections for cell-cell communication (Lo et al. 2002). In addition to reducing ECM
porosity and pore size, the densely packed collagen may also increase adhesion ligand
concentration, resulting in overly strong adhesive and contractile forces that impede
forward movement. Furthermore, cells adapt their mechanotransduction machinery to
reflect the mechanical changes to the microenvironment (Buxboim et al. 2014, Swift et al.
2013). For example, nuclear stiffness and lamin A content increase when mesenchymal
stem cells undergo differentiation (Pajerowski et al. 2007), and further escalate with aging
of the meniscus (Figure 3-8). Since nuclear deformability is essential for interstitial
migration through small pores, it is likely that adult meniscal cells are intrinsically less
mobile in situ than fetal cells. Interestingly, the premature aging disorder HutchinsonGilford Progeria Syndrome, caused by a mutation in the lamin A gene, is characterized by
stiffer nuclei and decreased cell mobility in tight interstitia (Booth-Gauthier et al. 2013).

Figure 3-8: Nuclear stiffness and lamin A content increase with cell age. (A) Schematic
showing relative nuclear stiffness of stem cells as they differentiate over time. Adapted from
(Swift et al. 2014). (B) Nuclear modulus and (C) lamin A content (normalized to β-actin) of
fetal (Fet), juvenile (Juv), and adult (Adu) bovine meniscal fibrochondrocytes, and juvenile
bovine mesenchymal stem cells (MSCs). Data courtesy of Claire McLeod (B) and Tristan
Driscoll (C).
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While monolayer migration of fetal and adult cells from various connective tissues has
been evaluated, including the meniscus (Ionescu et al. 2011), ligament (Stalling et al.
2008), tendon (Brink et al. 2006), and dermis (Sandulache et al. 2005), there is not a clear
age-dependent trend, nor are these results indicative of migratory capacity in a more
physiologic 3D setting. Sandulache et al. found that fetal dermal fibroblasts were more
invasive of low-density collagen gels than adult fibroblasts at early time points, in part due
to more frequent cell-matrix detachment (Sandulache et al. 2007). However, these
collagen matrices were too compliant and porous to sterically hinder migration. Thus, while
several cellular and ECM factors may contribute to the limited intrinsic repair capacity of
adult dense connective tissues, the relationship between aging, interstitial cell mobility,
and fibrous tissue healing remains to be explored.

3.6

Cell Migration in Engineered Materials

A fundamental understanding of how cells interact with their microenvironment is crucial
to success in tissue engineering. Ideally, the scaffold material would allow for cell
attachment, proliferation, and differentiation into a phenotype that culminates in synthesis
of the desired ECM components. In the presence of proper environmental signals, this
neo-tissue can be coaxed to mature, such that over time, the biochemical and
biomechanical properties resemble that of native tissue. However, rapid cell attachment
and proliferation on the scaffold surface may prevent cell penetration into the scaffold
depth, resulting in a cell-rich outer edge but a necrotic center. As such, achieving sufficient
cell density and homogenous distribution within the scaffold volume are vital steps towards
generating functional tissue replacements. The remainder of this chapter will focus on
techniques to enhance cell infiltration into 3D scaffolds, either after cell seeding in vitro or

48

implantation in vivo, by modulating scaffold micromechanics, microstructure, and insoluble
and soluble biochemical cues.

3.6.1

Scaffold Micromechanics

A major objective of orthopaedic tissue engineering is to recapitulate the macroscopic
mechanical properties of native tissues. Tensile moduli for dense connective tissues can
be up to several hundred MPa along the primary fiber direction (Bullough et al. 1970,
LeRoux et al. 2002, Proctor et al. 1989), although physiological loading usually occurs at
lower strains within the toe region, which has somewhat lower moduli (Jones et al. 1996,
Richards et al. 2003). One common way to fabricate biomimetic scaffolds is through
electrospinning, a technique that utilizes an electrical potential difference to draw polymers
into nanofibrous networks that can be either randomly deposited on a collector or highly
aligned by collection on a rotating mandrel, replicating the organization of dense
connective tissues (Mauck et al. 2009). Typical materials utilized for electrospinning
include biocompatible and biodegradable synthetics such as poly(ε-caprolactone) (PCL),
poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), as well as naturally-derived
polymers like chitosan, silk fibroin, and collagen (Mauck et al. 2009). The mechanical
properties of acellular constructs are determined by the intrinsic material properties of the
electrospun polymer, electrospinning parameters and environment, and fiber organization
within the scaffold. Most notably, uniaxial tensile strength is increased when nanofibers
are deposited parallel to the loading direction, as it is in native tissue (Baker et al. 2007,
Li et al. 2007).
Although bulk mechanics are undeniably important, the resulting micromechanical
environment is often overlooked and may not be optimized for cell migration. For example,
few studies provide insight to the forces seen by cells grown on nanofibrous substrates,
where focal adhesions may exert traction forces on single fibers and cellular processes
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are influenced by mechanical feedback. A study by Meehan et al. found that cell migration
speed on single, suspended polystyrene nanofibers decreased with structural stiffness,
whereas focal adhesion complex length increased (Meehan et al. 2014). Although bulk
tensile moduli for aligned nanofibrous scaffolds are typically in the MPa range, indentation
of single nanofibers reveal a Young’s modulus between ~0.1–3 GPa for PCL (Croisier et
al. 2012, Tan et al. 2005b, Thomas et al. 2006) and ~1 GPa for PLA (Inai et al. 2005, Tan
et al. 2005a), a difference that reflects the crystalline structure of the polymer. When
densely packed, these rigid fibers could present a formidable physical barrier to cell
ingress. Consequently, cell colonization of PCL scaffolds is limited to the scaffold
periphery after 10 weeks of in vitro culture (Baker et al. 2007, Baker et al. 2008), limiting
matrix accumulation in the construct interior as well as integration with native tissue.
To expedite cell infiltration of dense, stiff scaffolds, a common approach is to introduce
MMP-sensitive moieties to the polymer backbone or crosslinker to enable cell-mediated
remodeling. While this technique has been widely explored in the context of non-fibrous
hydrogels (Bott et al. 2010, Ehrbar et al. 2011, Feng et al. 2014, Miller et al. 2010), it can
also be applied to nanofibers (Law et al. 2007, Wade et al. 2015b). Cell-secreted
proteolytic enzymes result in localized polymer degradation over time, softening the
pericellular environment to enable cell mobility (Lee et al. 2005, Schultz et al. 2015).
Indeed, micrometer-sized tracks generated by migrating cells are observed, which
disappear with the addition of an MMP inhibitor. Cell migration and 3D network formation
is faster in MMP-degradable PEG hydrogels compared to MMP-insensitive gels, a
difference that is further accentuated in high stiffness gels (Ehrbar et al. 2011). As such,
cell infiltration into stiff hydrogels in vivo is enhanced in the presence of MMP-cleavable
linkages (Ehrbar et al. 2011) (Figure 3-9A). Adjusting the concentration and/or proteolytic
sensitivity of the peptide may offer control over the rate of migration (Lutolf et al. 2003).
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Figure 3-9: MMP-degradable hydrogels enhance cell invasion, matrix remodeling, and
matrix synthesis. (A) H&E staining of soft and stiff MMP-degradable and MMP-insensitive
(Non-degradable) poly(ethylene glycol) (PEG) hydrogels implanted within rat calvarial
defects. After 2 weeks, endogenous cells invade, degrade, and remodel MMP-degradable
matrices in a stiffness-dependent manner. Cell invasion is homogenous in soft gels and
becomes less regular in stiff gels, and fewer cells invade Non-degradable gels. Adapted
from (Ehrbar et al. 2011). (B) Schematic showing encapsulation of human mesenchymal
stem cells (hMSCs) in hyaluronic acid (HA) hydrogels using either MMP-degradable
peptides or MMP-insensitive (Non-degradable) crosslinkers. (C) Glycosaminoglycan (GAG)
and collagen content (normalized to the DNA content) of hMSC-laden HA hydrogels after 4
weeks of in vitro culture. Adapted from (Feng et al. 2014).

In addition to promoting migration, proteolytic remodeling enhances proliferation in stiff
environments (Bott et al. 2010) and encourages matrix synthesis (Feng et al. 2014)
(Figure 3-9C). Therefore, it may be possible to direct cell recruitment by controlling the
spatial distribution of soft vs. stiff territories within the scaffold (Singh et al. 2014,
Sundararaghavan et al. 2011). Interestingly, cellular MMP activity increases with substrate
stiffness (Leight et al. 2013, Nicodemus et al. 2011), illustrating the need for active cell
remodeling in the presence of biophysical barriers. Taken together, a promising strategy
to foster cell colonization of without compromising initial bulk mechanics may be to
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incorporate protease-sensitive domains into one fiber fraction within a composite
nanofibrous scaffold (Wade et al. 2015b).

3.6.2

Scaffold Microstructure

Macroscopically, the scaffold shape dictates the boundaries of tissue formation.
Microscopically, the scaffold’s structural framework controls cell ingrowth, neo-tissue
organization, and nutrient diffusion. Thus, a common strategy to increase cell infiltration
is to provide interconnected void spaces through which cells can migrate, such as pores
or channels. Polymer processing techniques utilized to create highly porous morphologies
include high-pressure gas foaming (Silva et al. 2006), porogen leaching (De Groot et al.
1996, van Tienen et al. 2003, van Tienen et al. 2002), freeze-drying (De Groot et al. 1996,
van Tienen et al. 2003, van Tienen et al. 2002), and phase separation (Liu et al. 2009).
Porous polyester and polyurethane foams (De Groot et al. 1996, Maher et al. 2010, Silva
et al. 2006, van Tienen et al. 2003, van Tienen et al. 2002) and type I collagen-based
sponges (Rodkey et al. 1999, Stone et al. 1992) have long been explored as meniscal
substitutes, with a pore diameter range of ~150–300 μm and porosity greater than 80%
being the most efficacious for cell infiltration (Klompmaker et al. 1993, van Tienen et al.
2002). While these materials facilitate cellular ingrowth, matrix deposition, and integration
with native meniscal tissue within 6 months (van Tienen et al. 2003, van Tienen et al.
2002), the internal microstructure does not permit the generation of circumferentially
oriented collagen fibers, which are essential for load transfer. Indeed, a study investigating
polyurethane foams for meniscal replacement found scaffold fragmentation and cartilage
damage after 2 years in a canine total meniscectomy model (Welsing et al. 2008).
To engineer functional dense connective tissues, it may thus be necessary to provide an
instructive microstructure that fosters organized collagen deposition and maturation. It is
well known that cells sense and respond to micro- and nanoscale topography, such as
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ridges, grooves, and channels (Lim et al. 2007). Anisotropic features, such as those
provided by aligned electrospun fibers, induce cell polarization and de novo collagen
alignment along the primary fiber direction (Figure 3-10), leading to greater increases in
tensile modulus compared to non-aligned scaffolds (Baker et al. 2007).

Figure 3-10: Nanofibrous topography organizes cells and matrix. (A) Scanning electron
micrographs of aligned (top) and non-aligned (bottom) PCL scaffolds. Scale = 50 µm. (B)
Mesenchymal stem cells cultured on nanofibrous scaffolds for 7 days (green = actin, blue =
nuclei). Cells are oriented with the primary fiber axis on the aligned scaffold. Scale = 50 µm.
(C) En face section of scaffold stained after 10 weeks of in vitro culture with Picrosirius Red
(collagen) and Alcian Blue (proteoglycans). Deposited collagen is aligned with the fiber
direction. Scale = 100 µm. Adapted from (Baker et al. 2007, Mauck et al. 2009).

Although these organized scaffolds promote ordered matrix deposition, dense aligned
nanofibers pose a challenge to cell infiltration. While scaffold alignment may increase
migration speed and persistence along the fiber length (Fraley et al. 2015, Riching et al.
2014), contact guidance also hinders migration normal to the fiber axis (Dickinson et al.
1994). Introducing porogens such as salt particles (Nam et al. 2007), ice crystals (Simonet
et al. 2007), or fibers with faster degradative rates (Baker et al. 2008, Lee et al. 2013a,
Phipps et al. 2012a), have been shown to increase porosity and cell infiltration.
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Figure 3-11: Fast-degrading nanofibers in a composite scaffold increase scaffold porosity,
cell infiltration, and integration with native tissue. (A) Schematic illustrating composite
PCL/PEO scaffold with fast-degrading PEO fibers (green) and slow-degrading PCL fibers
(red) before and after removal of PEO. (B) Scanning electron micrographs of scaffold with
0% or 60% PEO content removed. Scale = 50 µm. (C) DAPI staining showing nuclei of cellseeded scaffolds after 12 weeks of in vitro culture indicates enhanced cell colonization of
60% PEO scaffold. Scale = 0.5 mm. (D) Percent of nuclei in the center of the scaffold after
12 weeks of in vitro culture. (A–D) Adapted from (Baker et al. 2012). (E) Integration strength
of PCL/PEO scaffold with native meniscus after 4 and 8 weeks of in vitro culture shows
enhanced scaffold-tissue integration with 60% PEO scaffold at 8 weeks. Adapted from
(Ionescu et al. 2013).

For example, a composite scaffold of aligned, slow-degrading PCL fibers can be
interspersed with a second population of water-soluble poly(ethylene oxide) (PEO) fibers
(Baker et al. 2008) (Figure 3-11A). Rapid removal of the ‘sacrificial’ PEO fraction via
aqueous hydration results in a highly porous scaffold while preserving fiber directionality
and mechanical anisotropy (Figure 3-11B). Although high porosity scaffolds (60% PEO)
were initially weaker than low porosity scaffolds (0% PEO), collagen content within high
porosity scaffolds (60% PEO) was significantly higher after 12 weeks of in vitro culture,
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resulting in superior tensile properties in the long-term (Baker et al. 2012). Furthermore,
cellular infiltration of high porosity scaffolds (Figure 3-11C and Figure 3-11D) improves
integration with tissue explants compared to scaffolds without PEO (Ionescu et al. 2013)
(Figure 3-11E). Alternatively, instead of removing scaffold components, adding an
interpenetrating fiber population (Cai et al. 2013, Lee et al. 2013b, Moutos et al. 2007) can
provide vertical avenues for cellular ingress into the scaffold.

3.6.3

Biochemical Signals

Cellular perception of the biophysical microenvironment depends on the ability to adhere
and exert forces on the surroundings. Thus, tunable systems that offer combined control
over scaffold micromechanics, microstructure, and adhesivity have gained considerable
interest. An attractive strategy is to use crosslinkable hydrogels, where synthetic polymers,
such as poly(ethylene glycol) (PEG), and natural polysaccharides, such as hyaluronic acid
(HA), are modified with functional groups (e.g., vinyl or thiol groups) to form hydrophilic
crosslinked networks (Geckil et al. 2010). Mechanical properties rely on hydrogel
crosslinking density, which is largely controlled by macromer modification and macromer
density. Microstructure can be engineered via micromolding (Kim et al. 2012a),
photolithography (Singh et al. 2014, Wade et al. 2015a), electrospinning (Kim et al. 2013,
Wade et al. 2015a), and 3D printing (Billiet et al. 2012). Importantly, small oligopeptide
sequences found within ECM proteins (e.g., RGD) can be conjugated to core molecules
to provide adhesive ligands within the 3D matrix. For instance, Kim et al. fabricated
nanofibrous scaffolds using methacrylated hyaluronic acid (MeHA) macromers with either
35% or 100% modification, resulting in soft and stiff fibers after final crosslinking (Kim et
al. 2013). Additionally, RGD was coupled to the fibers at low, medium, or high
concentrations. Although there was almost an order of magnitude difference between the
bending moduli of soft and stiff fibers, cellular deformation of soft fibers were similar to
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that of stiff fibers at a low RGD density, and only became significantly different at a high
RGD density, illustrating that proper adhesive cues are necessary for cell
mechanosensing.
Furthermore, a depth-wise haptotactic RGD gradient can be formed within nanofibrous
scaffolds by altering the flow rate of two polymer solutions with different conjugated-RGD
concentrations to affect cell infiltration. Sundararaghavan and Burdick found that cell
migration from aortic arch explants was more efficient in the presence of a low-to-high
RGD gradient versus a high-to-low gradient (Sundararaghavan et al. 2011). Similarly,
RGD-gradient channels formed by UV laser micropatterning guided neurite outgrowth
towards a higher RGD concentration within a 3D hyaluronan gel (Musoke-Zawedde et al.
2006). Photo-immobilization of a laminin-1 gradient, an ECM glycoprotein found basement
membranes, also increased neurite outgrowth in an agarose gel (Dodla et al. 2006). These
results suggest that targeting adhesion via different ligand concentrations (Kim et al. 2013,
Peyton et al. 2011, Singh et al. 2014, Sundararaghavan et al. 2011), ligand peptide
sequences (Mhanna et al. 2014), and/or integrin antibodies (Wolf et al. 2013), can
modulate migration without changing underlying material properties.
Cells isolated from the meniscus (Bhargava et al. 1999), tendon (Caliari et al. 2011),
ligament (Hannafin et al. 1999), and shoulder capsule (Suzuki et al. 2001) can migrate
towards a wide variety of soluble chemical gradients, including platelet-derived growth
factor (PDGF) AB and BB (Bhargava et al. 1999, Bhargava et al. 2005, Hannafin et al.
1999, Suzuki et al. 2001), epidermal growth factor (EGF) (Kong et al. 2011), hepatocyte
growth factor (Bhargava et al. 1999, Bhargava et al. 2005, Hannafin et al. 1999, Suzuki et
al. 2001), bone morphogenetic protein-2 (BMP-2) (Bhargava et al. 1999, Hannafin et al.
1999), and interleukin-1 (Bhargava et al. 1999). Additionally, meniscal progenitors (Shen
et al. 2014) and mesenchymal stem cells (Kucia et al. 2004) home towards stromal-cell
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derived factor-1α (SDF-1α), although this effect may be reduced in the absence of an
injury (Abbott et al. 2004).
Therefore, biomaterials functionalized with chemoattractants also have potential to affect
3D cell infiltration. For example, Moore et al. immobilized neurotrophic gradients to
advance neurite penetration into hydrogels (Moore et al. 2006). However, immobilization
limits gradient sensing to cells that are already in contact with the scaffold, whereas
delivery of soluble chemoattractants may also induce cell migration towards the wound
site, thereby enhancing the intrinsic repair response of endogenous cells. In particular, the
large surface area of nanofibers is well suited for an initial burst delivery, followed by
sustained release as the fiber eventually degrades. Phipps et al. found that eluant from
nanofibrous PCL/collagen/hydroxyapatite composites adsorbed with PDGF-BB enhanced
directional migration of MSCs in vitro (Phipps et al. 2012b). Jin et al. used a PLA
nanofibrous scaffold, embedded with PLGA microspheres releasing PDGF-BB, to
enhance scaffold tissue ingrowth and neovascularization in a subcutaneous rodent model
(Jin et al. 2008). Notably, sustained PDGF release from microspheres was more effective
than a surface coating of PDGF, demonstrating that temporal control is necessary to
establish a soluble gradient in vivo. Likewise, localized release of SDF-1α increased
progenitor cell engraftment and colonization of scaffolds in subcutaneous experiments
(Thevenot et al. 2010), reducing inflammatory cell infiltration (Sarkar et al. 2011, Thevenot
et al. 2010) and improving the repair of various mesenchymal tissues, including bone
(Holloway et al. 2015), myocardium (Purcell et al. 2012), skeletal muscle (Rybalko et al.
2015), and skin (Sarkar et al. 2011). Collectively, these findings indicate that scaffolds
delivering soluble chemoattractants may also enhance dense connective tissue repair.
However, it is important to note that the steric hindrance posed by dense, stiff, and/or nondegradable scaffolds may limit cellular ingress regardless of haptotactic or chemotactic
cues.
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3.7

Summary and Future Directions

In conclusion, cell migration in confined 3D environments is governed by a complex set of
cellular and extracellular variables, including cell mechanics and force transduction, matrix
micromechanics and microstructure, and biochemical signals in the environment. While
blocking metastatic invasion remains the primary impetus behind basic research in this
field, enhancing interstitial migration can potentially benefit fibrous tissue repair and
regenerative medicine. Decreasing matrix density and stiffness at the wound interface
may facilitate local cell migration and intrinsic repair (Qu et al. 2015). Further modulating
cell mechanosensing after cell movement into tissue and scaffolds may direct cells toward
a proper lineage. For instance, while RGD ligands promote MSC adhesion and migration,
prolonged adhesion may inhibit chondrogenic differentiation in the long-term. By
combining a MMP-degradable sequence with the RGD peptide, Salinas and co-workers
demonstrated that cells within a hydrogel could self-regulate the amount of adhesive
ligands in the environment to support a chondrogenic phenotype (Salinas et al. 2008).
Recent advances in biosynthetic polymers (Krishna et al. 2010), drug encapsulation and
delivery (Garg et al. 2012), micro- and nanopatterning (Hahn et al. 2006, Kim et al. 2012a,
Lim et al. 2007), and rapid prototyping (Billiet et al. 2012) gives us more control over the
3D microenvironment now than ever before. However, most of the aforementioned studies
were performed in vitro with little or no mechanical loading. In an in vivo environment,
tissues and scaffolds experience a variety of tensile, compressive, and/or shear forces. In
dense connective tissues, strain transfer often depends on the relative sliding of collagen
fascicles, fibers, and/or fibrils, resulting in spatiotemporal changes in the tissue
microstructure (Han et al. 2013, Nerurkar et al. 2011, Szczesny et al. 2014). Dynamic
tensile loading also activates mechanoactive signaling pathways that influence
downstream cell force sensing and differentiation (Driscoll et al. 2015, Heo et al. 2011).
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Lastly, cell migration may be influenced by intercellular interactions, such as cell-cell
adhesions and paracrine signaling (Friedl et al. 2010, Raeber et al. 2007), inflammation
(Frenkel et al. 1996), and changes with cell age (Pajerowski et al. 2007). Although it is
unknown how these physiological events collectively affect interstitial migration in vivo, it
may be possible to study this phenomenon in vitro using bioreactors and live cell tracking
systems, coupled with real-time second harmonic generation imaging to visualize ECM
collagen.

By

designing

smart,

dynamic

scaffolds

that

reflect

the

optimal

microenvironmental niche for tissue growth and maintenance over time, ultimately we may
recapitulate, and perhaps even augment, the natural biological cues that direct repair and
regeneration.
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CHAPTER 4: BIOMATERIAL-MEDIATED DELIVERY OF DEGRADATIVE ENZYMES
TO IMPROVE MENISCUS INTEGRATION AND REPAIR

4.1

Abstract

Endogenous repair of fibrous connective tissues is limited, and there exist few successful
strategies to improve healing after injury. As such, new methods that advance repair by
promoting cell growth, extracellular matrix (ECM) production, and tissue integration would
represent a marked clinical advance. Using the meniscus as a test platform, we sought to
develop an enzyme-releasing scaffold that enhances integrative repair. We hypothesized
that the high ECM density and low cellularity of native tissue present physical and biologic
barriers to endogenous healing, and that localized collagenase treatment might expedite
cell migration to the wound edge and tissue remodeling. To test this hypothesis, we
fabricated a delivery system in which collagenase was stored inside electrospun
poly(ethylene oxide) (PEO) nanofibers and released upon hydration. In vitro results
showed that partial digestion of the wound interface improved repair by creating a
microenvironment that facilitated cell migration, proliferation, and matrix deposition.
Specifically, treatment with high-dose collagenase led to a 2-fold increase in cell density
at the wound margin and a 2-fold increase in integrative tissue compared to untreated
controls at 4 weeks (p≤0.05). Furthermore, when composite scaffolds containing both
collagenase-releasing and structural fiber fractions were placed inside meniscal tears in
vitro, enzyme release acted locally and resulted in a positive cellular response similar to
that of global treatment with aqueous collagenase. This innovative approach of targeted
enzyme delivery may aid the many patients that exhibit meniscal tears by promoting
integration of the defect, thereby circumventing the pathologic consequences of partial
meniscus removal, and may find widespread application in the treatment of injuries to a
variety of dense connective tissues.
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4.2

Introduction

Fibrous dense connective tissues of the musculoskeletal system, including the knee and
temporomandibular menisci, the annulus fibrosus of the intervertebral disc, and tendons
and ligaments, are characterized by an extracellular matrix (ECM) featuring aligned type I
collagen bundles. This fiber-reinforced microstructure gives rise to anisotropic mechanical
properties, permitting resistance to tensile stresses applied along the fiber direction. In the
knee meniscus, a semilunar fibrocartilaginous structure located between the femur and
tibia, circumferentially arranged collagen fibers resist tensile hoop stresses that arise with
joint loading (Fithian et al. 1990). Meniscal tears are common, accounting for over 1 million
surgical procedures each year in the United States (Hasan et al. 2014). These tears
disrupt the essential collagen architecture of the meniscus, decreasing its load transfer
functionality. The intrinsic healing capacity of this tissue is very poor, especially in
avascular regions. Even if some healing occurs, it does so through the formation of a
disorganized scar tissue, altering load transmission and eventually leading to
degenerative osteoarthritis of the affected knee compartment (Kawamura et al. 2003,
Makris et al. 2011, Tu et al. 2003).
While multiple repair techniques have been developed, their success is limited to simple
longitudinal tears that occur in the vascularized, peripheral one-third of the meniscus
(McCarty et al. 2002). Indeed, a postoperative evaluation of arthroscopically repaired
avascular meniscal tears reported that up to 75% of repairs had failed to heal completely,
with 20% requiring a secondary surgery (Rubman et al. 1998). The standard surgical
treatment after repair failure is a partial meniscectomy (Tu et al. 2003), although many
surgeons will perform this procedure as a first line treatment option given the poor
outcomes for most repair scenarios. However, resection of the damaged portion provides
only temporary alleviation of pain, and long-term consequences include increased peak
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pressures on the tibial plateau during loading, resulting in further degeneration of both the
meniscal fibrocartilage and articular cartilage and often culminating in the need for total
knee arthroplasty (Aagaard et al. 1999, Englund 2004).
An ideal alternative to surgical removal would be to reestablish native tissue function by
enhancing surgical repair and promoting cell growth, organized ECM production, and,
most importantly, integration at the wound site via the creation of an instructive
regenerative microenvironment. Experimental strategies to augment connective tissue
repair, specifically the avascular zone of the meniscus and other fibrous tissues, include
enhancing blood supply via vascular access channels or synovial flaps (Ochi et al. 1996,
Zhang et al. 1995), delivering growth factors to promote neovascularization, cell
proliferation, and matrix synthesis (Ionescu et al. 2012b, Petersen et al. 2007, Tumia et
al. 2004a, Tumia et al. 2009), and providing synthetic scaffolds that fill the tissue defect
(Baker et al. 2012, Maher et al. 2010, Martinek et al. 2006, Pabbruwe et al. 2010). A
number of factors play a role in successful meniscal repair, including control of the
inflammatory state (McNulty et al. 2007), provision of local vascularity (Arnoczky et al.
2010, Tu et al. 2003), and tissue maturity and matrix density (Ionescu et al. 2011).
Immature fibrous tissues such as meniscus (Ionescu et al. 2011), tendon (Beredjiklian et
al. 2003), and ligament (Provenzano et al. 2002) show enhanced healing capacity
compared to mature tissues, owing to their hypervascular and hypercellular state. Notably,
collagen content and diameter increase with developmental stage and skeletal maturation,
while cellularity decreases markedly (Clark et al. 1983). Furthermore, while the biologic
environment may favor regenerative healing of immature tissue, it has recently been
shown that fetal sheep tendon undergoes a robust healing response even when
transplanted to an adult in vivo setting (Favata et al. 2006), suggesting innate differences
mediate the different healing capacity as a function of developmental state.
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In agreement with this body of literature, our previous work on meniscus healing in vitro
suggests that the high ECM density of the mature meniscus represents a physical barrier
to endogenous healing (Ionescu et al. 2011), where matrix density acts to limit cell
proliferation, migration, and matrix remodeling at or near the wound site, leading to an
inferior repair response. In contrast to a two-dimensional environment, cells in tissues
must overcome the biophysical resistance imparted by their surroundings, and a dense
matrix with low porosity and degradability will obstruct cellular movement and activity
(Ehrbar et al. 2011, Klompmaker et al. 1993). Indeed, a number of studies have
demonstrated that treatment of the wound edge with matrix-degrading enzymes, including
trypsin, collagenase, and hyaluronidase, can enhance articular cartilage graft integration
(Janssen et al. 2006, Obradovic et al. 2001, van de Breevaart Bravenboer et al. 2004).
To render this technology clinically feasible, enzymatic degradation must be conducted in
a controlled and targeted manner to localize digestion to the wound site. One potential
delivery vehicle is nanofibrous scaffolds fabricated via electrospinning. In this wellestablished process, fibers that are hundreds of nanometers in diameter can be formed
and compiled into a non-woven 3D scaffold. Fibers within the scaffold can be collected to
resemble the organized collagen bundles found in many fibrous connective tissues.
Previously, we have shown that mesenchymal stem cells cultured on aligned poly(εcaprolactone) (PCL) nanofiber scaffolds organize and deposit collagen along the fiber
direction, producing meniscus-like engineered constructs that increase in mechanical
properties with time in culture (Baker et al. 2007). Furthermore, composites with multiple
fiber populations can be formed with differing degradative characteristics in each fiber
fraction. For instance, inclusion of water-soluble poly(ethylene oxide) (PEO) fibers into
such composites increased scaffold pore size upon hydration and expedited cellular
infiltration and tissue maturation (Baker et al. 2008, Baker et al. 2012, Ionescu et al. 2013).
These ‘sacrificial’ fibers can be modified to entrap drug-delivering microspheres (Ionescu
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et al. 2010), where release is dependent on microsphere composition, or directly liberate
biologic factors into an aqueous environment (Ionescu et al. 2012a).
With such regenerative tools at hand, our goal was to develop a functionalized scaffold to
enhance meniscal repair. We hypothesized that the high ECM density of the native adult
meniscus impedes healing and that decreasing the matrix density may improve cell
migration, division, and matrix deposition for integrative repair. To test this hypothesis, we
used an in vitro explant model to show that partial degradation of the wound edge can
alter the structure of adult meniscus, and demonstrated that this treatment improves
cellularity and production of new contiguous tissue spanning the wound site. More
importantly, we developed a novel method to deliver a controlled, low dose of matrixdegrading enzyme via electrospun composite nanofibrous scaffolds, where the sacrificial
PEO component released a single localized dose of collagenase.

4.3
4.3.1

Methods and Materials
Preparation and Culture of Meniscal Repair Constructs

Menisci from fetal (mid-gestation) and adult (skeletally mature) cows were sterilely
dissected and the synovium removed. Tissue cylinders were excised with an 8 mm biopsy
punch and concentrically cored with a 4 mm punch. In a first study, samples were
incubated in basal media (BM; Dulbecco’s Modified Eagle’s Medium with 10% Fetal
Bovine Serum and 1% Penicillin/Streptomycin/Fungizone) supplemented with 0.05 mg/mL
collagenase (type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg
solid, Sigma-Aldrich, St. Louis, MO) at 37°C for 6 hours, after which the cores were
replaced within the annuli. Controls were incubated in BM only. Repair constructs were
cultured in a chemically-defined medium (high glucose DMEM with 1% PSF, 0.1 mM
dexamethasone, 50 µg/mL ascorbate 2-phosphate, 40 mg/mL L-proline, 100 mg/mL
sodium pyruvate, 1X ITS (6.25 mg/mL Insulin, 6.25 mg/mL Transferrin, 6.25 ng/mL
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Selenous Acid, 1.25 mg/mL Bovine Serum Albumin, and 5.35 mg/mL Linoleic Acid) with
10 ng/mL TGF-β3) for 4 weeks in non-treated 6-well plates. To investigate the long-term
effect of collagenase pre-treatment, adult meniscus cores and annuli were incubated with
0 (BM), 0.01 (LC; low-dose collagenase), or 0.05 mg/mL (HC; high-dose collagenase)
collagenase, reassembled into repair constructs, and cultured for 1, 4, or 8 weeks as
above.

4.3.2

Histological, Biochemical, and MicroCT Analysis

At set intervals, repair constructs were fixed in 4% paraformaldehyde, embedded in
paraffin, and axially sectioned to 8 μm thickness onto glass slides. Sections were stained
with Hematoxylin and Eosin (H&E), Picrosirius Red (PSR), and 4’,6-diamidino-2phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island, NY) to visualize ECM density,
collagen, and cell nuclei, respectively. Quantitative parameters of integration were derived
from histological sections. Percent integration was defined as the cumulative distance of
annulus-to-core contact normalized by the core perimeter (n=3–4/group). Cell density at
the interface was determined by counting the number of nuclei present within 100 µm of
the interface using ImageJ (Wayne Rasband, NIH) (n=4/group). DNA content was
biochemically assessed in both the core and annulus at each time point in additional
constructs (n=6–7/group). Tissue segments were weighed separately, lyophilized, and
reweighed to determine water content. Following digestion in a buffer containing 2%
papain at 60°C, DNA content per dry weight was determined via the PicoGreen assay
(Invitrogen). Lastly, separate constructs from each group were saturated in Lugol’s
contrast solution (Sigma-Aldrich) for 24 hours and scanned via microcomputed
tomography at an energy level of 70 kV and intensity of 114 μA (µCT; ScanCo, VivaCT
70, Wayne, PA) to assess matrix changes at the interface (n=4/group).
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4.3.3

Fabrication and Characterization of Enzyme-Releasing Nanofibers

To fabricate enzyme-releasing nanofibers, a solution of 8% w/v PEO (200 kD,
Polysciences, Warrington, PA) was prepared in 1:1 EtOH and distilled H2O with 0.85%
w/v NaCl or 2.5% w/v trypsin in the same solution (Invitrogen). These solutions were
electrospun onto glass cover slips for 10–15 minutes using a custom device (Baker et al.
2008). The spinneret was charged to 15 kV and the polymer flow rate was set at 1.6
mL/hour to produce a stable electrospinning jet. Formed nanofibers were sputter coated
with AuPd and imaged via scanning electron microscopy (SEM; Philips XL 20, SEMTech,
North Billerica, MA) using an accelerating voltage of 10 kV. Fiber diameter was measured
using ImageJ (n=100/group).
To determine whether enzyme activity was preserved through the electrospinning
process, both cell- and tissue-based assays were employed. Using a cell-based approach,
approximately 0.2 and 0.4 g of each fiber type (PEO only or PEO-trypsin) were hydrated
in 4 mL of Hank’s Buffered Salt Solution (HBSS; Invitrogen) on an orbital shaker for 20
minutes. Confluent monolayers of bovine mesenchymal stem cells (bMSCs, isolated as in
(Baker et al. 2007)) were exposed to these eluted solutions. Four experimental conditions
were tested: BM, HBSS, HBSS containing hydrated PEO fibers (PEO), and HBSS
containing hydrated PEO-trypsin fibers (PEO-T). A standard solution of trypsin (Invitrogen)
at 0.25% w/v in HBSS was used as a positive control. bMSCs were maintained at 37°C in
a standard tissue culture incubator with images captured every 10–20 minutes with a light
microscope (n=2/group). Solutions were aspirated after 60 minutes for final imaging. Cells
were re-plated and cultured for 24 hours to ensure that cells remained viable after
treatment.
To further demonstrate efficacy and dosage of delivered trypsin, cylindrical articular
cartilage samples were sterilely isolated using 4 mm biopsy punches from the trochlear
groove of juvenile bovine femurs and trimmed to a height of 3 mm. Solutions containing
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hydrated PEO or PEO-trypsin nanofibers (0.4 g) were incubated with the cartilage
cylinders for 3 and 6 hours, along with BM and HBSS controls. HBSS/trypsin at 1.25% w/v
(20 minutes) was used as a positive control. After digestion, samples were embedded in
optimal cutting temperature compound (OCT; Sakura Finetek USA, Inc., Torrance, CA),
cut into 16 μm axial sections using a cryostat microtome (Microm HM500, MICROM
International GmbH, Waldorf, Germany), and stained with Alcian Blue (AB) to visualize
proteoglycan (PG) content. Matrix removal was assessed from diametric sections using
ImageJ and normalized to BM controls, where 100% indicates no loss in staining area and
0% indicates a complete removal of staining throughout the sample diameter (n=3/group).

4.3.4

Fabrication and Characterization of Collagenase-Releasing Nanofibers

Having established a mechanism for entrapping active enzymes, we next fabricated fibers
containing a more clinically relevant enzyme, namely collagenase. In initial studies,
nanofibers were spun from a solution of 8% w/v PEO in 1:1 EtOH and distilled H2O with
or without 1.25% w/v collagenase. Solutions were spun onto glass cover slips for 10–15
minutes as previously described. To demonstrate retention of collagenase activity, juvenile
bovine cartilage samples were prepared as described previously. PEO and PEOcollagenase (PEO-C) nanofibers (0.2 g) were hydrated in BM and the solutions were
incubated with cartilage cylinders for 3 and 6 hours, along with BM and BM containing
0.1% w/v collagenase (aqC) controls. Samples were cryotomed and stained with AB and
PSR

to

visualize

PG

and

collagen,

respectively

(n=4/group).

To

assess

glycosaminoglycan (GAG) loss, % GAG per wet weight was quantified after papain
digestion via the 1,9 dimethylmethylene blue (DMMB) assay (n=4/group) (Farndale et al.
1986).
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4.3.5

Scaffold-Mediated Degradation of the Meniscal Interface

Composite scaffolds were fabricated containing 40–50% PEO with the remaining fiber
fraction composed of PCL (80 kDa, Sigma-Aldrich). PEO solutions containing 0%, 0.125%
(low-dose collagenase, PEO-LC), or 1.25% w/v collagenase (high-dose collagenase,
PEO-HC) were electrospun simultaneously with 14.3% w/v PCL in 1:1 tetrahydrofuran and
N,N-dimethylformamide (Fisher Scientific, Pittsburgh, PA) onto a common rotating
mandrel as previously described (Baker et al. 2008). Electrospinning was carried out over
4 hours to form aligned mats approximately 0.5 mm thick, where one jet contained PCL
solution and the second jet contained PEO solution with or without collagenase. PEO
content was determined by measuring the dry weight of lyophilized scaffolds before and
after 24 hours of aqueous submersion on a shaking plate. PEO and PEO-HC solutions
were electrospun separately for SEM imaging and fiber diameter measurements
(n=100/group) as previously described.
To evaluate the efficacy of these composite scaffolds in providing controlled digestion of
the meniscal wound interface, juvenile bovine meniscal bodies were radially sectioned into
10 mm wedges and split horizontally along the inner edge to form a pocket, with two sides
remaining intact. Either no scaffold (NS) or a strip of PCL/PEO or PCL/PEO-HC (5 x 10
mm) was inserted into the pocket such that fibers aligned with the native collagen
architecture. The wound edges were pinned closed with a needle and the samples
cultured in BM for either 6 hours or 1, 3, or 7 days (n=3/group). Radial cryotome sections
were stained with AB to visualize PG removal from the wound margins. Following this
preliminary study, a long-term study with NS, PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC
juvenile bovine explant groups was conducted in a chemically-defined medium
supplemented with TGF-β3, with culture times of 25 and 50 days (n=8/group). Samples
were cryotomed to 16 μm radial sections and stained with either AB or DAPI to visualize
PG and nuclei, respectively (n=2/group). The remaining samples were frozen in OCT and
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the two intact edges removed by a freezing stage sledge microtome. Trimmed samples
were glued to sandpaper on a custom grip and extended to failure at 2.5 mm/min using
an Instron 5848 Microtester equipped with a 10 N load cell (Instron, Canton, MA). Samples
were imaged with a stereoscope after mechanical testing to quantify the area of potential
integration. Integration strength was calculated by dividing the maximum load before
failure by the contact surface area between the two tissue segments (n=5–6/group). To
determine if collagenase-releasing scaffolds could also improve integration in mature
meniscus, cylindrical adult bovine meniscal explants (8 mm diameter x 10 mm height) with
a horizontal defect were fitted with a PCL/PEO-LC or PCL/PEO-HC scaffold. In this case,
scaffolds were constructed in annular form (8 mm diameter with 5 mm core) to permit
tissue-to-tissue contact within the constructs, which were cultured for 7 days before
histological processing. Radial paraffin sections were stained with AB or H&E.

4.3.6

Statistical Analyses

All statistical analyses were done using SYSTAT (Chicago, IL). Experimental group sizes
were chosen based on power analysis using preliminary data. Significance was assessed
by one or two-way ANOVA with Tukey’s HSD post hoc test to make comparisons between
groups (p≤0.05). Data is presented as the mean ± standard deviation.

4.4
4.4.1

Results
Partial Enzymatic Degradation Enhances Meniscal Integration

Digestion of the adult meniscus with aqueous collagenase resulted in a marked decrease
in matrix density, such that ECM staining more closely resembled that of the fetal
meniscus (Figure 4-1B). As enzyme dosage was increased, a controllable level of
digestion of the wound edge was achieved, as was reflected by the altered µCT signal at
the construct edges 1 week after treatment (Figure 4-2A).
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Figure 4-1: Aqueous collagenase treatment reduces matrix density and increases cellularity
in the adult meniscus, producing a more fetal-like tissue state. (A) Schematic of annulus
and core meniscal repair constructs. (B) H&E (left) and DAPI (right) staining of constructs
after 4 weeks of culture, where the dashed line indicates the wound interface (n=1–2/group).
Scale = 0.25 mm.

Long-term culture of adult constructs showed improved cellularity and integration with
increasing levels of collagenase digestion. By 4 weeks, cells and new collagen fibrils
closed approximately 92% of the wound gap in adult HC samples, which exhibited superior
integration compared to LC samples (74%) and BM controls (43%) (Figure 4-2A and
Figure 4-2B, p≤0.05). Cell density at the annulus-core boundary was significantly higher
for HC samples compared to all other groups, with a 213% and 170% increase over BM
controls at 4 and 8 weeks, respectively (Figure 4-2C, p≤0.05). Similarly, total DNA content
per dry weight of HC samples was significantly higher than BM controls at 4 and 8 weeks,
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increasing by 44% and 55%, respectively (Figure 4-2D, p≤0.05). Although LC samples
did not show the same level of cellular proliferation relative to HC samples, cell density
and total DNA content were significantly higher than BM controls at 8 weeks (Figure 4-2C
and Figure 4-2D, p≤0.05). For both LC and HC groups, total DNA content increased
between 4 and 8 weeks by 41 and 38%, respectively, whereas BM controls did not show
a significant change in DNA over this time period (Figure 4-2D, p≤0.05).

Figure 4-2: Improved integration and interface cellularity of adult meniscus after low- (LC)
and high-dose (HC) collagenase treatment, compared to controls (BM). (A) Left: 1 week µCT
scans showing low (red) and high (yellow) signal intensity correlating to matrix loss at the
wound interface (n=4/group). Scale = 1 mm. Right: 8 week PSR staining of the interface
imaged under polarized light showing improved integration with treatment (n=4/group).
Scale = 0.25 mm. (B) Quantification of % integration normalized to core perimeter (n=3–
4/group), (C) cell density at the interface (n=4/group), and (D) total DNA content per dry
weight (n=6–7/group). * = p≤0.05 vs. BM. + = p≤0.05 vs. BM and LC. Line = p≤0.05 between 4
and 8 weeks.

4.4.2

Nanofibers Store and Deliver Bioactive Enzymes

To facilitate targeted enzyme delivery, PEO nanofibers containing active trypsin or
collagenase were fabricated. Nanofibers with and without trypsin were of similar fiber
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diameter and morphology (200 ± 50 vs. 192 ± 44 nm, p≥0.05). When cell monolayers were
exposed to PEO-trypsin fibers hydrated in HBSS (PEO-T), a dose- and time-dependent
change in cell morphology was observed. Cells in PEO-T rounded and lifted from the
substrate over a period of 60 minutes, mimicking standard trypsin treatment, though at a
much reduced time scale (Figure 4-3A). Conversely, there was no apparent change in
cell morphology with exposure to hydrated PEO fibers or BM; HBSS alone slightly
disrupted monolayer integrity. Cell viability was unaffected by the presence of PEO, as
lifted cells reattached after 24 hours upon addition of BM (data not shown).

Figure 4-3: Sacrificial PEO nanofibers deliver functional enzymes upon hydration. (A)
Morphology of cell monolayers treated with eluant from fibers containing trypsin for 60
minutes as a function of fiber mass (n=2/group). Scale = 0.2 mm. (B) Proteoglycan removal
from cartilage cylinders after 6 hours of incubation with BM or HBSS (controls) or eluant
from PEO or PEO-T nanofibers (n=3/group). Scale = 0.5 mm. (C) % AB staining of
proteoglycan in cartilage cylinders as a function of treatment group and time, normalized to
BM controls (n=3/group). Dashed line indicates treatment with 1.25% w/v trypsin for 20
minutes as a positive control. * = p≤0.05 vs. other groups at 3 hours. ** = p≤0.05 vs. all other
groups and time points.
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To further characterize the activity of delivered trypsin, cartilage cylinders were exposed
to PEO-T solutions. Staining for PG revealed a time-dependent increase in tissue
digestion, where exposure for 3 and 6 hours resulted in 52% and 73% PG removal,
respectively (Figure 4-3B and Figure 4-3C, p≤0.05). This pattern and extent of PG
removal was comparable to treatment with 1.25% w/v trypsin solution, which showed a
59% removal after 20 minutes of exposure (Figure 4-3C, dashed line). There was no
change in PG staining for cartilage exposed to BM, HBSS, or PEO fibers.

Figure 4-4: Fabrication of enzyme-delivering nanofibrous composites. (A) SEM micrographs
of PEO (left) and PEO-HC (right) nanofibers. Scale = 5 μm. (B) Schematic of electrospinning
setup and (C) composite scaffolds produced with PEO fiber fractions that deliver enzyme.

PEO nanofibers containing active collagenase were produced using a similar approach.
While SEM images of fibers with and without collagenase were again comparable in
diameter (Figure 4-4A, 329 ± 114 vs. 321 ± 135 nm, p≥0.05), fibers containing enzyme
were qualitatively rougher in appearance. To characterize enzyme activity, cartilage
cylinders were exposed to PEO-collagenase nanofibers hydrated in BM (PEO-C). PG
removal was evident after treatment with either PEO-C or 0.1% w/v aqueous collagenase
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(aqC) (Figure 4-5A). Quantitative analysis of cartilage cylinders showed that exposure to
PEO-C for 3 and 6 hours resulted in a 45% and 61% decrease in GAG content compared
to exposure to BM, respectively (Figure 4-5B, p≤0.05), and comparable to treatment with
aqC (61% at 3 hours, dashed line). PSR staining of collagen increased after digestion due
to the better penetration of the stain after GAG removal from the matrix (D'Andrea 2004).

Figure 4-5: Release of active collagenase from PEO fibers. (A) Combined AB and PSR
staining of cartilage cylinders after 6 hours of exposure to BM, PEO, PEO-C, or aqueous
collagenase (aqC, 0.1% w/v) solution (n=4/group). Scale = 0.5 mm. (B) GAG content of
cartilage cylinders as a function of treatment and time (n=4/group). Dashed line indicates
treatment with aqC for 3 hours. * = p≤0.05 compared to other groups at 3 hours. ** = p≤0.05
compared to all other groups at 6 hours.

4.4.3

Nanofibrous Composites Localize Enzyme Release to the Wound Site

When collagenase-releasing scaffolds were placed in a juvenile bovine meniscal defect,
loss of PG was apparent at the wound edge within 6 hours, with decreased staining
intensity persisting through day 7 (Figure 4-6B). This loss did not extend to the periphery
of treated samples and was not observed in controls, suggesting local action of the
enzyme. Long-term culture of these constructs revealed increased tissue porosity and
cellularity at the wound edge after collagenase delivery (Figure 4-6C).
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Figure 4-6: Integrative repair of juvenile meniscus treated with collagenase-releasing
scaffolds. (A) Schematic of repair construct with scaffold placed inside a horizontal
meniscal tear. (B) AB staining of meniscus on day 7 with insertion of control and of
collagenase-releasing composite scaffolds (n=3/group). Scale = 5 mm. (C) DAPI staining of
wound interface after 50 days of culture with PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC
scaffolds (n=2/group). Scale = 0.25 mm. (D) Integration strength as a function of culture
duration. Inset shows mechanical testing setup (n=5–6/group). * = p≤0.05 compared to
PCL/PEO-HC. Line = p≤0.05 between 25 and 50 days.

Although the integration strength of all groups remained relatively low at 25 days, by 50
days there was significant improvement for the PCL/PEO and low-dose collagenase
scaffold (PCL/PEO-LC) groups (Figure 4-6D, p≤0.05). Meniscal repairs with PCL/PEOLC scaffolds exhibited the highest integration strength at 50 days (13.5 ± 4.1 kPa),
showing a trend toward improvement compared to controls without scaffolds (7.5 ± 3.6
kPa, p≤0.1). However, integration strength of the high-dose collagenase scaffold
(PCL/PEO-HC) group at 50 days (6.9 ± 6.5 kPa, p≤0.05) was significantly lower than the
PCL/PEO-LC group, most likely due to over-digestion of the wound interface.
Collagenase-releasing scaffolds placed inside adult meniscal explants also showed
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evidence of localized digestion and PG loss after 7 days in culture (Figure 4-7B).
However, the scaffold appeared to inhibit tissue formation at the sample edge in the shortterm, and integration was only observed within the fenestrated portion of the annular
scaffold (Figure 4-7D).

Figure 4-7: Improved repair of adult meniscus with collagenase-releasing composite
scaffolds. (A) Repair construct schematic with annular scaffold insert. (B) AB and (C) H&E
staining of constructs containing annular PCL/PEO-LC scaffolds on day 7. Scale = 1 mm.
(D) Magnified areas from (C). Left: lack of integration at the edge occupied by the scaffold
(asterisk). Right: bridging tissue in the interior after collagenase delivery. Scale = 0.25 mm.

4.5

Discussion

Orthopaedic injuries involving dense connective tissues are prevalent and suffer from a
limited healing capability (Kawamura et al. 2003, Makris et al. 2011, Tu et al. 2003). In the
case of the meniscus, treatment success rate declines with age and resulting repair
failures frequently culminate in tissue removal to alleviate inflammation and pain (McCarty
et al. 2002, Rubman et al. 1998, Tu et al. 2003). However, partial meniscectomy alters
joint biomechanics and hastens osteoarthritis (Aagaard et al. 1999, Englund 2004),
prompting the need for novel methods to enhance endogenous repair processes. We
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hypothesized that decreasing the local ECM density may facilitate meniscal repair and
found that the in vitro integration of adult meniscus improved after collagenase treatment
of the wound boundary. This improvement was accompanied by an initial decrease in local
ECM density and an increase in cellularity and matrix synthesis at the interface, supporting
our hypothesis. To translate these findings clinically, we developed a delivery system in
which active enzyme is stored within water-soluble PEO nanofibers and released into the
environment upon hydration. Collagenase-releasing nanofibers, incorporated into a
composite scaffold and placed inside a meniscal defect, localized the degradation process
to the wound margin and improved tissue integration in a dose-dependent fashion. Given
its simplicity and capacity for rapid translation, this innovative approach could aid the many
patients who would otherwise undergo meniscus removal.
Repair potential of dense connective tissues declines significantly with age (Beredjiklian
et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002). While this is commonly attributed
to the hypovascular nature of the tissue as it matures and hence the lack of nutrients and
growth factors available for repair (Arnoczky et al. 1983, Kawamura et al. 2003, Makris et
al. 2011, Tu et al. 2003), decreased cellularity and increased ECM density may also play
a role (Clark et al. 1983, Ionescu et al. 2011). Although dense aligned collagen bundles
are necessary to resist deformation during physiologic loading, this microstructure may
also inhibit cell mobility and division, thus preventing reparative cells from migrating to the
wound site in sufficient numbers. Indeed, ECM of fetal constructs exhibited smaller
collagen fibers and had a visibly higher cell density compared to adult constructs (Figure
4-1B). Treating the adult constructs with collagenase from Clostridium histolyticum
cleaved collagen fibrils at the interface and may have increased ECM porosity near the
wound edge. Although over-digestion may result in a detrimental loss of structural proteins
and cell death (Syed et al. 2012), restricting digestion to the outermost portion of the
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wound interface initiated an integrative repair response that was reminiscent of the
skeletally immature meniscus.
Global enzymatic treatment has previously been used to stimulate connective tissue
repair, most frequently in cartilage-to-cartilage integration studies. Short duration
exposure of cartilage constructs to matrix-degrading enzymes increased proliferative
cells, ECM synthesis, and integration strength compared to controls (Janssen et al. 2006,
Obradovic et al. 2001, van de Breevaart Bravenboer et al. 2004). Similarly, our partiallydigested meniscus constructs had a higher cell density at the interface and greater DNA
content than untreated controls. More notably, bridging tissue closed over 90% of the
wound gap in HC constructs by 4 weeks, over a two-fold increase compared to BM
controls. Tissue filling the wound gap of treated constructs consisted of fine fibrils that did
not exhibit birefringence under polarized light, indicative of newly synthesized collagen. In
contrast, BM constructs did not produce bridging tissue even when the interface was
histologically in contact, making it difficult to determine the extent of true integration in
untreated controls. Thus, while matrix synthesis at the wound edge declines with
development (DiMicco et al. 2002), this trend can be reversed by decreasing the ECM
density to a less mature state, although decrease in tissue stiffness (Peyton et al. 2005),
removal of matrix PGs (Natoli et al. 2009), and/or presence of collagen fragments (Shi et
al. 2010) may also have contributed to the enhanced repair of digested constructs.
Importantly, injectable collagenase is already used to treat Dupuytren’s contracture, a
fibroproliferative disorder that affects digit mobility (Syed et al. 2012). If applied in a
targeted and controlled manner, this enzyme may prove beneficial to meniscal injuries as
well.
Having established the therapeutic potential of partial digestion for meniscus integrative
repair, we next developed a method by which local enzyme delivery to the wound site
could be achieved using well-established biomaterials. While the application of
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electrospun fibers as carriers of biological agents such as antibiotics (Hong et al. 2008)
and growth factors (Choi et al. 2008, Liao et al. 2006, Sahoo et al. 2010, Ye et al. 2011)
is abundant in the literature, the inclusion of enzymes is not well documented. A patent by
Smith et al. refers to preserving biological materials using fiber-forming techniques and
documents the storage of trypsin inside electrospun poly(ethyl oxazoline) (Smith et al.
2004). PEO was chosen for our study because of its biocompatibility, solubility in water,
and previous use in electrospun composites. In our earlier work, PEO nanofibers were
exploited as sacrificial filler in composite PCL/PEO scaffolds, designed to increase
porosity and improve cell infiltration (Baker et al. 2008, Baker et al. 2012, Ionescu et al.
2013). These fibers can be readily functionalized to include bioactive factors or drugcontaining microspheres during the electrospinning process, as PEO solutions can be
prepared and electrospun from water rather than organic solvents used for other
biodegradable polymers (Ionescu et al. 2010). Furthermore, PEO is an ideal delivery
system for factors that require a rapid initial release, including the degradative enzymes
in our study that are meant to act immediately upon scaffold implantation and denature
quickly thereafter to prevent over-digestion. Indeed, our studies show that eluant from
trypsin-containing fibers caused cell detachment from plastic substrates within 60 minutes
and both trypsin and collagenase released from PEO fibers removed approximately half
of the PGs within cartilage cylinders after 3 hours.
To form stable scaffolds with degradative capacity, enzyme-containing PEO nanofibers
were electrospun concurrently with PCL to create composites with discrete fiber
populations with differing roles. The aligned PCL fiber fraction acts as a physical template
to provide mechanical integrity and instruction for organized ECM synthesis (Baker et al.
2007). This may be particularly appropriate when such scaffolds are used to treat
horizontal or vertical tears of the meniscus, where the scaffold architecture matches the
collagen organization of the native tissue. On the other hand, PEO fibers rapidly dissolve
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upon hydration to release the embedded collagenase in order to partially degrade the
wound interface. A major consequence of PEO fiber removal is an increase in the scaffold
pore size, which facilitates cell migration into the regenerate space (Baker et al. 2008,
Baker et al. 2012, Ionescu et al. 2013). However, the scaffolds placed within meniscal
defects were not well colonized despite having an initial PEO content of 40–50%, a
composition that allowed cell infiltration yet maintained tensile properties in previous
studies (Baker et al. 2008). It is possible that compression imposed by the defect geometry
may have reduced scaffold porosity and as such, the increase in integration likely resulted
from the improved matrix synthesis and integration occurring adjacent to the scaffold. In
a preliminary study with adult meniscus, the insertion of an annular scaffold that permitted
contact of opposing tissue at the center of the construct resulted in rapid bridging matrix
formation (Figure 4-7). In future studies, additional fenestrations could be introduced to
maximize tissue-to-tissue integration.
By using complex scaffolds with multiple components, the fiber ratios, individual fiber
properties, and biofactor doses can be tuned to optimize the instructive microenvironment
and mechanical properties. For example, composite scaffolds were also utilized by Hong
et al. for abdominal laparotomy management, wherein poly(lactide-co-glycolide) fibers
released an antibiotic and poly(ester urethane) urea provided elasticity (Hong et al. 2008).
Moreover, fiber modification techniques allow bioactive molecules to be blended inside
fibers (Hong et al. 2008, Sahoo et al. 2010, Smith et al. 2004), conjugated to the fiber
surface (Choi et al. 2008, Ye et al. 2011), sequestered inside a co-axial core (Liao et al.
2006, Sahoo et al. 2010), or delivered via microspheres (Ionescu et al. 2010).
Consequently, numerous factors can be incorporated into a single scaffold to allow for a
multitude of release profiles and therapeutic effects. Building upon this platform, our
scaffolds may be further functionalized to include growth factors such as platelet-derived
growth factor (Tumia et al. 2009) and TGF-β3 (Ionescu et al. 2012b) to recruit reparative
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cells and stimulate ECM synthesis after the initial enzymatic treatment. Currently, we are
investigating how biomaterial-mediated collagenase delivery impacts in vivo meniscal
healing in a subcutaneous rat xenotransplant model. For definitive evidence of scaffold
efficacy, an ovine model will be used to evaluate integration by inserting the scaffold into
a surgically created bucket-handle meniscal defect.

4.6

Conclusions

The principles outlined in this paper establish a new approach to enhance repair that
recapitulates natural healing processes, including local degradation, cell recruitment, and
matrix synthesis. Once validated in vivo, the nanofibrous networks developed herein,
tuned to enhance each phase of fibrous tissue repair, may find widespread application for
treating a variety of musculoskeletal tissues.
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CHAPTER 5: REPAIR OF DENSE CONNECTIVE TISSUES VIA BIOMATERIALMEDIATED MATRIX REPROGRAMMING OF THE WOUND INTERFACE

5.1

Abstract

Repair of dense connective tissues in adults is limited by their intrinsic hypocellularity and
is exacerbated by a dense extracellular matrix (ECM) that impedes cellular migration to
and local proliferation at the wound site. Conversely, healing in fetal tissues occurs due in
part to an environment conducive to cell mobility and division. Here, we investigated
whether the application of a degradative enzyme, collagenase, could reprogram the adult
wound margin to a more fetal-like state, and thus abrogate the biophysical impediments
that hinder migration and proliferation. We tested this concept using the knee meniscus,
a commonly injured structure for which few regenerative approaches exist. To focus
delivery and degradation to the wound interface, we developed a system in which
collagenase was stored inside poly(ethylene oxide) (PEO) electrospun nanofibers and
released upon hydration. Through a series of in vitro and in vivo studies, our findings show
that partial digestion of the wound interface improves repair by creating a more compliant
and porous microenvironment that expedites cell migration to and/or proliferation at the
wound margin. This innovative approach of targeted manipulation of the wound interface,
focused on removing the naturally occurring barriers to adult tissue repair, may find
widespread application in the treatment of injuries to a variety of dense connective tissues.

5.2

Introduction

Dense connective tissues play central load-bearing roles in the musculoskeletal system
and thus are commonly injured. Damage to the knee and temporomandibular menisci
(Makris et al. 2011), the annulus fibrosus of the intervertebral disc (Guterl et al. 2013), and
tendons and ligaments (Yang et al. 2013), alters joint biomechanics and instigates
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degenerative changes. The poor intrinsic healing capacity of these tissues, especially
those lacking robust vasculature, reduces the efficacy of surgical repair procedures.
Indeed, repair is so limited in some of these tissues that excision, rather than repair, is the
treatment of choice (Makris et al. 2011). Methods that improve endogenous repair would
represent a significant advance in the treatment of injuries involving these tissues.
It is well appreciated that adult dense connective tissues have impaired healing compared
to fetal tissues (Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002). This
decrease in healing potential is independent of the fetal biochemical milieu, in that
differences persist in vitro (Ionescu et al. 2011, Stalling et al. 2008) as well as when fetal
tissues are transplanted to the adult in vivo environment (Favata et al. 2006). Instead, the
biophysical properties of these tissues may dictate repair potential. Since repair and
integration rely on the de novo synthesis of extracellular matrix (ECM) proteins to bridge
the wound gap, it follows that access to the wound site and colonization by matrixproducing cells are essential for repair to occur. In fetal tissue, collagen fibers are slender
and immature and the matrix is hypercellular relative to the adult. As tissues adapt to
muscular contractions in utero and ambulation after birth, collagen fiber size and density
increase, boosting mechanical properties, while cellularity markedly decreases (Ansorge
et al. 2011, Clark et al. 1983, Ionescu et al. 2011, Scott et al. 1994). While enabling
function in adults, this high ECM density and stiffness, coupled with a lower cellularity,
may pose barriers to endogenous healing. In contrast to 2D migration, cells in 3D must
overcome the biophysical resistance of their microenvironment in order to move, including
the high matrix stiffness (Ehrbar et al. 2011) and limited pore size (Wolf et al. 2013).
Similarly, tissue density and steric constraints may limit the capacity for a local proliferative
response. As tissue cellularity decreases, the distance a cell must travel also increases.
Therefore, improving interstitial cell mobility through the dense ECM of adult tissues as
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well as the local proliferative potential may be a crucial first step to fostering repair and
regeneration.
In this study, we use the knee meniscus as a test bed in which to evaluate a novel
approach to enhance connective tissue repair. The meniscus is a fibrocartilaginous
structure in the knee that mediates force transfer from the femur to the tibia. Meniscal
ECM structure is intrinsic to its function, where circumferential collagen bundles develop
to resist tensile hoop stresses (Fithian et al. 1990). Tissue maturation is inversely related
to the healing capacity of the meniscus, such that increasing patient age is correlated with
worse clinical outcomes, including higher rates of repair failure (Eggli et al. 1995,
Vanderhave et al. 2011). Importantly, patients over 40 with meniscal tears have fewer
cells at the wound interface than younger patients (Mesiha et al. 2007). Since 2D migration
is comparable between fetal and adult meniscal fibrochondrocytes (Ionescu et al. 2011),
these results suggest that the 3D microenvironment engendered by tissue maturation
antagonizes cellular migration, predisposing the meniscus to a limited repair capacity.
To evaluate the role of the ECM in meniscal healing, we reprogrammed the wound margin
of the adult meniscus towards a fetal-like state that would be more permissive to cell
migration and division. Specifically, we tested whether treatment with collagenase, a
matrix-degrading enzyme, could alter the density and stiffness of the wound
microenvironment to expedite cellular egress from tissue and/or local proliferation so as
to increase interfacial cellularity. To localize enzyme release, we developed composite
electrospun nanofibrous networks that could be tuned to release collagenase upon
implantation. Finally, we demonstrated enhanced repair using these novel materials in
both a subcutaneous xenotransplant (rat) model and an orthotopic meniscal injury (ovine)
model. These findings define a new paradigm in the treatment of connective tissue
injuries, wherein the ECM at the wound interface can be reprogrammed to a state that is
more amenable to repair.
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5.3
5.3.1

Methods and Materials
Cellular Egress from Meniscal Explants with Digestion

Menisci were isolated from adult cows (skeletally mature, 20–30 months) and tissue
cylinders excised using an 8 mm biopsy punch. Cylinders were concentrically cored with
a 4 mm punch to generate annuli and cores. To determine the effect of partial enzymatic
digestion on cell egress from explants, annular samples were incubated in basal media
(BM) (Qu et al. 2013) supplemented with collagenase (type IV from Clostridium
histolyticum, ≥125 collagenase digestion units/mg solid; Sigma-Aldrich, St. Louis, MO) at
37°C for 3 hours on an orbital shaker, after which they were rinsed in 1X phosphate
buffered saline (PBS) (Qu et al. 2013). Three conditions were tested: BM only (Control),
low-dose collagenase (LowC; 0.02 mg/mL), and high-dose collagenase (HighC; 0.06
mg/mL). Annuli were cultured at 37°C in BM (n=3 samples/group). Cell egress was
monitored on a daily basis via bright-field microscopy. After 10 days, explants were
removed, embedded in optimal cutting temperature (OCT) sectioning medium, and
cryosectioned axially to 16 µm thickness (Qu et al. 2013). Sections were stained with
Alcian Blue (AB) or Picrosirius Red (PSR) for sulfated proteoglycans (PGs) and collagen,
respectively, and imaged under bright-field microscopy. The remaining adherent cells
were incubated for 20 minutes with Hoechst 33342 (5 µg/mL; Invitrogen, Grand Island,
NY) to label cell nuclei and imaged by fluorescence microscopy. Cell density from four
distinct regions per sample was determined using ImageJ (Wayne Rasband, NIH).

5.3.2

Integration of Meniscal Repair Constructs with Digestion

To study the effect of enzymatic pre-treatment on integration, annuli and cores were
incubated in BM with 0 (Control), 0.01 (LowC), or 0.05 mg/mL (HighC) collagenase at
37°C for 6 hours on an orbital shaker, rinsed with 1X PBS, and assembled into repair
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constructs (Qu et al. 2013). Constructs were cultured in chemically-defined medium with
10 ng/mL TGF-β3 (Qu et al. 2013) for 1, 4, or 8 weeks. At set intervals, repair constructs
were fixed in 4% paraformaldehyde, embedded in paraffin, and axially sectioned to 8 μm
thickness for imaging, or embedded in OCT medium and axially sectioned to 20 μm
thickness for micromechanical measurements. Second harmonic generation (SHG)
imaging of the wound interface was performed at an excitation wavelength of 840 nm (Carl
Zeiss Microscopy GmbH, Jena, Germany) using unstained paraffin sections to visualize
the fibrillar architecture of collagen at the earliest time point (1 week of in vitro culture). To
identify nuclei, paraffin sections were stained with 4’,6-diamidino-2-phenylindole (DAPI;
Invitrogen) and imaged by fluorescence microscopy. Cell density at the interface was
determined by counting the number of nuclei within 100 µm of the interface present in
either the annulus or core (n=4 samples/group) (Qu et al. 2013).

5.3.3

Tissue Micromechanics in Meniscal Repair Constructs with Digestion

Force spectroscopy was performed on cryosections in PBS using an atomic force
microscope (AFM) mounted on top of an inverted optical microscope (Agilent, Santa Clara,
California). A V-shaped pyramidal-tipped cantilever was positioned either at the tissue
center or edge (a region within 100 µm of the wound interface). The probe tip was brought
into contact and force and displacement recorded. Elastic moduli were computed using a
Hertzian model (Sanchez-Adams et al. 2013) to an indentation depth of 300 nm using a
custom program. Measurements with a fitted R2≥0.98 were included (n=3 samples/group,
n=10 measurements/sample).

5.3.4

Fabrication of Nanofibrous Scaffolds to Enable Localized Digestion

Nanofibrous composites were formed via electrospinning using a custom tri-jet device
(Baker et al. 2009b). Composites contained a poly(ε-caprolactone) (PCL; 80 kDa, Sigma86

Aldrich) structural fiber fraction along with two water-soluble poly(ethylene oxide) (PEO;
200 kDa, Polysciences, Warrington, PA) fiber fractions. PEO fibers contained either no
collagenase (Scaffold) or 15.6% type IV collagenase by mass (Scaffold+C) (Qu et al.
2013). Electrospun mats were ~0.5 mm thick and stored at -20°C until use. To
demonstrate collagenase activity, cylindrical juvenile articular cartilage samples were
isolated using 4 mm biopsy punches. Cartilage cylinders were incubated in BM that
contained either no scaffold (Control), a control scaffold (Scaffold, 0.04 mg), or a
collagenase-releasing scaffold (Scaffold+C, 0.04 mg) at 37°C for 24 or 72 hours on an
orbital shaker. Samples were cryotomed to 16 μm, stained with AB, and imaged (Qu et al.
2013).

5.3.5

Subcutaneous Assessment of Collagenase-Releasing Scaffolds

To test the effect of enzymatic treatment on meniscal repair in vivo, a nude rat
xenotransplant model was employed. All procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) of the Philadelphia Veterans Affairs Medical
Center. Adult bovine meniscal explants (8 mm diameter, 4 mm height) were incised to
create a horizontal defect. The defect was either incubated in BM (Control) or in BM with
0.4 mg/mL collagenase at 37°C for 6 hours on an orbital shaker (aqC), or filled with a
control scaffold (Scaffold) or a collagenase-releasing scaffold (Scaffold+C). Scaffolds
were cut to 5 x 5 mm with a 2 mm diameter fenestration to permit tissue-to-tissue contact
and sterilized by UV. Defects were closed with absorbable sutures (3-0 Monocryl) before
subcutaneous implantation into male athymic nude rats under aseptic conditions (Hsd:RHFoxn1rnu, ~300 g). Under general anesthesia, four pockets were created in each rat. One
randomized construct per group was placed in each pocket and the incision was closed.
At 1 week (n=1/group) and 4 weeks (n=4/group), rats were euthanized by CO2
asphyxiation. Retrieved samples were paraffin embedded, sectioned to 8 µm, and stained
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with Hemotoxylin & Eosin (H&E), PSR, or DAPI. Integration was quantified by dividing the
cumulative length of integrated segments by the defect length in PSR sections (n=3–4
samples/group). Given the increased cell density of in vivo samples, cellularity at the
interface was evaluated using a modified protocol. Specifically, the nuclear signal from
DAPI-stained micrographs was converted to white (intensity=255) and background to
black (intensity=0) using ImageJ. Next, pixel intensity relative to the interface was
averaged across the defect length, starting from the interface up to a distance 700 µm
perpendicular to the defect. Signal intensity with respect to location was binned into 100
µm intervals for analysis (n=4 samples/group). Finally, immunohistochemistry was
performed to identify type I or type II collagen (Farrell et al. 2013).

5.3.6

Assessment of Collagenase-Releasing Scaffolds in an Ovine Model

All procedures were approved by the IACUC at the University of Pennsylvania, and studies
were performed in accordance with the NIH guidelines for the care and use of laboratory
animals. Under general anesthesia, bilateral femorotibial joint surgeries were performed
on five adult female Dorsett-Finn sheep. Following aseptic preparation, the medial
collateral ligament (MCL) was isolated and reflected distally using a bone block to
preserve the bone-ligament interface. A medial arthrotomy was performed followed by
placement of stay sutures in the body of the medial meniscus to allow traction for
increased exposure. A 10 mm full thickness longitudinal cut was made in the avascular
zone of the meniscus using a scalpel blade, followed by repair with vertical mattress
stitches using a braided polyester suture (2-0 Ethibond). Four groups were compared: 1)
repair only, 2) treatment with a control PCL/PEO scaffold placed in the defect (trimmed to
10 mm in length x 3 mm in width, with three 1 mm diameter fenestrations along the length)
in combination with repair, 3) treatment with a PCL/PEO scaffold releasing collagenase in
combination with repair, and 4) a partial meniscectomy (removing the meniscus tissue
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axial to the longitudinal injury). Treatments were randomized (n=3 for control scaffold
group, n=2 for all other groups). Afterwards, the joint capsule was repaired and the bone
block was repositioned and secured using a bone screw and washer. Animals received a
course of perioperative antimicrobials consisting of Potassium Penicillin and Gentamicin.
Analgesia was provided in the form of transcutaneous fentanyl patches for 3 days, intraarticular morphine and bupivacaine delivered intra-operatively, and NSAIDs for 7 days.
Animals were housed in individual 5 x 5 foot pens allowing for visual and olfactory contact.
All animals had uneventful recoveries with no noticeable gait deficits after 2 weeks. At 4
weeks, sheep were sedated and euthanized with an injection of commercial euthanasia
solution.
Following euthanasia, stifle joints were opened, and photographs taken of the meniscus,
cartilage, and other soft tissues. Menisci and other soft tissues (e.g. ligaments, fat pad)
were isolated and fixed in 10% formalin. Gross damage to the cartilage surfaces of the
tibial plateau and femoral condyles was assessed via India ink staining as previously
described (Gruchenberg et al. 2014) and quantified using ImageJ, where damage was
expressed as a percentage of the total area of the cartilage surface. For histology, menisci,
cartilage, and bone were paraffin embedded and sectioned to 6 μm thickness (Farrell et
al. 2013). For the menisci, radial cross-sections through the injury site were stained with
H&E and PSR and imaged. The cartilage and bone sections were stained with Safranin O
and Fast Green and imaged to visualize PGs and fibrous tissue, respectively.

5.3.7

Statistical Analyses

Statistical analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA) and
SPSS Statistics (IBM Corporation, Armonk, NY). Normality was assessed via the
Kolmogorov-Smirnov test. One or two-way ANOVA with Tukey’s HSD post hoc test was
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utilized to determine significant differences between groups (p≤0.05). Data is presented
as the mean ± standard deviation, unless specified otherwise.

5.4
5.4.1

Results
Enzymatic Digestion Enhances Cellular Egress from Explants

Adult meniscal explants incubated in collagenase showed dose-dependent degradation
of collagen and removal of sulfated proteoglycans (PGs) at the tissue margin, indicated
by Picrosirius Red (PSR) and Alcian Blue (AB) staining, respectively. While matrix
digestion was minimal for the low-dose collagenase group (LowC), high-dose collagenase
treatment (HighC) resulted in noticeable loss of peripheral matrix (Figure 5-1A),
consistent with previous findings (Qu et al. 2013).

Figure 5-1: Partial enzymatic digestion with collagenase enhances cellular egress from
meniscal explants in vitro. (A) Alcian Blue (AB) and Picrosirius Red (PSR) staining for
proteoglycans (PGs) and collagen, respectively. Collagenase digestion removes PGs and
collagens from the tissue edge. Scale = 100 µm. (B) Top-down schematic illustrating partial
enzymatic digestion of ring-shaped explants and emergent cells (blue dots). Box indicates
area imaged for (A). (C) Cell outgrowth onto tissue culture-treated plates 10 days after pretreatment with low- (LowC; 0.02 mg/mL) and high-dose (HighC; 0.06 mg/mL) collagenase
(n=3 samples/group, 4 measurements/sample, mean ± standard deviation). * = p≤0.05 vs.
Control and LowC.
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When treated explants were placed on tissue culture substrates (Figure 5-1B), meniscal
fibrochondrocytes emerged within 6 days. At 10 days, cell outgrowth was higher for HighC
samples (94 ± 43 cells/mm2) compared to other groups, with a 36% and 395% increase
over LowC (69 ± 60 cells/mm2) and untreated control (19 ± 13 cells/mm2) groups,
respectively (Figure 5-1C, p≤0.05). These data illustrate that the removal of physical
impediments at the wound edge can expedite cellular egress.

5.4.2

Degradation of the Wound Interface Reduces Matrix Density, Increases
Cellularity, and Alters Micromechanics

To focus on the wound interface, partial digestion of annuli and cores was performed prior
to their reassembly into concentric ‘repair’ constructs. Collagenase pre-treatment resulted
in dose-dependent modulation of the wound interface. After 1 week, second harmonic
generation (SHG) imaging revealed dense collagen bundles in untreated controls, with no
tissue formation across the wound gap. Conversely, HighC samples had thin, immature
fibrils populated by a higher number of cells bridging the wound gap (Figure 5-2A and
Figure 5-2B). Indeed, cell density at the annulus-core boundary was greater for HighC
samples (444 ± 139 cells/mm2) compared to all other groups by the 1 week time point,
with a 96% and 242% increase over LowC (226 ± 62 cells/mm2) and control (130 ± 37
cells/mm2) groups, respectively (Figure 5-2C, p≤0.05). These differences in matrix
density, defect integration, and cellularity persisted through 8 weeks for HighC compared
to all other groups, despite stable tissue-to-tissue apposition in all groups. Once the
differences in cell density were established, these values did not change with additional
time in culture, suggesting that partial degradation leads to a rapid and sustainable
accumulation of cells at the wound margin.
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Figure 5-2: Degradation of the wound interface reduces matrix density and increases
cellularity in an in vitro meniscal repair model. (A) Second harmonic generation imaging
shows collagen fibers (green) at the wound interface of control, low-dose collagenase
(LowC; 0.01 mg/mL), and high-dose collagenase (HighC; 0.05 mg/mL) repair constructs after
1 week of in vitro culture. Blue indicates autofluorescent signal. Arrows point to cells within
the matrix. Scale = 100 µm. (B) DAPI staining of axial sections show cell nuclei at the
interface (dashed line) after 1 week. Scale = 100 µm. (C) Cell density at the interface with
respect to treatment group and in vitro culture time (n=4 samples/group, mean ± standard
deviation). Cores (dark) and annuli (light) were counted as independent data points (no
statistical difference). Inset shows schematic of repair explant in an axial section, where the
boxes highlight the cell counting regions. * = p≤0.05 vs. Control. † = p≤0.05 vs. Control and
LowC. There was no difference between time points within the same treatment group.

Force spectroscopy via atomic force microscopy (AFM) of repair constructs (Figure 5-3A)
cultured for 8 weeks revealed persistent changes in micromechanics at the interface with
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treatment (Figure 5-3B). The Young’s modulus (EY) of the defect edge for LowC (345 ±
138 kPa) and HighC (210 ± 79 kPa) samples was lower than that of controls (488 ± 155
kPa) (Figure 5-3C, p≤0.05). Digestion with high-dose collagenase also reduced EY of the
HighC construct center (312 ± 133 kPa) compared to that of LowC (441 ± 151 kPa) and
control (496 ± 120 kPa) groups. Taken together, our results suggest that collagenase dose
can be tuned to mediate local matrix digestion and advance repair.

Figure 5-3: Location-dependent matrix micromechanics of repair constructs after 8 weeks
of in vitro culture. (A) Schematic of AFM nanoindentation measurements of matrix stiffness
across the wound interface of a HighC construct stained with PSR (collagen). Scale = 50 µm.
(B) Force indentation curves for each condition taken at the wound edge (mean ± standard
error of the mean for all samples). (C) Elastic modulus of the construct center and wound
edge

of

Control,

LowC,

and

HighC

constructs

(n=3

samples/group,

10

measurements/sample, mean ± standard deviation). * = p≤0.05 vs. Control. † = p≤0.05 vs.
Control and LowC. ‡ = p≤0.05 vs. all other groups.

5.4.3

Scaffolds Improve Integration in a Subcutaneous Model

Given the improvements in repair observed in vitro with collagenase pre-treatment, we
next translated these findings to the in vivo scenario. Here, we utilized a multi-jet
electrospinning setup in which poly(ε-caprolactone) (PCL) fibers (stable, structural) were
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electrospun along with two poly(ethylene oxide) (PEO) fiber fractions (soluble, factor
delivering), with each fraction collected simultaneously onto a common rotating mandrel
(Figure 5-4A) (Baker et al. 2009b). This fabrication scheme resulted in an aligned
composite scaffold containing ~50–60% PEO by mass, where the PEO fraction delivered
collagenase at varying doses. The morphology and bioactivity of PCL and PEO nanofibers
with or without collagenase have been previously characterized (Baker et al. 2008, Qu et
al. 2013). Incubation of cartilage explants with collagenase-releasing scaffolds
(Scaffold+C) (Figure 5-4B) decreased AB staining intensity at the tissue edge within 24
hours (data not shown), with further reductions at 72 hours (Figure 5-4C). Untreated
explants (Control) or those incubated with non-bioactive scaffolds (Scaffold) did not show
any alterations in staining intensity.

Figure 5-4: Fabrication of composite nanofibrous scaffolds with and without collagenase.
(A) Schematic of tri-jet electrospinning. (B) Schematic of composite scaffold composed of
poly(ε-caprolactone) (PCL) and poly(ethylene oxide) (PEO) fiber fractions, where enzyme
activity was localized to soluble PEO fibers. Bioactivity was verified by incubation with
cartilage cylinders. (C) AB staining of cartilage after 72 hours in Control, Scaffold, and
Scaffold+C groups. Staining intensity decreased at the tissue edge, indicating bioactivity of
the released collagenase. Scale = 250 µm.
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To evaluate scaffold-mediated repair in an in vivo setting, we placed bovine meniscal
repair constructs, either pre-treated with aqueous collagenase (aqC) or provided with a
bioactive scaffold (Scaffold+C), subcutaneously in nude rats (Figure 5-5A). Empty defects
(Control) and non-bioactive scaffolds (Scaffold) were used as negative controls. Control
and Scaffold groups retained a dense local ECM, had few cells present at the wound
margin, and showed little matrix deposition at the center of the defect. In contrast, samples
pre-treated with aqC or with Scaffold+C showed increased cellularity and interface
bridging by 1 week (data not shown). Quantification showed a trend towards improved
integration for Scaffold+C samples (87 ± 9%) compared to controls (59 ± 16%) by 4 weeks
(Figure 5-5B, p=0.07), with regions of the scaffold staining positive for cells (Figure 5-5C)
and type I and II collagen (Figure 5-5D).
As seen with aqueous collagenase treatment in vitro, the increase in cellularity at the
wound edge began as early as 1 week (data not shown). After 4 weeks, cell signal intensity
local to the interface was higher in Scaffold+C repairs compared to all other groups
(Figure 5-6A). This increase in cell number was significant for a distance up to 300 µm
from the wound compared to aqC, and 400 µm compared to Control and Scaffold groups
(Figure 5-6B, p≤0.05). The highest cell density was within 100 µm of the interface for both
aqC and Scaffold+C groups. This gradient in cellularity was not observed in Control or
Scaffold groups, where the matrix remained intact. Collectively, these data suggest that
collagenase-releasing scaffolds can modulate repair in vivo.
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Figure 5-5: Collagenase treatment improves meniscal integration after 4 weeks of
subcutaneous implantation. (A) Schematic of repair construct assembly. Scaffold is
fenestrated to allow tissue-to-tissue contact. (B) Quantification of histological integration
normalized to defect length (n=3–4 samples/group, mean ± standard deviation). Line
indicates trend for difference between groups (p=0.07). (C) H&E (cells and matrix) and PSR
(collagen) staining at the defect site after 4 weeks. Asterisk indicates scaffold. Scale = 100
µm. (D) Immunohistochemistry for type I and II collagen. Staining at interface was of higher
intensity for collagenase-treated groups (aqC and Scaffold+C), and largely absent in Control
and Scaffold groups. Arrow indicates suture track in aqC sample. Schematic illustrates
transverse cross-section with or without fenestrated scaffold present. Scale = 2 mm.
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Figure 5-6: Cellularity proximal to the wound interface increases with collagenase treatment
after 4 weeks of subcutaneous implantation. (A) Thresholded images of DAPI-stained nuclei
for each group at 4 weeks. Interface is on the left (red line). Scale = 100 µm. (B) Average
intensity with respect to distance from the interface (n=4/group, mean ± standard deviation).
* = p≤0.05 vs. all other groups at the same distance, † = p≤0.05 vs. Control and Scaffold at
the same distance, ‡ = p≤0.05 vs. aqC distances ≥400 µm, § = p≤0.05 vs. all other Scaffold+C
distances.

5.4.4

Scaffolds Promote Meniscal Repair in an Ovine Model

To advance this technology towards clinical translation, we tested scaffolds in a pilot study
using an orthotopic large animal model representative of the mechanically challenging and
avascular environment of the adult synovial joint. The ovine model was chosen based on
its consistency with human meniscal anatomy, function, and limited healing response
(Arnoczky et al. 2010). Full-thickness vertical incisional defects were created in the
avascular body of the medial meniscus (Figure 5-7A). Defects were repaired by suture
following standard surgical protocol (Repair), or repaired with suture in addition to a control
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scaffold (Scaffold) or a scaffold releasing collagenase (Scaffold+C). One additional group
consisted of a partial meniscectomy (partial removal).

Figure 5-7: Collagenase-releasing scaffolds promote repair at 4 weeks in an ovine meniscal
defect model. (A) Schematic and photograph of surgical approach, longitudinal meniscal
injury, and suture repair with scaffold. Asterisk indicates the bone block. (B) Radial sections
of the repaired meniscus at 4 weeks, stained with PSR (collagen). Arrow indicates suture
track. Scale = 2 mm. Magnified area shows enhanced integration of Scaffold+C with adjacent
tissue, where the asterisk indicates the scaffold. Scale = 100 µm. (C) Quantification of
damage to cartilage using India ink. Collagenase release by Scaffold+C did not adversely
affect the cartilage.

Four weeks post-operatively, all Scaffold and Scaffold+C groups and one Repair group
remained intact. One Repair sample failed partially due to suture pulling through the injury
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site. Histological staining of the meniscus (Figure 5-7B) revealed variations in healing
based on group. For partial meniscectomy, the original injury site was readily visualized,
with no new tissue formation. For the Repair group, the injury was clearly identified as a
gap that persisted across the inner and outer portions of the meniscus, with no new tissue
formation. Similar findings were obtained for the Scaffold group. Defects treated with
Scaffold+C groups, however, showed clear apposition of the margins and tissue formation
both within and around the scaffold across the length and height of the defect, suggestive
of a robust healing response (Figure 5-7B, inset).
To determine whether cartilage and other joint structures were perturbed by either injury
or treatment, India ink staining was performed. This analysis revealed low levels (<5%) for
all specimens from the non-operative joint compartment (the lateral tibial plateau, Figure
5-7C). In the operative compartment (the medial tibial plateau), the partial meniscectomy
group had the highest values. All repair groups had low levels of cartilage damage (3–
11%), though all were higher than that of the non-operative side. Evaluation of other joint
tissues (anterior cruciate ligament, posterior cruciate ligament, fat pad, synovium) showed
no changes with Scaffold or Scaffold+C compared to controls (data not shown), indicating
that enzymatic degradation was indeed confined to the wound margin.

5.5

Discussion

This study demonstrates that matrix reprogramming of the adult meniscal ECM to a fetallike state improves integrative repair. This in vivo analysis, consistent with our previous in
vitro studies (Qu et al. 2013), illustrates the potential of partial degradation of the meniscal
wound edge to enhance healing. Here, we establish that delivery of collagenase facilitates
repair by expediting cell migration to and/or proliferation at the wound site. Furthermore,
we reduce this concept to practice by demonstrating that localized collagenase delivery
via composite nanofibrous scaffolds in vivo enhances closure of meniscal defects without
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perturbing other intra-articular tissues. Collectively, these data define a novel methodology
for the treatment of dense connective tissues that are recalcitrant to regenerative healing
due to the intrinsic characteristics of their dense and hypocellular ECM.

Figure 5-8: Extracellular matrix reprogramming of the wound interface to a fetal-like state
augments dense connective tissue repair. (A) Injury to fetal tissue results in a robust repair,
with cells rapidly colonizing the wound site and depositing new matrix. (B) Conversely,
healing of adult tissue is limited because few cells arrive at the wound site. (C) Scaffoldmediated reprogramming via collagenase-releasing nanofibers (green) reduces local matrix
stiffness and density, thereby releasing cells from these steric constraints. The wound gap
is bridged as cells colonize the defect and deposit matrix around the remaining scaffold
(pink). Over time, the scaffold degrades, allowing cells to remodel the interface.

This new endogenous tissue engineering approach may find widespread application in
injuries to tissues having low cellularity or lacking proper blood supply. When circulating
stem cells are precluded from the repair response (as is the case with dense connective
tissues), the pool of reparative cells is limited to those residing within the tissue itself or
those that migrate from neighboring structures. Unlike the hypercellular repair response
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seen in injured fetal tissue (Figure 5-8A), cells within adult tissue do not readily undergo
interstitial migration or local proliferation, resulting in a hypocellular wound margin with
minimal repair tissue formation (Figure 5-8B). It is likely that the high density and stiffness
of collagen bundles retard proteolysis-mediated migration and restrict proliferation. To
enhance cell mobility and provide sufficient space for division, we digested the tissue
border with collagenase, a proteolytic enzyme that cleaves fibrillar collagens (Figure
5-8C). Until recently, partial degradation has only been explored in the context of articular
cartilage repair. Short-term enzymatic treatment can increase interfacial chondrocyte
density and improve interfacial strength in vitro (van de Breevaart Bravenboer et al. 2004),
as well as enhance integration of cartilage explants to engineered cartilage (Obradovic et
al. 2001) and to acellular scaffolds (Ng et al. 2012). In concordance with this literature, we
show here that collagenase also enhances the integration of the knee meniscus, and can
be applied in conjunction with a standard suture repair to meniscal injuries in vivo.
Reducing ECM stiffness and density at the wound margin via enzymatic treatment may
improve fibrous wound healing by freeing cells from their spatial confinements to improve
migration and/or local proliferation, although other factors may contribute as well. For
instance, collagen fragments can act as biochemical signals for cell proliferation
(Koohestani et al. 2013) and migration (Shi et al. 2010). Likewise, exposing cells to the
underlying collagen network via depletion of PGs may stimulate matrix deposition
(MacBarb et al. 2013). Degrading the defect edge may also release matrix-bound latent
transforming growth factor-beta (TGF-β) (Tatti et al. 2008), which could promote either a
myofibroblastic phenotype that may be beneficial to fibrous wound healing (Hinz 2007,
Kambic et al. 2000) and/or recruit endogenous stem cells to the wound environment (Lee
et al. 2010). Regardless of the precise mechanism of action, increasing the quantity of
matrix-producing cells at the wound interface benefits the early phase of repair. While
collagenase improved the interface in our study, additional cues may be required to
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accelerate ECM maturation to prevent re-injury. For example, delivery of TGF-β could
enhance matrix synthesis (Ionescu et al. 2012b), while lysyl oxidase could stabilize the
wound interface by promoting collagen crosslinking (DiMicco et al. 2002, Makris et al.
2014). On the tissue level, controlled resumption of load-bearing activity, engendering
both tensile and compressive loading, could promote development of native tissue
architecture (Baker et al. 2011, Puetzer et al. 2012). Since 3D migration depends on
deformation and contraction-mediated movement through tight interstitia, cell mechanics
and contractility pathways might also be manipulated to enhance mobility (Harada et al.
2014, Wolf et al. 2013) and thereby improve endogenous tissue repair.
In order to translate our findings towards clinical application, we developed methods by
which enzyme delivery could be localized to the wound margin. Injectable collagenase is
currently in clinical use for the treatment of Dupuytren’s contracture, a fibroproliferative
disorder (Bendon et al. 2012), where the factor is directly injected into the aberrant tissue.
However, such diffuse, non-targeted injection into a synovial joint would reduce the
efficacy of the factor and could damage surrounding intra-articular structures. To
overcome this, we developed collagenase-releasing nanofibrous scaffolds that could be
inserted into the wound site. We and others have used such bioactive nanofiber-based
systems to direct new tissue formation for the meniscus and other musculoskeletal tissues
(Fu et al. 2008, Manning et al. 2013, Qu et al. 2013). Here, we took advantage of the rapid
dissolution of the PEO fiber fraction to provide an immediate and localized burst delivery
of enzyme. Incubating these scaffolds with cartilage and meniscus resulted in matrix
digestion and PG removal at the tissue margins, demonstrating retention of bioactivity
during scaffold fabrication and sterilization. When inserted into meniscal defects,
composite scaffolds released collagenase in a targeted manner, creating a gradient of
matrix loss. After PEO dissolution, the stable, aligned PCL fiber fraction remained as a
physical template to provide instruction for ECM synthesis (Baker et al. 2012). Both PEO
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and PCL are FDA-approved materials, making these acellular scaffolds an attractive
system for translation.
Having established a biocompatible delivery vehicle, we next evaluated whether
biomaterial-mediated matrix degradation of the meniscal wound interface could be
achieved in vivo, and whether this might enhance cellular infiltration, local proliferation,
and tissue integration. In both a subcutaneous xenotransplant model in the nude rat and
an orthotopic injury model in adult sheep, meniscal defects treated with collagenasereleasing scaffolds showed improved cellularity at the wound margin. While it is difficult to
decouple increased migration at the wound margin from cell division, both may have
contributed to increase local cellularity within this region; future studies will include BrdU
labeling during repair to identify the specific contributions of these two complementary
processes. Regardless, this increased cellularity at the wound margin correlated with
matrix deposition around and within the scaffolds, resulting in wound closure by 4 weeks.
Notably, there was neither gross nor histological evidence of adverse changes outside the
defect. Based on this data, we believe that, when used alongside a standard suture repair,
this acellular, bioactive scaffold will enable wound healing in an environment that is
biologically and biomechanically unfavorable for repair.
While nanofibrous composites have previously been exploited for tissue engineering of
the meniscus (Baker et al. 2012), this is the first instance where localized delivery of
therapeutics via nanofibers was used to enhance endogenous meniscal integration.
Simultaneous electrospinning of multiple, discrete fiber families allows for the fabrication
of highly tunable scaffolds (Baker et al. 2009b) that are capable of delivering multiple
biologic factors with varying release profiles. As such, this technology may be modified to
deliver additional agents to facilitate repair, including chemoattractants to recruit both
native (Bhargava et al. 1999) and endogenous stem cells (Barreto Henriksson et al. 2013),
growth factors to promote matrix deposition (Ionescu et al. 2012b), and anti103

inflammatories to prevent matrix catabolism (McNulty et al. 2009). Likewise, the aligned
nanofibers themselves can direct matrix deposition (Baker et al. 2007), allowing the
scaffold topography to foster tissue formation that recapitulates essential structural and
mechanical anisotropies of the native meniscus and other organized connective tissues,
such as tendons and ligaments (Zhang et al. 2012). Lastly, biomaterial-mediated matrix
reprogramming may be utilized to enhance the integration of autologous meniscal
fragments (Kobayashi et al. 2010) or bioengineered replacements (Cook et al. 2006,
Gruchenberg et al. 2014, Kon et al. 2014, Maher et al. 2010, Verdonk et al. 2011) to
surrounding native tissue, currently a major logistical hurdle to translation.

5.6

Conclusions

In summary, limited cell mobility arising from inherent changes that occur with maturation
may limit endogenous healing of the adult meniscus and other dense connective tissues.
An innovative strategy to promote repair may be to first reduce the natural biophysical
constraints on native cells so as to facilitate their migration to and local proliferation at the
wound site. Given the long time course and high re-failure rate of fibrous tissue repair,
translational tools that enhance integration will improve treatment options for a multitude
of common orthopaedic injuries, changing the paradigm from one of resection to one of
regeneration.
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CHAPTER 6: MATRIX REPROGRAMMING ENHANCES INTERSTITIAL CELL
MIGRATION IN THE ADULT MENISCUS

6.1

Abstract

Few regenerative approaches exist for the treatment of injuries to adult dense connective
tissues. Compared to fetal tissues, adult connective tissues are hypocellular and show
limited endogenous cell-mediated healing after injury. However, it is unknown whether this
deficiency in repair is due to the limited cell number itself, by steric constraints to cell
mobility imposed by the extracellular matrix (ECM), or by a combination of the two. We
hypothesized that robust repair occurs in fetal tissues due to an immature ECM conducive
to cell migration, and that this process fails in adults as a consequence of the dense and
stiff ECM that acts as a biophysical impediment. Using the knee meniscus as a test
platform, this study evaluated the microstructure and micromechanics of fetal and adult
tissues, with a particular focus on the inter-fibrillar regions through which cells might
migrate. Further, we monitored the morphology and interstitial migration of adult meniscal
cells through fetal and adult tissue microenvironments. Finally, building from our recent
studies showing that local pre-treatment with collagenase improves cellular colonization
of the wound interface in the adult meniscus, we measured adult cell migration through a
pre-digested adult ECM. Our results show that the microstructure and micromechanics of
the adult meniscus ECM act as physical barriers to cell mobility, and that modulating the
ECM microstructure via an exogenous matrix-degrading enzyme permits cell migration
through this otherwise impenetrable collagenous network.
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6.2

Introduction

Dense connective tissues, such as the knee and temporomandibular menisci, tendons
and ligaments, and the annulus fibrosus of the intervertebral disc, are essential for the
mechanical functionality of the musculoskeletal system. However, injuries often result in
poor self-repair, leading to altered biomechanical function and eventually joint
degeneration. Unfortunately, what little regenerative capacity exists also declines with
tissue maturation. For example, fetal connective tissues exhibit a robust healing response
(Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002), and meniscal tears
are rarely seen in young children but are a common orthopaedic injury in adults (Andrish
1996, Clark et al. 1983). Moreover, increasing patient age is correlated with worse clinical
outcomes after meniscal repair, including higher rates of repair failure (Barrett et al. 1998,
Eggli et al. 1995, Tenuta et al. 1994, Vanderhave et al. 2011). Consequently, many clinical
treatments focus on tissue removal instead of restoration, which reduces pain in the shortterm but ultimately leads to irreversible deterioration of the affected joint (Makris et al.
2011). As such, strategies that enhance endogenous repair may benefit the aging
population by delaying or even eliminating the need for end-stage total joint replacement.
Healing is characterized by cellular invasion into the defect, with subsequent proliferation,
synthesis of new matrix to bridge the wound gap, and tissue remodeling (Kambic et al.
2000, Kawamura et al. 2003). Therefore, a sufficient number of reparative cells at the
wound interface are critical for successful integrative repair. However, cellularity
decreases progressively with maturation until a low cell density is reached in the adult
(Clark et al. 1983, Ionescu et al. 2011). Importantly, Mesiha et al. found that patients with
meniscal tears who were over 40 years old had significantly fewer cells at the wound
interface than younger patients (Mesiha et al. 2007). This deficiency may be compounded
by the limited cell mobility through the physically restrictive microenvironment of adult
tissue. During development, ECM collagen and proteoglycan (PG) content increase with
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load-bearing use of the tissue, resulting in increased bulk mechanical properties (Ionescu
et al. 2011). Unlike migration in 2D, adult cells in 3D must overcome the increased
biophysical resistance of their surrounding environment. As the pores through which cells
crawl become progressively smaller, migration rates decline and eventually cells are
rendered immobile (Wolf et al. 2013). Extremely stiff or non-degradable matrices also
obstruct cell movement because they cannot be effectively remodeled to allow cell
passage (Ehrbar et al. 2011, Raeber et al. 2007). Thus, spatial confinement within the
ECM may prevent endogenous cells from reaching the injury site to affect repair in adult
dense connective tissues.
Despite the wealth of knowledge gained from recent 3D migration studies, the vast
majority of in vitro microenvironments, such as Matrigel (Zaman et al. 2006) and collagen
gels (Miron-Mendoza et al. 2010, Wolf et al. 2013), synthetic hydrogels (Ehrbar et al. 2011,
Singh et al. 2014), or microfabricated chambers (Lautscham et al. 2015, Pathak et al.
2012), bear little resemblance to native dense connective tissues. Importantly, the
collagen content of juvenile bovine dense connective tissues (200–250 mg/mL)
(Eleswarapu et al. 2011) is up to 100 times the concentration typically used for collagen
gels in vitro (Even-Ram et al. 2005). Furthermore, the high level of collagen crosslinking
and alignment in native tissue results in a tightly packed fibrous network with increased
resistance to proteolysis (Reiser et al. 1992). This matrix density and organization likely
make such interstitial spaces considerably less permissive to migration than in vitro
preparations commonly used in this field to evaluate migration. Indeed, it is likely that such
in vitro observations in isotropic, non-native environments will not fully recapitulate the
impediments to migration seen in dense connective tissues, and so there is a pressing
need to develop new systems to study 3D cell migration in a more physiologic context.
To address this limitation, we investigated interstitial cell migration in a physiologically
relevant environment by using devitalized tissue substrates as our experimental 3D milieu.
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We hypothesized that the native ECM is a biophysical impediment to cell mobility during
repair, and that reduction of this steric hindrance would expedite cell migration to the
wound site. Using the adult knee meniscus as a test platform, we determined that agerelated micromechanical and microstructural changes in the ECM are inhibitory to cell
migration. Furthermore, we demonstrated that modulating ECM properties via the
application of an exogenous matrix-degrading enzyme enhances interstitial mobility, and
that this acted synergistically with cell-produced endogenous MMPs to promote cell
migration through the dense ECM. By clarifying the role of local matrix properties in wound
repair, these studies may establish new clinical strategies to promote endogenous repair
of the meniscus and other fibrous tissues of the musculoskeletal system.

6.3
6.3.1

Materials and Methods
Tissue Substrate Fabrication

Fetal (late 2nd–3rd trimester) and adult (20–30 months) bovine stifle joints were sterilely
dissected and the knee menisci isolated. Cylindrical tissue explants (8 mm diameter) were
excised from the middle zone of medial meniscal bodies and embedded in Optimal Cutting
Temperature sectioning medium (OCT; Sakura Finetek, Torrance, CA). Samples were
axially cut into ~35 µm thick sections onto positively charged glass slides using a cryostat
microtome (Microm HM500; MICROM International GmbH, Waldorf, Germany), such that
the predominant fiber direction was parallel with the slide surface (Longitudinal). Also,
samples cut in the radial plane, such that the majority of fiber bundles were perpendicular
to the slide surface, were used to qualitatively image interpenetrating radial fibers (Cross
Section). Sections were stored at -20ºC until use.
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6.3.2

Second Harmonic Generation Imaging and Microstructural Analysis

Second harmonic generation (SHG) imaging was utilized to visualize fibrillar collagen
bundles in fetal (fECM) and adult (aECM) tissue sections (n=4 samples/group) (Qu et al.
2015). Prior to imaging, slides were hydrated and coverslipped with Permount. Beam
scanning was performed using a Zeiss LSM 510 NLO/META with a Zeiss Axiovert 200M
inverted microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). A 20X, 0.8 NA Plan
Apochromat air immersion objective was used for image acquisition (1X zoom). A tunable
1W Coherent Chameleon laser with a 90 MHz repetition rate and pulse width of <200
femtoseconds was used to generate an excitation wavelength of 840 nm. SHG and
autofluorescent signals were separated into different channels using bandpass filters of
390–465 and 500–550 nm, and represent fibrillar collagen parallel with the slide surface
and tissue ECM, respectively. Z-stacks at 1 µm intervals were acquired through the entire
tissue thickness, beginning at the apical tissue surface. Image analysis was performed via
the open-source platform Fiji (Schindelin et al. 2012). Maximum z-stack projections were
converted into binary images to identify discrete areas of positive and negative SHG
signal, representing organized fiber bundles parallel to the substrate and inter-fibrillar
material that constitutes the remaining tissue ECM (including radial fibers that interject
perpendicularly to the in-plane circumferential fibers). Inter-fibrillar area fraction was
calculated as a percentage of the total region of interest (450 x 450 µm). The average
diameter of each inter-fibrillar region was quantified via the Local Thickness plugin
(Dougherty et al. 2007). Regions smaller than 50 µm2 were excluded as artifacts.

6.3.3

Atomic Force Spectroscopy and Micromechanical Analysis

To assess tissue micromechanics as a function of age, force spectroscopy was performed
on hydrated fECM and aECM sections using an atomic force microscope (AFM).
Cryotomed sections on glass slides were gently rinsed in 1X phosphate buffered saline
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(PBS) to remove residual OCT compound prior to micromechanical testing. Force
spectroscopy was conducted in PBS with a Dimension Icon AFM (Bruker, Billerica, MA),
using a colloidal spherical tip (R ≈ 5 µm, nominal k ≈ 0.6 N/m) as described in (Li et al.
2015). Indentation force as a function of depth into the tissue was measured as the
microspherical tip indented the sample at a rate of 10 µm/s (n=50 indentations/group for
3 samples). Effective indentation modulus, Eind, was calculated using a finite thicknesscorrected Hertz model (Dimitriadis et al. 2002) with a Poisson’s ratio (ʋ) of 0.01 (Sweigart
et al. 2004) and a 35 µm nominal sample thickness via a custom MATLAB program
(MathWorks, Inc., Natick, MA).

6.3.4

Scanning Electron Microscopy

Scanning electron microscopy (SEM) was used to make qualitative assessments of ECM
organization at the nanoscale. Cryosections were fixed with Karnovsky’s fixative (Electron
Microscopy Sciences, Hatfield, PA) for 3 hours at room temperature, and stored in PBS
at 4°C until dehydration (<24 hours). The samples were dehydrated in a series of graded
ethanol-water mixtures (ethanol volume ratio: 25%, 50%, 75%, 80% and 100%), each for
two 10 minute immersions. Slides were then immersed in a series of graded mixtures of
hexamethyldisilazane (HMDS) (Sigma-Aldrich) and ethanol (HMDS volume ratio: 25%,
50%, 75% and 100%), each for two 10 minute immersions. Samples were air dried
overnight and stored in a desiccator prior to imaging. Samples were sputter coated with
platinum and micrographs were taken under high vacuum with a 3 kV electron beam using
a Supra 50VP SEM (Zeiss, Jena, Germany).

6.3.5

Cell Egress onto Tissue Substrates

Cell interaction and infiltration of devitalized tissue substrates were investigated using fetal
(fECM) and adult (aECM) meniscal cryosections, which were UV sterilized for 1 hour and
111

triple rinsed in PBS to remove residual OCT compound. To assess the effect of tissue age
on interstitial cell mobility and to determine whether the matrix can be ‘reprogrammed’ to
influence migration, three substrate conditions were tested in a first study (n=4
samples/group): fetal (fECM), adult (aECM), and aECM pre-treated with basal media (BM;
Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% Fetal Bovine Serum (FBS) and
1% Penicillin/Streptomycin/Fungizone (PSF)) supplemented with 0.1 mg/mL of
collagenase (type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg
solid; Sigma-Aldrich, St. Louis, MO) for 1 hour (aECM-C). To obtain freshly isolated cells,
adult explants (4 mm diameter, 3 mm height) from the middle zone of the medial meniscus
were incubated in BM. After ~3 weeks of in vitro culture, explants were rinsed in PBS and
incubated in 5 µg/mL of 5-chloromethylfluorescein diacetate (CellTracker™ Green;
Thermo Fisher Scientific Inc., Waltham, MA) in serum-free media (DMEM with 1% PSF)
for 1 hour to fluorescently label cells lining the explant surface. Explants were maintained
in serum-free media for an additional 30 minutes prior to being placed atop tissue
substrates to allow for cell egress. Slides with explants were placed in 4-well plates (Nunc,
Rochester, New York), covered with BM, and cultured at 37 ºC. Tissue explants cultured
directly on glass slides were used as controls.

6.3.6

Confocal Imaging and Morphometric Analysis

After 48 hours in BM, explants were removed from the substrate, and slides were rinsed
in PBS, fixed in 4% paraformaldehyde for 12 minutes, and rinsed twice more in PBS before
staining with 4’,6-diamidino-2-phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island,
NY) to visualize cell nuclei. Confocal z-stacks at 20X magnification and 1 µm intervals
were obtained in the FITC and DAPI channels to visualize cells, nuclei, and devitalized
matrix (autofluorescent in the DAPI channel) using a Nikon A1 confocal microscope (Nikon
Instruments; Melville, NY). Binarized maximum z-stack projections (GFP channel only)
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were used to quantify 2D cell projected area and morphology, including aspect ratio,
circularity, and solidity, using the software Fiji (n=71–97 cells/group) (Table 2-1). In
addition, samples were imaged via SHG to visualize collagen and cells, which were highly
autofluorescent.

Shape descriptor

Description

Equation

Aspect Ratio (AR)

Measure of elongation; ratio of the largest
diameter and the smallest diameter
orthogonal to it

Circularity

Measure of the degree to which a particle
is similar to a circle, taking into
consideration perimeter smoothness

Solidity

Measure of the boundary irregularity (the
overall concavity of a particle)

Table 6-1: Morphometric descriptors used for 2D projected cells.

6.3.7

Analysis of Interstitial Cell Migration

Interstitial cell migration was assessed by quantifying infiltration depth, defined as the
distance between the apical surface of the tissue and basal surface of the cell (n=15
cells/group). To edge detect cell and tissue boundaries respectively, confocal z-stacks in
the FITC (cell) and DAPI (tissue) channels were binarized using Fiji. Specifically, cells and
tissue were converted to white (intensity=255) and the background to black (intensity=0).
A region of interest (ROI) that circumscribed each cell was derived from the FITC
maximum projection. Then, a signal intensity profile in the z dimension (z-profile) was
generated, where 0 and 255 indicated 0% and 100% area with positive signal within the
ROI. The z location where the ROI first reached 127.5 (50% positive signal) was defined
as the apical surface of the cell or tissue. Similarly, the basal surface was defined as the
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last z location before the signal dropped below 127.5. Cells within artificial substrate
defects were excluded from analysis.

6.3.8

Enzymatic Degradation of Tissue Substrates

To better understand the effect of matrix degradation on the tissue microenvironment and
interstitial migration, 3 adult ECM groups of varying degraded states were tested:
untreated adult ECM (Control), and adult ECM pre-treated with 0.05 or 0.1 mg/mL of
collagenase in BM for 1 hour (LowC or HighC). Adult meniscal explants were incubated in
CellTracker™ Green and then placed atop sections to allow for cell egress as previously
described. To assess the contribution of endogenous, cell-produced matrix degrading
enzymes to migration, two media conditions were tested for each substrate group (n=4
samples/group): BM with or without 1 µg/mL of the broad spectrum MMP inhibitor GM6001
(MMPi; EMD Millipore Corporation, Billerica, MA). After 48 hours of incubation, samples
were processed as in the previous study, and cell morphology and infiltration depth were
quantified (n=100 cells/group).
To assess changes in tissue microstructure after collagenase treatment, SHG imaging
was used to characterize the inter-fibrillar area fraction and average diameter, as
previously described (n=10 stacks/group). Analysis focused on z-stacks that contained
primarily circumferential fibers, and those with large areas of perpendicular radial fibers
were excluded. Lastly, to assess changes in tissue micromechanics, force spectroscopy
was performed on a separate set of adult ECM substrates. Cryosections were first
incubated in BM with varying concentrations of collagenase (n=19–20 indentations/group):
0 (Control), 0.005, 0.01, 0.025, or 0.05 mg/mL. Samples were rinsed in PBS after 30
minutes of incubation, and micromechanics evaluated as previously described.
Afterwards, samples were processed for SEM imaging as previously described.
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6.3.9

Statistical Analyses

All experiments were performed for 2–3 meniscal donors per condition. Statistical
analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA). Significance
was assessed by one or two-way ANOVA with Tukey’s HSD post hoc for matrix stiffness,
inter-fibrillar area fraction and average diameter, cell area and shape descriptors, and
infiltration depth (p≤0.05). A cumulative distribution plot, coupled with the KolmogorovSmirnov test, was used to determine whether the distribution of infiltration was different
between groups (p≤0.05). Independent variables include tissue age, substrate treatment,
and media condition. Data are presented as mean ± standard error of the mean unless
specified otherwise.

6.4
6.4.1

Results
Microstructural and Micromechanical Changes with Meniscus Age

Devitalized tissue substrates, approximately 30–35 µm thick, were successfully prepared
and evaluated on glass slides. SHG imaging and AFM analysis of fetal (fECM) and adult
(aECM) meniscal sections revealed distinct microenvironments (Figure 6-1A). For
Longitudinal substrates in both age groups, the majority of tissue was positive for SHG
signal (green), confirming that the bulk structural component of the meniscal ECM was
aligned, fibrillar collagen (McDevitt et al. 1992). As with Longitudinal substrates, Cross
Section substrates showed increasing collagen fiber organization with age. The collagen
fibers in fetal tissue had poorly defined boundaries and appeared as a disorganized
network that weaved in and out of the substrate plane (Figure 6-1B). In contrast, the
radial fibers in aECM were evident as an arborizing pattern that wrapped around distinct
collagen fiber bundles. Examination of Cross Section substrates revealed significant SHG
signal attenuation when the prevailing fiber direction was perpendicular to the slide
surface, whereas the autofluorescent signal (red) intensity remained constant for
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substrates from both sectioning planes. SHG attenuation was also seen in the fiber
bundles in adult Longitudinal sections, suggestive of fiber crimping (Williams et al. 2005).
Despite regions of low SHG signal, the homogeneous and ubiquitous autofluorescent
signal indicated that the tissue did not contain vacuous pores through which cells might
migrate, but rather discontinuities in the collagenous microstructure (areas negative for
autofluorescence appeared to be sectioning artifacts). Thus, the inter-fibrillar regions
identified in the Longitudinal substrates corresponded either to organized collagen (so
called radial) fibers in the perpendicular plane, or other non-collagenous material in the
ECM, such as proteoglycans.

Figure 6-1: Collagen fiber organization increases with age. SHG images of fetal and adult
meniscal ECM in orthogonal planes with composite SHG (green) and autofluorescent signal
(red). (A) Longitudinal and (B) Cross Section substrates show circumferential and radial
fibers parallel to the glass slide, respectively. Scale = 100 µm.

Qualitatively, aECM had thicker and more organized collagen bundles than fECM. The
area fraction of inter-fibrillar ECM, indicated by the absence of SHG signal (black), was
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lower for aECM compared to fECM (Figure 6-2C, p≤0.05). However, discrete inter-fibrillar
areas were on average larger for aECM compared to fECM, most likely due to the welldeveloped radial fibers in this tissue (Figure 6-2D, p≤0.05). The average local modulus of
aECM was approximately 2 times greater than that of fECM (Figure 6-2E, p≤0.05).

Figure 6-2: Adult meniscal microenvironment is denser and stiffer than that of fetal tissue.
(A) Experimental schematic. (B) Top: SHG signal (green) of fECM and aECM. Scale = 50 µm.
Bottom: Binarized images depicting inter-fibrillar areas in black. (C) Area fraction and (D)
average diameter of inter-fibrillar regions (n=7–9 stacks/group, mean ± standard error of the
mean). (D) Tissue elastic modulus measured via AFM indentation and normalized to fECM
(n=50 indentations/group, mean ± standard error of the mean). # = p≤0.05 vs. fECM.

6.4.2

Cell Morphology and Migration Are Dependent on ECM Properties

We next investigated the impact of matrix age and ECM degradation on interstitial cell
migration. Adult meniscal cells from explants adhered, spread, and infiltrated into fECM,
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aECM, and aECM collagenase-treated (aECM-C) substrates within 48 hours (Figure
6-3B). The absence of tracker dye dilution over this period indicated minimal proliferative
activity. Cell morphology on native tissue showed an ECM-dependent response. Cells on
aECM were 3x larger than on fECM (Figure 6-3C, p≤0.05). Cells on both substrates
aligned in the fiber direction of the underlying tissue, although cells on aECM had a higher
aspect ratio and exhibited lower circularity and solidity compared to cells on fECM (Figure
6-3C, p≤0.05). Cells that egressed onto aECM-C were smaller and rounder compared to
those on aECM, better approximating those on fECM (Figure 6-3C, p≤0.05).

Figure 6-3: Cell morphology is dependent on tissue age and treatment. (A) Experimental
schematic. (B) 2D z-projections of cells on fECM, aECM, and aECM-C. Scale = 50 µm. (C)
Morphology of adult meniscal cells on aECM and aECM-C, normalized to fECM values
(dashed red line) (n=71–97 cells/group, mean ± standard error of the mean). # = p≤0.05 vs.
fECM. * = p≤0.05 vs. all other groups.
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Cells migrating through aECM were visibly more deformed compared to those migrating
through fECM and aECM-C. Indeed, within this dense ECM, cells formed narrow
protrusions into the surrounding matrix (Figure 6-4A and Figure 6-4B). Infiltration depth
was greater for cells on fECM compared to cells on aECM (Figure 6-4C and Figure
6-4D, p≤0.05). When the adult ECM was digested, cells migrated to a similar extent as on
fECM, with 20% of the population reaching depths of ≥25 µm from the surface (Figure
6-4C and Figure 6-4D, p≤0.05). Collagen degradation was confirmed with SHG and SEM
imaging (Figure 6-5A and Figure 6-5B), which demonstrated the disruption of organized
collagen fiber bundles on the microscale and breakdown of collagen fibrils on the
nanoscale. These microstructural changes were reflected by changes in the local
modulus, which decreased with increasing collagenase dose (Figure 6-5C, p≤0.05).

Figure 6-4: Interstitial cell migration is dependent on tissue age and treatment. (A) 2D
confocal slices showing cells (green) within the tissue depth (blue). Scale = 50 µm. (B) 3D
confocal reconstruction of the cells in (A). Arrows indicate protrusions. Scale = 10 µm. (C)
Cell infiltration depth with schematic inset (n=15 cells/group, mean ± standard error of the
mean). (D) Cumulative frequency of infiltration depth. * = p≤0.05 vs. all other groups.
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Figure 6-5: Degrading fibrillar collagen reprograms adult matrix to a fetal-like state. (A) 2D
SHG images of autofluorescent cells (red) interacting with collagen fibers (green) on the
tissue surface. Box indicates relative scale of micrographs in (B). Scale = 50 µm. (B) SEM
micrographs of collagen fibrils. Scale = 1 µm. (C) Local indentation modulus of tissue
substrates after digestion with varying concentrations of collagenase, normalized to
untreated adult Control values (dashed red line) (n=19–20 indentations/group, mean ±
standard error of the mean). Dashed blue line indicates relative modulus of fetal tissue. * =
p≤0.05 vs. Control. ** = p≤0.05 vs. all other groups except 0.025 mg/mL.

6.4.3

Dose-Dependent ECM Degradation Enhances Interstitial Cell Migration

SHG imaging of adult meniscal sections pre-treated with various levels of collagenase
revealed distinct microenvironments (Figure 6-6A). Qualitatively, untreated Control
substrates had thicker and more organized collagen bundles than the low-dose (LowC)
and high-dose (HighC) collagenase groups. The area fraction of inter-fibrillar ECM,
indicated by the absence of SHG signal, increased with collagenase dose (Figure 6-6B,
p≤0.05). The average diameter of discrete inter-fibrillar regions also increased with
collagenase dose, suggesting local interruption of the native collagen network (Figure
6-6C, p≤0.05).
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Figure 6-6: Matrix degradation decreases ECM density in a dose-dependent manner. (A)
SHG signal (green) of substrates showing altered fibrillar collagen structure with digestion.
Arrows indicate inter-fibrillar regions. Scale = 20 µm. (B) Area fraction and (C) average
diameter of inter-fibrillar regions (n=10 stacks/group, mean ± standard error of the mean). *
= p≤0.05 vs. all other groups.

Adult meniscal cells from explants adhered and infiltrated into the devitalized tissue
substrates within 48 hours (Figure 6-7A). Cells in the untreated Control group remained
predominantly spread on the tissue surface, whereas cells in the collagenase groups were
found within or below the tissue substrate (Figure 6-7B). Cell infiltration depth was
significantly greater for the HighC group compared to the LowC and Control groups, with
approximately half of the cells migrating ≥10 µm from the surface, and over 10% of cells
reaching depths of ≥20 µm (Figure 6-7C and Figure 6-7D, p≤0.05). When cell-produced
MMPs were inhibited (MMPi), cellular infiltration depth was decreased for the HighC group
only. This suggests that endogenous MMPs play a lesser role than exogenous MMPs in
enhancing interstitial cell mobility, and that a certain degradative threshold must be
reached before cell-mediated proteolysis can effectively promote migration through adult
meniscal ECM.
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Figure 6-7: Exogenous and endogenous matrix degradation work synergistically to enhance
interstitial cell migration. (A) 3D confocal reconstruction of adult meniscal cells (green) on
tissue substrates (blue). Scale = 20 µm. (B) Cross-sectional view of (A). Arrows point to
infiltrating cells. Scale = 10 µm. (C) Average and (D) cumulative frequency distribution of
cell infiltration depth (n=100 cells/group, mean ± standard error of the mean). * = p≤0.05 vs.
all other groups. ++ = p≤0.1 vs. Control.

While cells on all substrates aligned in the fiber direction of the underlying tissue, cell
morphology was dependent on substrate degradation and MMP inhibition. Cell area
decreased with increasing substrate degradation, but was not affected by MMPi (Figure
6-8B, p≤0.05). Circularity and solidity also increased with substrate degradation in the
absence of MMPi (Figure 6-8D and Figure 6-8E, p≤0.05).
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Figure 6-8: Migratory cell morphology is determined by exogenous and endogenous matrix
degradation. (A) Binarized confocal maximum projections showing cells (white) on
substrates of various degradative states with or without MMP inhibition (MMPi). Scale = 50
µm. (B) Cell area and morphometric values, including (C) aspect ratio, (D) circularity, and
(E) solidity, were calculated from z-projections (n=100 cells/group, mean ± standard error of
the mean). * = p≤0.05 vs. Control and LowC. + = p≤0.05 vs. Control. ++ = p≤0.1 vs. Control. #
= p≤0.05 vs. MMPi.
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Figure 6-9: Cell morphology as a function of infiltration depth for different substrate
treatments (Control, LowC, and HighC) and media conditions (with or without MMPi). Scatter
plot markers represent individual cells and lines represent group averages. (A) Cell area and
morphometric values, including (B) aspect ratio, (C) circularity, and (D) solidity, were
calculated from z-projections (n=100 cells/group). Cells with infiltration depth ≥10 µm are
considered highly infiltrative.
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Cells became more elongated, less circular, and less solid (more cellular protrusions) in
the presence of MMPi for both the LowC and HighC samples (Figure 6-8C–E, p≤0.05).
Morphometric changes due to MMPi were only observed in the collagenase-treated
groups, and were most striking when comparing highly infiltrative cells on substrates with
low levels of digestion (Figure 6-9). That is, cells in the LowC MMPi group that reached
depths of ≥10 µm into the tissue (4% of the cells) were extremely elongated, with an
average aspect ratio 2 times greater than the population average and an average
circularity 2 times lower than the population average (Figure 6-9B and Figure 6-9C).
These differences were present but attenuated in the LowC group and altogether absent
in the HighC substrate groups. These findings suggest that once sufficient enzymatic
degradation is achieved, the degree of deformation required for migration is reduced.

6.5

Discussion

Cell migration plays a pivotal role during tissue repair, where cells must first migrate to the
defect, and then proliferate and form new matrix. Both high extracellular matrix (ECM)
stiffness and density have been implicated as barriers to 3D migration (Ehrbar et al. 2011,
Wolf et al. 2013), especially when cell-mediated proteolysis via matrix metalloproteinases
(MMPs) is inhibited. Although the highly organized ECM of mature dense connective
tissues enables mechanical function, these densely packed collagen fibers may inhibit cell
migration after injury, resulting in poor healing in adults. Our findings suggest that cell
mobility through dense connective tissues decreases with tissue maturation, which may
be attributed to biophysical impediments in the adult microenvironment. Compared to the
fetal ECM, adult ECM is denser and stiffer on the microscale. Circumferentially aligned
collagen fibers, the bulk constituent of the meniscal ECM, are thicker and more organized
in adult tissue. This qualitative difference extends to collagen fibrils (the building blocks of
fibers), indicating there may be also age-dependent supramolecular changes on the
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nanoscale. Furthermore, the interdigitating radial fibers in adult ECM appear to
circumscribe the circumferential fibers and group them into distinct bundles, a
phenomenon that is largely absent in fetal ECM. Consequently, there is less matrix
discontinuity in adult tissues, although the presence of well-developed radial fibers and/or
proteoglycan-rich microdomains (Han et al. 2013) gives rise to larger inter-fibrillar regions.
These observations are consistent with previous histologic findings (Ionescu et al. 2011,
Melrose et al. 2005), as well as other anatomical descriptions that span a wide range of
imaging modalities (Andrews et al. 2014, Campo-Ruiz et al. 2005, Rattner et al. 2011).
To study interstitial cell mobility within a native tissue microenvironment, freshly isolated
meniscal cells and devitalized tissue cryosections were used. Cells sense and respond to
the anisotropic topography of meniscal tissue, where they align along the primary fiber
axis of Longitudinal substrates but do not exhibit a preferred orientation on Cross Section
substrates (data not shown), similar to behavior on aligned versus non-aligned
electrospun nanofibrous scaffolds (Baker et al. 2007). Furthermore, cell morphology and
behavior is dependent on both ECM and cell age. In addition to biophysical changes to
the microenvironment, differences in the amount and distribution of adhesion ligands such
as fibronectin (Singh et al. 2014) may affect cell mechanotransduction and migration. Cellintrinsic factors, such as cell mechanics (Harada et al. 2014), receptor-mediated adhesion
(Wolf et al. 2013), and cytoskeletal contractility (Wolf et al. 2013), may also contribute to
these discrepancies. Interestingly, the morphological disparities seen between fetal and
adult substrates are lost with cell expansion on tissue culture plastic (data not shown).
This phenotypic convergence is likely due to increased contractility and α-smooth muscle
actin expression that occurs with in vitro culture on rigid substrates (LeBlon et al. 2015,
Majd et al. 2009, Talele et al. 2015, Yang et al. 2014). As such, we chose to use Passage
0 cells for our migration studies to preserve the native cell phenotype.
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While enhanced microstructural organization, combined with higher collagen and
glycosaminoglycan content, improves the mechanical properties of adult tissues, it does
so at the expense of interstitial cell mobility. Adult meniscal cells on fetal tissue are smaller
and more invasive than the same cells on adult tissue, which exhibit enhanced cell
spreading on the substrate surface and elongation along the collagen fiber direction.
Importantly, infiltration occurred primarily at inter-fibrillar regions, which are more
numerous and compliant in immature fetal tissue. Migrating cells appear rounded within
fetal tissue, whereas cells migrating through adult tissue must deform through narrow
crevices between rigid, aligned collagen bundles, similar to the steric constraints imposed
by decreasing pore size in Transwell assays (Rowat et al. 2013, Wolf et al. 2013) and
microchannels (Lautscham et al. 2015). It is known that large pores and a soft matrix favor
cell rounding and rapid migration, whereas small pores and a stiff matrix force cells to
shrink their diameter and lengthen, reducing migration speed (Friedl et al. 2010).
Interestingly, cells do not prefer direct routes through the depth of adult tissues, which
would force them to advance perpendicular to the circumferential bundles. Instead, highly
infiltrative cells navigate downward with a gradual, sloped trajectory, such that the cell and
nucleus remain highly elongated and aligned with the surrounding collagen. This behavior
is not apparent in isotropic environments and highlights how ECM density and architecture
of the mature meniscus influence the mode and efficiency of cell migration. In addition,
deformation through small pores (≤3 µm diameter) is limited by the nucleus (Lautscham
et al. 2015, Rowat et al. 2013, Wolf et al. 2013), which is the largest organelle and 2–4
times stiffer than the surrounding cytoplasm (Guilak et al. 2000). Stem cell differentiation
and increased tissue micromechanics have been implicated in higher nuclear stiffness
(Pajerowski et al. 2007, Swift et al. 2013), and our preliminary data indicate that adult
meniscal cell nuclei are less deformable than their fetal counterparts (data not shown).
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Thus, the biophysical properties of both the cells and their surrounding matrix may
contribute to the dearth of reparative cells at the wound site and subsequent poor repair
in the adult meniscus, and could be simultaneously targeted in future therapies to optimize
cell migration.
Since obstructed interstitial cell migration may prevent proper healing of the adult
meniscus and other dense connective tissues, an innovative strategy to promote repair
may be to first free native cells from the matrix so as to facilitate migration to the wound
site. Indeed, we found that interstitial cell mobility increases with matrix degradation. Adult
meniscal cells on devitalized adult tissue sections pre-treated with collagenase were
smaller, rounder, and more invasive than the same cells on untreated tissue, similar to
cells on fetal tissue. Partial enzymatic digestion improved cell mobility by increasing the
area fraction and size of inter-fibrillar regions (via cleavage of collagen fibrils and/or
removal of PGs (Qu et al. 2013)) and also by decreasing the local ECM stiffness. The
softer, fetal-like matrix may also promote cell invasion by up-regulating endogenous MMP
secretion and inducing the formation of protrusive structures called invadosomes (Gu et
al. 2014). In addition, denatured collagen fragments may influence cell migration by acting
as chemoattractants (Shi et al. 2010) and/or by altering cell-substrate binding (Tuckwell
et al. 1994). On a smaller scale, proteolytic remodeling of the pericellular matrix by cellsecreted enzymes may generate gaps to allow for cell passage (Friedl et al. 2009).
Blocking cellular MMPs in our system increased cell elongation and decreased infiltration
depth, suggesting that exogenous and endogenous MMPs act synergistically to remodel
the ECM during migration. However, this effect was only observed in the high-dose
collagenase group, indicating that when the steric barrier is too great, endogenous MMPs
are insufficient to enable migration, and cells instead rely more on cell deformation through
the inter-fibrillar clefts. Since only one time point was evaluated, it is unclear whether
endogenous MMP activity will increase with time and eventually become sufficient to
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counteract physical hindrance. To address these unknowns, we are currently developing
a computational model that predicts the likelihood of migration based on cellular and
extracellular parameters.
Our results suggest that a critical dose of exogenous matrix-degrading enzyme may be
required to initiate interstitial cell migration after injury. This may be especially relevant in
the context of aged and/or degenerate menisci in osteoarthritic tissues, which exhibit
increased micromechanical heterogeneity and overall higher moduli than healthy human
menisci (Kwok et al. 2014). However, treatment must be targeted to the defect to prevent
further structural and mechanical damage to the meniscus and adjacent articular tissues.
To that end, we developed a nanofibrous system that delivers a controlled release of
collagenase directly to the wound site (Qu et al. 2013). Previously, we showed that
reprogramming the meniscal wound interface with collagenase reduces local ECM density
and stiffness, increases interfacial cellularity, and facilitates repair in vitro as well as in vivo
in an orthotopic model of meniscal repair (Qu et al. 2015). This technique has been widely
explored in the context of articular cartilage repair, where short-term treatment with
enzymes such as trypsin, collagenase, and hyaluronidase increased chondrocyte density
at the interface and improved interfacial strength of native and engineered cartilage in vitro
(Bos et al. 2002, Janssen et al. 2006, Obradovic et al. 2001, van de Breevaart Bravenboer
et al. 2004). Partial enzymatic degradation with collagenase has also successfully
enhanced interfacial cellularity and integration of cartilage to a synthetic scaffold (Ng et al.
2012). Here, we provide further evidence that expedited migration to the injury site is a
major mechanism underlying these superior healing responses. Once cells have reached
their destination, additional cues may be introduced to stimulate matrix deposition
(Ionescu et al. 2012b), prevent matrix catabolism (McNulty et al. 2007), and promote
collagen crosslinking (Makris et al. 2014) and alignment (Baker et al. 2011). By combining
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these diverse but complementary processes, the standard treatment paradigm for fibrous
tissue injuries will soon shift from resection and replacement to preservation and repair.

6.6

Conclusions

Partial enzymatic digestion of the adult ECM expedites interstitial cell migration, a first step
in endogenous tissue repair. Collectively, our data indicate that providing the proper
microenvironment for interstitial migration may ultimately result in enhanced cellularity and
integration at the wound interface. By addressing the inherent limitations to repair imposed
by the mature ECM, these studies may define a new clinical methodology for repairing
damaged dense connective tissues.
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CHAPTER 7: DIRECTING CELL MIGRATION VIA A CHEMOATTRACTIVE
GRADIENT TO ENHANCE MENISCAL REPAIR

7.1

Abstract

Few regenerative approaches exist for the treatment of injuries to adult dense connective
tissues. Compared to fetal tissues, adult tissues are hypocellular and lack a sufficient
population of endogenous cells at the wound site to affect repair. We hypothesized that
this deficiency in cell number at the wound edge is exacerbated by the dense and stiff
adult extracellular matrix (ECM), a biophysical barrier that restricts cell mobility. We also
hypothesized that chemotactic cues might help overcome this barrier and promote cell
migration through small pores. Using the knee meniscus as a test platform, we
investigated the age-dependent response of cells to physical migratory barriers and
developed a novel ‘tissue Boyden chamber’ system to determine whether interstitial cell
migration through native tissue is enhanced by a chemoattractant. Our findings show that
while adult cells were less mobile than fetal cells, provision of a local platelet-derived
growth factor-AB (PDGF-AB) gradient enhanced migration of this adult cell population. To
translate this new knowledge towards potential improvements in meniscal repair, we
developed nanofibrous composites that release a matrix-degrading enzyme and PDGFAB in a localized and coordinated manner at the site of injury. By first decreasing matrix
density at the wound interface and then recruiting endogenous cells, the staged delivery
of biologics from these scaffolds promoted healing of this dense connective tissue.

7.2

Introduction

Dense connective tissues of the musculoskeletal system function in demanding
biomechanical environments. To withstand cyclic mechanical loads, tissues such as the
knee meniscus (McDevitt et al. 1992), tendons and ligaments (Russo et al. 2015), and the
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annulus fibrosus of the intervertebral disc (Adams et al. 1977), develop densely aligned
extracellular matrices (ECM) composed primarily of type I collagen. Although this
structure-function relationship is optimal for load transfer in the healthy state, injuries
compromise this fiber-reinforced architecture and severely reduce load-bearing capacity
(Makris et al. 2011, Yang et al. 2013). Moreover, mature dense connective tissues exhibit
impaired healing capacity (Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al.
2002), thus predisposing the joint to further degenerative changes. This deficit is
commonly attributed to the poor vascular supply and low cell density of adult tissues, which
limit the local supply of regenerative cells that can affect repair. Additionally, there is
evidence that interstitial migration of cells to the injury site is restricted by the adult
microenvironment (Qu et al. 2015). We thus hypothesized that improving the number of
endogenous cells at the wound margin may be the critical first step towards enhancing
dense connective tissue repair.
Age-related changes in native tissue cells and ECM during development may be
implicated in the reduced cell-mediated healing response of adult tissues compared to
fetal tissues, which exhibit robust integrative repair even without a blood supply in vitro
(Ionescu et al. 2011). At the ECM level, collagen density and organization, as well as bulk
tissue stiffness, increase during development (Clark et al. 1983, Ionescu et al. 2011),
resulting in an environment that may physically impair cell mobility, proliferation, and
matrix remodeling. At the cellular level, differences in cell adhesion, contractility, and
nuclear mechanics may likewise influence migration through the dense connective tissue
(Friedl et al. 2010). Since adult cells reside in a stiffer microenvironment (Marturano et al.
2013, Swift et al. 2014), it is likely that they sense and exert higher forces than fetal cells.
While adhesive and contractile forces are prerequisites for cell locomotion, forces that are
too high may resist forward translocation (Peyton et al. 2005) and cause cell stiffening
(Solon et al. 2007). Furthermore, cells with stiff nuclei display limited migratory capacity
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within physically restrictive environments (Booth-Gauthier et al. 2013, Lautscham et al.
2015), whereas cells with compliant nuclei that lack lamin A/C, such as leukocytes and
certain cancer cells, remain highly mobile (Friedl et al. 2011, Rowat et al. 2013, Wolf et al.
2013). Since both stem cell differentiation and increased tissue micromechanics have
been implicated in higher nuclear stiffness (Pajerowski et al. 2007, Swift et al. 2013), we
hypothesized that adult cells are stiffer than their fetal counterparts, and consequently less
mobile in the presence of steric constraints, and that this may contribute to the poor repair
of adult tissues.
Previously, we showed that partial degradation of the wound site enhances cellular
infiltration and tissue integration of the knee meniscus by reducing local ECM stiffness
and density (Qu et al. 2015), suggesting that adult cells are capable of repair once they
have reached the wound margin. While manipulating the ECM is one approach to
enhancing cellularity, the mechanical function of the tissue may be compromised in the
process, leading to unwanted secondary tears. Therefore, it is necessary to maximize cell
migration while minimizing the amount of matrix degradation required. Since directional
movement of reparative cells into damaged tissue is integral to neotissue formation during
the normal healing response (Yang et al. 2013), we hypothesized that the provision of an
exogenous chemoattractive gradient might similarly recruit cells to the wound site to
accelerate repair, and that this effect would be enhanced with partial matrix degradation.
In addition, this chemoattractive gradient may expedite cell colonization of acellular
scaffolds (Bhargava et al. 2005, Robu et al. 2013) and encourage rapid tissue-to-scaffold
integration.
In this work, we used the knee meniscus to test whether a chemoattractant can augment
cell mobility and dense connective tissue repair. To localize effects in vivo, we used
electrospun nanofibrous scaffolds as a drug delivery vehicle. This technique utilizes an
electrical potential difference to draw polymers into highly aligned nanofibrous networks
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that replicate the organization of dense connective tissues (Mauck et al. 2009). Scaffolds
can be fabricated with multiple discrete fiber components (Baker et al. 2009b), which can
be functionalized with bioactive factors, either adsorbed or annealed to the fiber surface
(Choi et al. 2008, Fu et al. 2008, Phipps et al. 2012b), blended directly into the fiber (Fu
et al. 2008, Qu et al. 2013, Sahoo et al. 2010, Thakur et al. 2008), contained within the
core of a hollow ‘co-axial’ fiber (Kuihua et al. 2013, Liao et al. 2009, Sahoo et al. 2010), or
by including drug-loaded microspheres (Ionescu et al. 2010). Depending on the fiber
fabrication method and degradative rate, release profiles can range from an immediate
burst release to a sustained delivery over the course of several weeks.
In this study, we sought to enhance endogenous meniscal repair via the application of
tailored tri-component nanofibrous scaffolds releasing multiple factors to enhance healing
in a targeted manner. To enable cell migration, a ‘sacrificial’ water-soluble poly(ethylene
oxide) (PEO) fiber fraction first delivered a burst dose of a matrix-degrading enzyme to the
wound interface (Qu et al. 2015), after which slower-degrading fibers composed of
hyaluronic acid (HA) (Purcell et al. 2012), a natural polysaccharide, released a
chemoattractant to guide cells to the defect. A remaining population of stable poly(εcaprolactone) (PCL) fibers acted as a physical template that provided mechanical integrity
and instruction for organized ECM synthesis upon cell arrival at the wound site (Baker et
al. 2012). By combining these diverse but complementary approaches to remove the
natural impediments to endogenous meniscal repair, we recapitulated the hypercellular
healing response exhibited by fetal menisci, an initial step towards repair and regeneration
of dense connective tissues.
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7.3
7.3.1

Materials and Methods
Cell Isolation and Culture

Fetal (late 2nd–3rd trimester) and adult (20–30 months) bovine stifle joints were sterilely
dissected and the knee menisci were removed. To isolate cells, medial menisci (middle
zone) were minced, placed onto tissue culture plastic (TCP), and incubated in basal media
(BM), which consisted of Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% Fetal
Bovine Serum (FBS) and 1% Penicillin/Streptomycin/Fungizone (PSF). Cells that
egressed from the minced tissue onto TCP were grown to 80% confluency before being
detached with trypsin-EDTA (0.25%; Invitrogen). These cells (Passage 1; P1) were replated, expanded, and passaged again (Passage 2; P2) for initial Transwell assays of cell
mobility through pores. Subsequent studies either used P1 or Passage 0 (P0) cells, which
have not been exposed to TCP. This was done to minimize cell de-differentiation and
alteration of their mechanobiologic state as a consequence of culture on stiff substrates
(Talele et al. 2015). Prior to chemotaxis studies, cells were starved overnight in low-serum
media (LM; DMEM with 1% FBS and 1% PSF) to minimize exposure to serum, which can
mask the effect of the chemoattractant being tested.

7.3.2

Transwell Migration Assay

A first study to screen for potential chemoattractants and their optimal doses was
conducted using a 96-well Transwell migration assay (Chemicon QCM™ 96-well Migration
Assay; Millipore). This assay system consists of a top well insert with a microporous
membrane (8 µm diameter pores) for cell seeding and a bottom feeder chamber for the
chemoattractant. Four agents were investigated: human recombinant platelet-derived
growth factor-AB (PDGF-AB; Prospec Bio), human fibroblast growth factor 2 (FGF2;
Prospec Bio), recombinant human stromal cell-derived factor-1α (SDF-1α; R&D Systems),
and transforming growth factor-β3 (TGF-β3). Each factor was reconstituted to 10 µg/mL
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in either H2O or 1X phosphate buffered saline (PBS) with 0.1% bovine serum albumin and
stored at -20ºC until use. For the assay, factors were further diluted in LM to
concentrations of 10, 50, 100, and 250 ng/mL, and 150 µL of each solution was added per
bottom feeder chamber (n=4 wells/group). Low serum (LM) and high serum (BM) were
used as negative and positive controls, respectively (n=4 wells/group). Afterwards, the top
well insert was placed atop the bottom feed chamber, with the microporous membranes
in contact with the chemoattractant solutions. Adult meniscal cells (P2) in LM were seeded
at 50,000 cells per top well and incubated for 16 hours before being detached from the
bottom surface (i.e., isolating cells that had migrated through the pores). These cells were
lysed, and the DNA content was fluorimetrically quantified according to the manufacturer’s
instructions. The average background signal from the dye/lysis buffer solution (n=4/group)
was subtracted from the each well. Fluorescence signal intensity was normalized to the
LM group for each condition.

7.3.3

Cell Age and Pore Size-Dependent Migration

To assess migration in the presence of physical barriers, 96-well Transwell migration
assays with pore diameters of 3, 5, or 8 µm were used (Millipore). Cells (P1) in LM were
seeded at 50,000 cells per top chamber and incubated for 16 hours before being
fluorimetrically quantified as previously described. Three media conditions in the bottom
chamber were tested (n=3 wells/group): LM (Control) and LM with either 50 or 100 ng/mL
PDGF-AB (Low or High PDGF). Fluorescence signal intensity was normalized to the 3 µm
pore group for each condition. To visualize cell migration, fetal and adult tissue explants
(8 mm diameter) were incubated in 5 µg/mL of 5-chloromethylfluorescein diacetate
(CellTracker™ Green; Thermo Fisher Scientific Inc., Waltham, MA) in serum-free media
(DMEM with 1% PSF) for 1 hour to fluorescently label cells on the surface of explants.
Explants were maintained in serum-free media for an additional 30 minutes prior to being
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placed on the microporous membranes to allow for cell egress. After 48 hours in LM,
explants were removed from the substrate, and microporous membranes were rinsed in
PBS, fixed in 4% paraformaldehyde for 12 minutes, and rinsed twice more in PBS before
staining with 4’,6-diamidino-2-phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island,
NY) to visualize cell nuclei. Membranes were mounted onto glass slides, and confocal zstacks at 20X magnification and 1 µm intervals were obtained 20X in the FITC, DAPI, and
TRITC channels to visualize cells, corresponding nuclei, and membranes (autofluorescent
in the TRITC channel) using a Nikon A1 confocal microscope (Nikon Instruments; Melville,
NY). To evaluate the nuclear dimensions of cells engaged with the membranes, binarized
z-stacks from the DAPI channel were used to quantify nuclear volume (n=150 cells/group)
using the open source platform Fiji (Schindelin et al. 2012).

7.3.4

Tissue Boyden Migration Assay

To generate a tissue-like microenvironment as a barrier to migration, cylindrical tissue
explants (8 mm diameter) were excised from the middle zone of fetal medial meniscal
bodies and embedded in Optimal Cutting Temperature sectioning medium (OCT; Sakura
Finetek, Torrance, CA). Samples were axially cut into ~35 µm thick sections onto positively
charged glass slides to cover four laser-cut holes (1 mm diameter) using a cryostat
microtome (Microm HM500; MICROM International GmbH, Waldorf, Germany), such that
the predominant fiber direction was parallel with the slide surface. Prior to tissue mounting,
a thin mesh of randomly aligned methacrylated hyaluronic acid (MeHA) nanofibers (Kim
et al. 2013) was electrospun onto the slides to provide support over the holes. To fabricate
a ‘tissue Boyden chamber’ that allows interstitial migration of cells towards a chemotactic
gradient, the tissue-mounted slide was set atop a concave glass slide containing 140 µL
of either LM (Control) or LM with 200 ng/mL PDGF-AB (PDGF). The top and bottom slides
were sealed with stainless steel clips, and fetal or adult tissue explants incubated in
137

CellTracker™ Green were placed atop the tissue sections (n=3/group). After 48 hours in
LM, slides were stained as above. Confocal z-stacks were obtained at 10X and 2 µm
intervals in the FITC and DAPI channels to visualize cells and nuclei engaging with and
migrating through the devitalized tissue spanning the slide holes (autofluorescent in the
DAPI channel). To assess interstitial migration within the slide holes, cells from five tissue
cross-sections were counted for each hole (n=3 holes/group). Cells that were entirely
embedded within the tissue or had emerged onto the opposite side were considered to
have migrated through the tissue.

7.3.5

Traction Force Microscopy

Traction force microscopy (TFM) was conducted using fetal and adult meniscal cells (P0
and P1) to assess whether differences in cell contractility contributed to age-dependent
migration. For the P0 group, cylindrical tissue explants (8 mm diameter) excised from the
middle zone of fetal and adult medial meniscal bodies were placed atop fibronectin-coated
polyacrylamide hydrogels (5 kPa elastic modulus, verified by atomic force microscopy)
that contained 2 µm diameter fluorescent microspheres (Invitrogen). Explants were
incubated in BM for 2–3 days to allow for cell egress onto the hydrogel. For the P1 group,
cells that had first egressed onto TCP from minced meniscal tissue were seeded onto the
hydrogels at 3,000 cells/cm2 and allowed 24 hours for attachment. Phase contrast and
fluorescence images of individual cells and associated beads within the substrate were
captured at 40X magnification before and after cell lysis with SDS buffer in an
environmental chamber (37°C, 5% CO2) using a Deltavision Deconvolution Microscope.
Images were used to determine cell area and surrounding bead displacement after lysis
using a freely available plugin suite for ImageJ created by Tseng et al. (Tseng et al. 2012),
which was adapted from (Dembo et al. 1999). Using a custom MATLAB script, traction
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force vectors maps were analyzed to determine cellular area, average traction stress
generated by each cell, and total force exerted per cell (n=12 cells/group).

7.3.6

Nanofibrous Scaffold Fabrication

To fabricate nanofibers that deliver a chemoattractant (PDGF-AB), sodium hyaluronate
(HA) (74 kDa; Lifecore Biomedical) was functionalized with hydroxyethyl methacrylate
(HeMA) to allow for hydrolysis (via ester groups) and photo-initiated crosslinking (via
methacrylate groups). Hydroxyethyl methacrylate-modified hyaluronic acid (HeMA-HA)
was synthesized in a three-step process, as described previously (Purcell et al. 2012,
Sahoo et al. 2008). HeMA-HA was purified via extensive dialysis against deionized water
at 4°C, lyophilized, and analyzed by 1H NMR (360 MHz Bruker DMX 360) to determine
HeMA functionalization percent. To facilitate cell adhesion, the RGD peptide
(GCGYGRGDSPG, Genscript) was coupled to the HA backbone via a Michael addition
reaction (1 mM concentration) prior to electrospinning (Kim et al. 2013).
Fibrous scaffolds were fabricated through tri-jet electrospinning (Baker et al. 2009b) with
the following components: (1) 14.3 wt% poly(ε-caprolactone) (PCL; 80 kDa; SigmaAldrich) in a 1:1 mixture of dimethylformamide (DMF; Fisher) and tetrahydrofuran (THF;
Fisher); (2) 8 wt% poly(ethylene oxide) (200 kDa PEO; Polysciences) in 50% ethanol in
deionized water; and (3) 4 wt% HeMA-HA with 2 wt% PEO (900 kDa) and 0.05 wt%
Irgacure 2959 (Ciba) in deionized water. For scaffolds containing collagenase, 2 wt%
collagenase (Type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg
solid; Sigma-Aldrich) was added to the PEO solution immediately before electrospinning
(Qu et al. 2013). For scaffolds with PDGF-AB, 50 μg/mL PDGF-AB (Shenandoah
Biotechnology Inc.) was added to the HeMA-HA solution immediately before
electrospinning. Each solution was loaded into individual syringes with 18 gauge needles
and placed at an equal radial distance focused on a common, vertical collection mandrel
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that rotated at ~10 m/s to align collected fibers, as in (Baker et al. 2009b). Electrospinning
was performed using the following parameters: +12–15 kV, 2.0 mL/hr, 15 cm (PCL), +12–
15 kV, 2.5 mL/hr, 15 cm (PEO), and +24–28 kV, 1.4 mL/hr, 16 cm (HA), corresponding to
the applied voltage, polymer flow rate, and spinneret to mandrel distance. Additionally,
voltages were applied to the mandrel (-3 kV) and deflectors (+4 kV) to further direct fibers
to collect on the mandrel. Electrospinning was performed for 3.5 hours in a humiditycontrolled room (20–40% relative humidity) to maintain stable fiber formation and solvent
evaporation. To enable crosslinking post-fabrication, electrospun fiber scaffolds were
exposed to 10 mW/cm2 of ultraviolet light under nitrogen for 15 minutes on each side of
the scaffold.

Polymer

Flow rate
(mL/hr)

Concentration
(g/mL)

Flow rate
(g/hr)

Theoretical Spin
Weight (g)

Fiber Fraction
(% mass)

PCL

2

0.143

0.286

1.001

50.2

PEO

2.5

0.08

0.2

0.7

35.1

HA

1.4

0.06

0.084

0.294

14.7

Table 7-1: Polymer fiber fraction calculations (% mass) based on solution flow rate and
concentration for a 3.5 hour electrospinning period.

Biofactor

Flow rate
(mL/hr)

Concentration
(g/mL)

Flow rate
(g/hr)

Theoretical Spin
Weight (g)

Amount
(µg/mg
scaffold)

Collagenase

2.5

0.02

0.05

0.175

80.65

PDGF-AB

1.4

0.00005

0.00007

0.000245

0.113

Table 7-2: Biofactor loading calculations (µg/mg scaffold) based on solution flow rate and
concentration for a 3.5 hour electrospinning period.

For fiber imaging, thin films of fibers were collected and crosslinked onto either aluminum
foil or glass slides for scanning electron and fluorescence microscopy measurements,
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respectively. To determine dry fiber diameter, fibers were imaged using an environmental
scanning electron microscope (ESEM; FEI Quanta 600), where fiber diameter was
measured using ImageJ (NIH) (n=4 samples/group, 50 fibers/sample). To visualize distinct
fiber fractions, the PCL, PEO, and HA solutions were doped with methacryloxyethyl
thiocarbamoyl rhodamine B (PolyFluor® 570; Polysciences), 5(6)-carboxyfluorescein
(Sigma), and 4',6-diamidino-2-phenylindole (DAPI; Invitrogen), respectively. Using a
slowly rotating mandrel, randomly aligned fibers were electrospun onto glass slides and
imaged using fluorescence microscopy.

7.3.7

In Vitro Biofactor Release and Activity Assays

Fibrous scaffold biomolecule release was evaluated as a function of time at 37°C for
scaffolds of ~0.5 mm in thickness. After electrospinning and crosslinking, tri-component
fibrous scaffolds were immersed in PBS. The eluant was collected and replaced with fresh
PBS at set time intervals and stored at -20°C until analysis. Bulk scaffold mass loss (%)
was determined through measurement of the dry fiber weight before and after immersion
in PBS (and subsequent lyophilization) at various time points (n=3–4 samples/scaffold for
3 different scaffolds). The amount of uronic acid, a component of HA, in the supernatant
was quantified over 45 days using a modified uronic acid assay that has been described
in detail elsewhere (Bitter et al. 1962, Khetan et al. 2009) and compared to known
concentrations of HA (ranging from 2.0 to 0.1 μg/mL) in order to determine HA loss from
the HeMA-HA fiber component as a function of time.
Collagenase release over 96 hours was quantified by measuring the protein absorbance
in the solution at 280 nm compared to a standard curve (n=5 samples/scaffold). PDGFAB release over 16 days was measured using a PDGF-AB enzyme-linked immunosorbent
assay (ELISA) kit (DY222, R&D Systems) (n=6 samples/scaffold). Additionally, the effect
of electrospinning on collagenase activity was evaluated using a fluorogenic peptide
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substrate assay (R&D Systems). After electrospinning and crosslinking, fibrous scaffolds
were immersed in Triton-Tris-Calcium buffer (TTC; 0.05 (v/v)% Triton X-100 (SigmaAldrich), 50 mM tris hydrochloride (EMD Biosciences), 1 mM calcium chloride (SigmaAldrich), pH 7.4) and shaken to rapidly release the collagenase. After two hours, the eluant
was collected and immediately analyzed for activity. Using a 96-well plate, 50 µL of the
sample and 50 µL of a matrix metalloprotease-sensitive fluorogenic peptide substrate
(Mca-PLGL-Dpa-AR-NH2; R&D Systems), for a final peptide concentration of 10 μM, was
added to each well before immediately performing a fluorescence kinetic study at 320/405
nm excitation/emission with continual measurements over five minutes. The initial rate for
each sample was calculated from the initial linear slope of fluorescence as a function of
time. These data were compared to a collagenase standard curve to determine the
amount of active collagenase in the sample. Percent activity was calculated by
comparison with the total amount of collagenase released from each sample measured
using absorbance, where the absorbance reading is not adversely affected by activity
(n=3–4 samples/scaffold for 3 different scaffolds). A tri-component scaffold without
collagenase was used as a control.

7.3.8

In Vitro Cell Behavior on Nanofibrous Scaffolds

Cell behavior and viability on nanofibers were evaluated using randomly aligned
nanofibrous substrates that were electrospun directly onto glass slides (~20 µm
thickness). Solutions were fluorescently doped with rhodamine prior to electrospinning to
allow for fiber visualization. To assess the effect of RGD on cell adhesion, adult meniscal
explants labeled with CellTracker™ Green were placed atop HeMA-HA fibers with or
without RGD coupling (HA±RGD). After 48 hours in BM, slides were fixed and cell nuclei
stained with DAPI as previously described. Confocal z-stacks at 20X magnification and 1
µm intervals were obtained in the FITC, DAPI, and TRITC channels to visualize cells,
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corresponding nuclei, and nanofibers. To assess the effect of scaffold porosity on cell
infiltration, labeled explants were placed atop either a nanofibrous composite of
PCL/PEO/PEO (high porosity) or PCL/PEO/HA with RGD (low porosity). Prior to tissue
culture, substrates were washed in PBS to remove the sacrificial PEO fiber fraction. After
48 hours in BM, slides were processed and imaged as previously described.
Cell infiltration into the nanofibrous substrate was assessed by quantifying infiltration
depth, defined as the distance between the apical surface of the scaffold and z-centroid
location of the cell (n=16 cells/group). Z-stacks in the FITC (cell) and TRITC (nanofiber)
channels were binarized using Fiji, respectively. The first z location where fiber signal was
detected beneath the cell was defined as the apical surface of substrate. The cell zcentroid was determined using the BoneJ Particle Analyzer plugin (Doube et al. 2010).
Cells located within scaffold perforations or defects were excluded from analysis. To
assess scaffold porosity, the pore size and area fraction were quantified using a central zslice from the TRITC channel (n=3 stacks/group), where areas absent of fibers were
considered pores (areas <20 µm2 were considered artifacts and excluded from analysis).
The average diameter of discrete pores was determined using the Local Thickness plugin
in Fiji (Dougherty et al. 2007).

7.3.9

Subcutaneous Xenotransplant Model

To test the effect of chemoattractant-directed migration on meniscal repair in an in vivo
setting, a nude rat xenotransplant model was employed (Qu et al. 2015). All procedures
were approved by the Animal Care and Use Committee of the Philadelphia VA Medical
Center. Adult bovine meniscal explants (8 mm diameter, 4 mm height) were incised to
create a horizontal defect. To evaluate the combined effect of collagenase and PDGF, the
defect was either left empty (Control) or filled with one of 4 scaffolds: a tri-component
scaffold with RGD-coupled HA fibers (PCL/PEO/HA), a tri-component scaffold releasing
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collagenase from PEO fibers (PCL/PEO-C/HA), a tri-component scaffold releasing PDGFAB from HA fibers (PCL/PEO/HA-P), or a scaffold releasing both factors (PCL/PEO-C/HAP). Aligned scaffolds (~0.5 mm thick) were cut to 6 mm diameter with a 2 mm diameter
central fenestration to permit tissue-to-tissue contact inside the repair construct. Biofactor
loading was estimated to be ~173 µg of collagenase and/or ~242 ng of PDGF per scaffold
(~2.14 mg), based on biofactor flow rate and scaffold mass calculations (Table 7-2).
Scaffolds were sterilized under ultraviolet light for 30 minutes on each side prior to use.
Defects were closed with absorbable sutures (3-0 Monocryl) before subcutaneous
implantation into male athymic nude rats (Hsd:RH-Foxn1rnu, 8–10 weeks old, ~300 g,
Harlan). Rats were anesthetized with isoflurane and the dorsal area shaved and swabbed
with ethanol and betadine. Four incisions (1 on the cranial and caudal aspects, on each
side of the midline of the rat) were made on each rat and a subcutaneous pocket formed
using blunt dissection. One randomized repair construct per group was placed in each
pocket and the incision was closed with wound clips.
At 2 and 4 weeks, rats (n=6/time point) were euthanized by CO2 asphyxiation and the
constructs were removed from the subcutaneous tissue. Retrieved samples were paraffin
embedded, sectioned to 8 µm, and stained with hematoxylin & eosin (H&E), Picrosirius
Red (PSR) for collagen, or DAPI for cell nuclei. To assess cellularity at the 2 week time
point, cell signal intensity relative the interface was quantified by converting the DAPI
nuclear signal to white (intensity=255) and the background to black (intensity=0) using
ImageJ, as described in (Qu et al. 2015). Next, the pixel intensity relative to the interface
was averaged starting from the interface up to a distance 700 µm perpendicular to the
defect. Intensity of DAPI signal with respect to location was binned into 100 µm intervals
and normalized to the empty defect (Control) value at the interface (n=4–5
samples/group).
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7.3.10 Statistical Analyses
All experiments were performed for 1–2 meniscal donors per condition. Statistical
analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA). Significance
was assessed by one or two-way ANOVA with Tukey’s HSD post hoc for migrated cell
signal intensity and cell number, nuclear volume, cell spread area, average traction stress
and total force, scaffold pore size and area fraction, cell infiltration depth, and interfacial
cellularity (p≤0.05). Independent variables include chemoattractant agent and dose,
Transwell membrane pore diameter, cell age and passage number, nanofibrous scaffold
composition, repair construct treatment, and distance from the wound interface. Data are
presented as mean ± standard deviation unless specified otherwise.

7.4
7.4.1

Results
Platelet-Derived Growth Factor-AB Stimulates Cell Migration

Initial screening of potential chemoattractants, including platelet-derived growth factor-AB
(PDGF-AB), fibroblast growth factor 2 (FGF2), stromal cell-derived growth factor-1α (SDF1α), and transforming growth factor-β3 (TGF-β3) revealed that PDGF-AB was most
effective at increasing adult meniscal cell (P2) migration in a Transwell chemotaxis assay.
Cell migration was ~1.4 times higher for the 100 ng/mL PDGF-AB group than for the lowserum (1% FBS) control after 16 hours (Figure 7-1, p≤0.05). However, PDGF-AB at other
concentrations did not significantly influence cell migration, suggesting a dose-dependent
response to PDGF-AB. As expected, the presence of 10% FBS also increased cell
migration compared to controls.
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Figure 7-1: Adult cell (P2) migration through 8 µm diameter pores is enhanced by PDGF-AB
but not by FGF2, SDF-1α, or TGF-β3 at similar concentrations (n=4 wells/group, mean ±
standard deviation). Migrated cell signal intensity is normalized to the low-serum control
(1% FBS; red dashed line). Blue dashed line indicates 10% FBS. * = p≤0.05 vs. all other
groups.

7.4.2

Cell Mobility is Dependent on Pore Size and Cell Age

Having established that PDGF was an effective chemoattractant for meniscal cells, we
next assessed migration of fetal and adult meniscal cells (P1) as a function of pore size
and PDGF dose. Confocal images revealed that, for both age groups, nuclei were able to
deform and pass through 5 and 8 µm pores, but could not pass through 3 µm pores
(Figure 7-2A and Figure 7-2B). In the absence of a PDGF gradient (Control), there was
no difference between pore size groups for either age group (Figure 7-2C and Figure
7-2D, p>0.05). With the addition of PDGF to the bottom chamber, pore size had a
significant effect, with cell migration increasing as a function of pore size for both ages
(p≤0.05). Addition of 100 ng/mL PDGF-AB (High PDGF) to the bottom chamber
significantly increased migration through both the 5 and 8 µm pores compared to the 3 µm
pores (p≤0.05). A similar trend was seen for the 50 ng/mL PDGF-AB (Low PDGF) group,
though in this case, migration was increased for only the 8 µm pores (p≤0.05). While
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migration increased with PDGF dose for both age groups, fetal cells were more mobile
than adult cells. However, no matter what the concentration of PDGF, migration through
3 µm pores was limited.

Figure 7-2: PDGF-AB enhances fetal and adult (P1) cell migration through intermediate size
pores. (A) 3D confocal reconstruction of adult cells (green) passing through microporous
membranes (red) of 3, 5, and 8 µm diameter. Arrow points to constricted nucleus (blue).
Scale = 10 µm. (B) Cross-section of the cells in (A). Scale = 10 µm. (C) Migrated fetal and (D)
adult cell signal intensity normalized to the 3 µm pore group for each media condition (n=3
wells/group, mean ± standard deviation). * = p≤0.05 vs. High PDGF. ** = p≤0.05 vs. all other
media conditions. # = p≤0.05 vs. 3 µm pore.

To determine whether meniscal cells undergo enhanced interstitial migration towards a
PDGF gradient in a more physiologic tissue-like environment, a ‘tissue Boyden chamber’
was fabricated (Figure 7-3). When fetal and adult tissue explants were placed atop the
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devitalized meniscal tissue, egressing cells adhered, spread, and began migrating into the
substrate within 48 hours. In the absence of PDGF in the bottom chamber (Control), more
fetal cells migrated onto the tissue substrate than adult cells, though few cells from either
age migrated through the tissue depth (Figure 7-4C and Figure 7-4D, p≤0.05). Addition
of 200 ng/mL PDGF-AB to the bottom chamber significantly increased the total adult cell
number as well as the number of cells that had migrated through the tissue for both age
groups, compared to Controls (p≤0.05), such that there was no longer a significant
difference between fetal and adult cells.

Figure 7-3: Construction of a ‘tissue Boyden chamber.’ (A) Experimental schematic. (B)
Tissue slide atop concave slide containing media. Inset shows tissue cryosection with a
black box around a slide hole. Scale = 5 mm. (C) 3D confocal reconstruction showing cells
(green) on the tissue (blue) over a slide hole. Arrow indicates migrated cell.
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Figure 7-4: PDGF-AB enhances fetal and adult cell (P0) migration through native tissue. (A)
Confocal z-projection of cells within the slide hole (dotted circle). Scale = 100 µm. (B) Crosssection showing cells migrating through the tissue section in the region spanning the slide
hole. Arrows point to migrated cells. Scale = 20 µm. (C) Total number and (D) subset of
migrated fetal and adult cells within slide hole for each media condition (n=3 holes/group,
mean ± standard deviation). * = p≤0.05 between groups.

To investigate whether biophysical differences between fetal and adult cells contribute to
differential 3D migration, nuclear volume and cell contractility were assessed in these cell
populations. Adult cells (P0) on microporous membranes had larger nuclei than fetal cells
(Figure 7-5D, p≤0.05), but the average traction stress and the total contractile force
generated was not significantly different between fetal and adult cells (P0) on
polyacrylamide gels (Figure 7-5E, p>0.05). Interestingly, when adult cells (P1) were first
expanded on TCP, their average traction stress and total force increased substantially
compared to all other groups (p≤0.05), whereas fetal cells (P1) did not exhibit changes in
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contractility. Cell spread area, which scaled linearly with total force for all groups,
increased for both fetal and adult cells after passage, although this was significant for adult
cells only (Figure 7-5F, p≤0.05). This suggests that adult cells are particularly sensitive
to exposure to stiff tissue culture plastic, and upregulate their mechanosensing machinery
in response to this mechanical input.

Figure 7-5: Biophysical differences between fetal and adult cells. (A) 3D confocal
reconstruction of fetal and adult cells (P0) and (B) corresponding nuclei atop microporous
membranes with 3 µm diameter holes. Scale = 20 µm (top) and 10 µm (bottom). (C) Traction
stress generation by fetal and adult cells (P0 and P1) on 5 kPa polyacrylamide hydrogels.
Outline indicates cell shape and position. (D) Nuclear volume of fetal and adult cells (P0) on
microporous membranes (n=150 cells/group, mean ± standard error of the mean). * = p≤0.05
vs. fetal. (E) Average traction stress of fetal and adult cells (P0 and P1) measured via TFM
(n=12 cells/group, mean ± standard error of the mean). * = p≤0.05 vs. all other groups. (F)
Total contractile force generated by individual fetal and adult cells (P0 and P1) as a function
of cell spread area. Total contractile force and cell spread area were significantly larger for
adult P1 cells compared to all other groups (p≤0.05).
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7.4.3

Controlled Biofactor Release from Tri-Component Scaffolds

Composite nanofibrous scaffolds containing three components were fabricated via
electrospinning

onto a

common

rotating

mandrel:

poly(ε-caprolactone)

(PCL),

poly(ethylene oxide) (PEO), and hyaluronic acid (HA) with 25% HeMA functionalization.
Scaffolds were approximately 50% PCL, 35% PEO, and 15% HA by mass based on
theoretical loading (Table 7-1), although PEO and HA yields were lower than predicted
(fibers are lost to neighboring surfaces). Images of fluorescently labeled fibers validated
the presence of three discrete populations within the scaffold (Figure 7-6B). When these
fibers were collected on a rotating mandrel, SEM micrographs revealed a uniaxial fiber
alignment oriented in the direction of rotation (Figure 7-6C). Fibers appeared smooth and
uniform, with an average fiber diameter of 308 ± 143 nm.
Collagenase and PDGF-AB were successfully incorporated and released from the PEO
and HA fiber fractions, respectively. Biofactor release occurred independent of one
another and corresponded with the degradative rate of the respective fiber fraction
(Figure 7-6D–G). As expected, there was an instantaneous burst release of collagenase
from the water-soluble PEO fiber fraction, where 80% was released within 5 hours of
incubation in PBS (Figure 7-6D). Based on activity assays, ~58% of the total released
collagenase was bioactive, with 26±4 µg of active enzyme delivered per mg scaffold
(enzyme activity was not detected in control scaffolds). Bulk scaffold mass loss occurred
in a similar fashion. After 2 hours, 18% of the total mass was lost, with this mass likely
representing the loss of the PEO via dissolution and diffusion of uncrosslinked HA from
the network (Figure 7-6E). After 24 hours, mass loss reached 22%, and remained
constant thereafter, indicating that the majority of PEO had been removed from the
scaffold, with ~80% removed in the first 2 hours. In contrast to collagenase release from
PEO fibers, PDGF release from HA fibers showed a more linear profile over the course of
2 weeks (Figure 7-6F). Approximately 66% and 85% of PDGF was released after 4 and
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7 days, respectively, corresponding to 35% and 46% loss in scaffold mass due to HA fiber
degradation. After 16 days, ~60% of the HA had degraded and PDGF was no longer
detectable in the eluant (Figure 7-6F and Figure 7-6G). After 45 days, only 14% of the
HA remained, resulting in a scaffold that was comprised primarily of PCL.

Figure 7-6: Controlled biofactor release from tri-component scaffolds. (A) Electrospinning
schematic with three independent fiber jets collecting simultaneously on a common rotating
mandrel. (B) Fluorescent image of randomly aligned PCL (red), PEO (green), and HA (blue)
fibers collected on a slow rotating mandrel. Scale = 20 µm. (C) SEM micrograph of uniaxially
aligned PCL/PEO/HA scaffold collected onto a fast rotating mandrel. Scale = 5 µm. (D)
Cumulative collagenase release from PEO fibers and (E) bulk scaffold mass loss (% of total)
over 96 hours (n=3–4 samples/scaffold for 3 different scaffolds, mean ± standard deviation).
(F) Cumulative PDGF release from HA fibers (via ELISA, n=6 samples/scaffold, mean ±
standard deviation) and (G) HA mass loss (% of total) over several weeks (via the uronic
acid assay, n=5 samples/scaffold, mean ± standard deviation).
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7.4.4 Cell Adhesion and Infiltration into Tri-Component Scaffolds
Adult meniscal explants were placed atop nanofibrous substrates to assess cell behavior
and viability on scaffolds. After 48 hours, cells had egressed onto the substrates and
appeared viable. Cells adhered and spread on HA fibers with RGD, but failed to spread
on those without RGD, instead clustering into multi-cellular aggregates (Figure 7-7A). In
addition, relatively few cells were found on the HA fibers without RGD. To ensure cell
adhesion and migration into scaffolds, all subsequent experiments included RGD.
Analysis of cell infiltration into high (PCL/PEO/PEO) and low (PCL/PEO/HA) porosity
scaffolds revealed that infiltration depth was affected by fiber density. PCL/PEO/HA
scaffolds had significantly fewer and smaller pores than PCL/PEO/PEO scaffolds, which
contained an additional sacrificial PEO fraction (Figure 7-7C–F, p≤0.05). Pores consisted
of 8% of the total area of PCL/PEO/HA composites, with an average diameter of ~4 µm,
whereas in PCL/PEO/PEO scaffolds, 32% of the area was occupied by pores of ~5 µm
average diameter (Figure 7-7E and Figure 7-7F). However, a substantial number of
pores were smaller than the population average for both groups, with the most frequent
pore diameter being 3 and 4 µm for PCL/PEO/HA and PCL/PEO/PEO scaffolds,
respectively (Figure 7-7C). Furthermore, the total percentage of small pores (≤3 µm
diameter) was 2x higher in PCL/PEO/HA scaffolds (43%) compared to PCL/PEO/PEO
scaffolds (21%) (Figure 7-7D). Consequently, cell infiltration depth through PCL/PEO/HA
scaffolds was 50% less than through PCL/PEO/PEO scaffolds (Figure 7-7G, p≤0.05).
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Figure 7-7: RGD and high porosity scaffolds facilitate cell adhesion and infiltration. (A) 3D
confocal reconstruction of adult cells (P0) on randomly aligned HA fibers ± RGD and (B) on
high (PCL/PEO/PEO) and low (PCL/PEO/HA) porosity scaffolds. Scale = 20 µm. (C)
Distribution of pore diameter for randomly aligned PCL/PEO/PEO and PCL/PEO/HA
scaffolds, shown as % frequency and (D) % cumulative frequency (n=3 stacks/group). Red
dashed line indicates average pore diameter for PCL/PEO/HA scaffolds. (E) Average pore
diameter and (F) area fraction of PCL/PEO/PEO and PCL/PEO/HA scaffolds (n=3
stacks/group, mean ± standard deviation). (G) Cell infiltration depth after 48 hours of in vitro
culture (n=16 cells/group, mean ± standard error of the mean). * = p≤0.05 vs. PCL/PEO/PEO.
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7.4.4

Bioactive Scaffolds Enhance Meniscal Cellularity and Integration

To evaluate the effect of scaffolds on meniscal repair in vivo, adult meniscal repair
constructs were placed subcutaneously in athymic rats and evaluated histologically at 2
and 4 weeks. All repair constructs remained intact after 2 weeks, encapsulated by a layer
of hypercellular, fibrous tissue. At 2 weeks, interfacial cellularity at the center of the repair
construct was significantly higher for samples that contained bioactive scaffolds compared
to the empty defect (Control) and PCL/PEO/HA scaffold groups (Figure 7-8B, p≤0.05).

Figure 7-8: Collagenase-releasing scaffolds increase interfacial cellularity after 2 weeks of
subcutaneous implantation. (A) Thresholded images of DAPI-stained nuclei (white) at the
center of repair constructs. Interface is on the left (red line). Scale = 100 µm. (B) Average
intensity with respect to distance from the interface, normalized to the empty defect Control
value at the interface (n=4–5 samples/group, mean ± standard deviation). * = p≤0.05 vs.
Control and PCL/PEO/HA. ** = p≤0.05 vs. PCL/PEO/HA-P. # = p≤0.05 vs. all other distances
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Constructs with scaffolds containing collagenase (PCL/PEO-C/HA) and both collagenase
and PDGF (PCL/PEO-C/HA-P) showed the highest cell signal intensity within 100 µm of
interface, with increases of 683% and 745% over the Control group, respectively. While
interfacial cellularity was lower for the PDGF-only scaffold (PCL/PEO/HA-P) compared to
the collagenase-releasing scaffolds, PDGF delivery on its own did result in a 440%
increase over Control implants. For all scaffold groups, the cell signal intensity was
significantly higher within 100 µm of interface than at distances >100 µm from the
interface, indicating that presence of the material itself may increase interfacial cellularity
(Figure 7-8B, p≤0.05). There were no significant differences in cellularity between
treatment groups at distances >100 µm, indicating that biofactor release and activity was
localized to the defect.
The high cell density at the tissue-scaffold interface, coupled with collagen degradation,
appeared to enhance integration of the scaffold with the native meniscal ECM at 2 weeks
(Figure 7-9A). Despite the complete loss of PEO and partial loss of HA at 2 weeks, few
cells were observed within the scaffold center for all groups (data not shown), suggesting
that scaffold porosity was too low at this early time point to allow effective cell infiltration.
By 4 weeks, however, cells were present within scaffolds from all groups, likely facilitated
by the additional HA loss over this time period. While cells were evenly distributed
throughout the entire thickness of collagenase-releasing scaffolds (PCL/PEO-C/HA and
PCL/PEO-C/HA-P), cell ingress was limited to the periphery of scaffolds lacking
collagenase (PCL/PEO/HA and PCL/PEO/HA-P) (Figure 7-10). Matrix degradation and
remodeling at the tissue-scaffold interface were most evident in the collagenase-releasing
scaffold groups, where a loose network of thin, interconnected collagen fibers bridged the
scaffold and tissue edges by 4 weeks (Figure 7-9B). Additionally, de novo collagen
synthesis within the scaffolds themselves was most frequently observed in the groups
delivering collagenase. While some collagen deposition did occur at the interface of empty
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defect Control samples at 4 weeks, the amount was minimal, and did not appear well
integrated with the surrounding tissue. Taken together, these findings suggest that
localized delivery of a matrix-degrading enzyme appears to be the primary catalyst
towards advancing cell-mediated wound repair.

Figure 7-9: Bioactive scaffolds enhance tissue-scaffold integration. (A) PSR staining of
repair constructs showing collagen and nanofibrous scaffolds at the wound site after 2
weeks and (B) 4 weeks of subcutaneous implantation. Matrix degradation and remodeling
at the tissue-scaffold interface are evident in collagenase-releasing scaffold groups.
Collagen deposition is observed within collagenase-releasing scaffold groups after 4
weeks. Scale = 100 µm.
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Figure 7-10: Collagenase delivery increases cellular infiltration into scaffolds at 4 weeks. (A)
H&E and (B) DAPI staining of repair constructs showing cells and nuclei within nanofibrous
scaffolds after 4 weeks of subcutaneous implantation. Cells were distributed throughout the
full thickness of collagenase-releasing scaffolds, but were limited to the scaffold periphery
for non-collagenase-releasing groups. Scale = 100 µm.

7.5

Discussion

The ECM of the knee meniscus and other dense connective tissues is a physically
restrictive 3D microenvironment. The densely packed, anisotropic arrangement of
collagen fibers acts as a steric constraint to cell migration, forcing cells into extremely
deformed states as they squeeze through narrow gaps between fiber bundles. While low
interstitial cell mobility may contribute to the lack of cell-mediated repair in the adult
meniscus, this limitation may be partly overcome via the provision of a soluble chemotactic
gradient that promotes migration to the injury site. Here, we show that a PDGF-AB gradient
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enhances cell infiltration through membranes of intermediate pore sizes, as well as
through a physiologic microenvironment using a novel ‘tissue Boyden chamber.’
Furthermore, localized delivery of PDGF-AB in vivo increased cellularity at the meniscal
wound interface, suggesting that combining cell recruitment with a low level of matrix
degradation may be optimal for promoting meniscal repair.
As with other cell types (Lautscham et al. 2015, Wolf et al. 2013), meniscal cell migration
declines with decreasing pore size and eventually the cells are rendered immobile, a trend
that is made apparent with the addition of a chemoattractive gradient. Consistent with
other reports in the literature (Bhargava et al. 1999, Bhargava et al. 2005), we found that
PDGF-AB was the most effective chemoattractant for meniscal cells, although this may
vary with species, age, meniscus zone, and PDGF-AB concentration. Importantly, PDGFAB can also recruit a host of other cell types, including articular chondrocytes, fibroblasts,
tenocytes, and mesenchymal stem cells (MSCs) (Haugh 2006, Caliari et al. 2011, Mishima
et al. 2008), rendering it applicable to a wide range of musculoskeletal tissues. Other
factors that have been noted as potential chemoattractants for meniscal cells include SDF1 (Shen et al. 2014), interleukin-1 (IL-1) (Bhargava et al. 1999), bone morphogenic protein2 (BMP-2) (Bhargava et al. 1999), and hepatocyte growth factor (Bhargava et al. 1999,
Bhargava et al. 2005). Although SDF-1 did not affect cell migration in this study, possibly
due to a lack of the receptor CXCR4 (Kucia et al. 2004), delivery of SDF-1 in vivo has
been found to enhance mesenchymal stem cell and/or progenitor cell homing to the
meniscus (Shen et al. 2014), articular cartilage (Chen et al. 2015), and tendon (Shen et
al. 2010) after injury.
Our findings also indicate that fetal cells may be more mobile in 3D environments than
adult cells. Similarly, Sandulache et al. found that fetal fibroblasts attach to and infiltrate
3D collagen gels faster than adult fibroblasts (Sandulache et al. 2007). Since 3D migration
depends on deformability through interstitial space, age-related changes in cell and/or
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nuclear mechanics may play a role in the differential mobility seen between fetal and adult
cells. Surprisingly, our data indicate that contractility is not different between fetal and
adult cells (P0), although passaged adult cells are significantly larger and more contractile.
It is possible that differential expression of adhesion ligands influenced the contractility
results. Moulin et al. found that freshly isolated adult dermal fibroblasts (P0) were more
contractile on collagen gels than fetal fibroblasts, and that when grown in monolayer, adult
cells, but not fetal cells, showed rapid changes in contractile capacity and integrin
expression at early passages (Moulin et al. 2002). In particular, adult cells express more
α-smooth muscle actin than fetal cells in the presence of TGF-β (Moulin et al. 2001),
assuming a myofibroblastic phenotype that is often associated with fibrosis and scarring
(Tomasek et al. 2002). Taken together, these findings suggest that expansion of adult
cells on TCP, a common practice in autologous cell therapy, alters the adult cell
mechanotransduction machinery and may make them less suitable for regenerative
medicine applications than fetal cells (Talele et al. 2015).
In order to pass through small pores in stiff or non-degradable matrices, cells must
overcome the steric constraints that are imposed by its own nucleus, which is 2–4 times
stiffer than the surrounding cytoplasm and considered the rate-limiting organelle in
migration (Friedl et al. 2011, Guilak et al. 2000). Notably, nuclear volume scales inversely
with the ability to navigate narrow channels, and cell velocity significantly decreases when
the nuclear cross sectional area is 4 times larger than the constriction (Lautscham et al.
2015). In this study, we found that nuclear volume was significantly larger for adult cells
compared to fetal cells, which may contribute to their differential mobility. Furthermore,
recent work from our lab indicate that adult nuclei are 2 times stiffer than fetal nuclei and
contain twice the amount of lamins A and C (lamin A/C) (data not shown), proteins that
provide structure and stability to the nuclear envelope (Lammerding et al. 2006). This is
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consistent with studies suggesting that stem cell differentiation and/or increased tissue
micromechanics result in increased lamin A/C expression, nuclear stiffness, and volume
(Pajerowski et al. 2007, Swift et al. 2013, Vishavkarma et al. 2014). Interestingly, restoring
nuclear plasticity by lamin A/C knockdown enhances migration through small pores
(Greiner et al. 2014, Harada et al. 2014), and over-expressing lamin A reduces 3D cell
mobility (Lautscham et al. 2015, Rowat et al. 2013). These data suggest that barriers
posed by the dense ECM may also be overcome if endogenous cells can adopt a ‘softer’
nuclear phenotype, although depletion of lamins beyond a certain threshold may lead to
apoptosis from migration-induced stress imposed on the nucleus (Harada et al. 2014).
Given the inherently low cell density and interstitial cell mobility of adult dense connective
tissues, we sought to increase cellularity at the wound interface by removing ECM
impediments to migration and by introducing a chemoattractant to recruit endogenous
cells to the defect. To target these inputs to the injury site, electrospun nanofibrous
composites were engineered to deliver a burst of the matrix-degrading enzyme
collagenase from water-soluble PEO fibers over the course of 24 hours, followed by a
sustained release of PDGF-AB from slower-degrading HA fibers over the course of 2
weeks. Importantly, since this fabrication is aqueous-based, biologic activity of
encapsulated factors is easily preserved relative to harsher organic solvents used for
synthetic fibers. While delivery of a chemoattractant (PDGF-BB) from nanofibrous
scaffolds has been previously reported (Jin et al. 2008, Phipps et al. 2012b), this is the
first instance, to the best of our knowledge, that two factors were delivered in a sequential
fashion to enhance cell migration. Although we investigated only one concentration and
release rate for each biofactor, our data indicate that these complementary approaches
can independently enhance interfacial cellularity. The highest cell densities were achieved
by scaffolds releasing collagenase, most likely due to their impact on enhancing cell
migration and proliferation after removal of collagen and other matrix constituents at the
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interface. Delivery of PDGF-AB alone resulted in a significantly higher cellularity than
control scaffolds at the interface, but its impact was less than either collagenase-releasing
scaffold, confirming that the ECM presents a formidable barrier to cell-mediated repair.
Therefore, an ideal formulation may be to combine PDGF-AB delivery with a lower dose
of collagenase to optimize cellularity while minimizing ECM damage.
Cellular colonization is essential for acellular scaffolds that rely on endogenous matrix
deposition to bolster mechanical properties and ensure survival in a dynamically loaded
environment. While biofactor delivery increased cellularity at the interface, few cells had
infiltrated into the scaffolds at 2 weeks. Consequently, both the tissue-scaffold interface
and the scaffold itself were prone to mechanical failure during sectioning, despite the
abundance of cells at the interface. It is possible that scaffold density was too high to allow
cell invasion even though a ‘sacrificial’ PEO component was included (Baker et al. 2008).
Indeed, our in vitro studies showed that replacement of a PEO fiber fraction with HA
reduced scaffold pore size and number, and impeded cell migration through the scaffold.
Although the RGD adhesion motif was coupled to HA fibers to encourage cell adhesion
and migration (Kim et al. 2013), cell infiltration depth was still impaired compared to higher
porosity substrates. To facilitate interstitial mobility, HA fiber degradation could be
accelerated by reducing the macromer molecular weight or crosslinking density (Burdick
et al. 2005), altering the modification of the HA backbone to allow increased rate of
hydrolysis (Sahoo et al. 2008), or by introducing protease-cleavable peptides (Wade et al.
2015b). In our study, modification of HA with hydroxyethyl methacrylate (HeMA) groups
promoted fiber degradation in aqueous environments via the hydrolyzable ester group,
resulting in a HA mass loss of approximately 80% after 4 weeks. Indeed, cellular ingress
into scaffolds was apparent by 4 weeks in all groups, although infiltration appeared most
advanced in the collagenase-releasing scaffolds. It is possible that the fragmented
collagen at the wound interface weakens cell anchorage to the ECM, allowing temporal
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detachment to facilitate migration (Carragher et al. 1999). Alternatively, Clostridium
collagenase and its soluble collagen degradation products may act as chemoattractants
(Shi et al. 2010). Interestingly, while a PDGF-AB gradient expedited short-term migration
in vitro and increased cellularity at the wound interface of repair constructs in vivo at 2
weeks, it did not visibly improve cell infiltration of scaffolds at 4 weeks when combined
with collagenase. In contrast, Stringa et al. found that PDGF-BB stimulation enhanced
vascular smooth muscle cell migration on degraded ECM (Stringa et al. 2000). It is
possible that sustained delivery of a high dose of PDGF-AB, a mitogen (Bhargava et al.
1999, Tumia et al. 2009) and stimulator of matrix synthesis (Spindler et al. 1995, Tumia et
al. 2009), resulted in cell proliferation instead of migration (De Donatis et al. 2008). Future
work will focus on evaluating the long-term anabolic effects of PDGF-AB and tailoring its
in vivo delivery profile to optimize cell homing after matrix degradation. We will likewise
explore other chemoattractants whose activity is directed solely towards migration, with
little mitotic secondary effects (e.g., SDF-1α).
While this study showed improved migration to the wound site and colonization of the
scaffold with a two-phase release profile of collagenase and PDGF-AB, additional
functionality may be added to the system. For instance, to enhance the quantity and
quality of matrix produced by the recruited cells, the remaining fiber fraction may be further
modified to incorporate microspheres (Ionescu et al. 2010) that slowly release TGF-β3, a
potent fibrochondrogenic growth factor (Ionescu et al. 2012b), and/or lysl oxidase, which
could act to crosslink and stabilize nascent collagen fibrils (Makris et al. 2014). Lastly,
while the subcutaneous implantation model allows short-term assessment of biofactor
delivery in an in vivo setting, the subcutaneous environment is vastly different from the
synovial joint in terms of biochemical milieu, cellular constituents, immune response, and
dynamic mechanical loading, all of which could affect wound repair. Ultimately, these
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novel biomaterials must be evaluated in an orthotopic large animal model of meniscal
injury to prove long-term therapeutic efficacy.

7.6

Conclusions

In summary, the healing of dense connective tissues is limited in part by the inability of
endogenous cells to migrate to the wound site. To enhance cell infiltration and tissue
integration, we developed novel multi-component nanofibrous scaffolds that are both
biomimetic and bioactive. When tuned appropriately, the release of collagenase and
PDGF increased cell mobility to the wound margin in the short term and resulted in
superior scaffold colonization and tissue repair in the long term. Through coordinated
reprogramming of both cells and matrix, this technology will remove the natural
impediments to endogenous repair of the meniscus and other dense connective tissues,
providing a translational framework with which to treat many common musculoskeletal
injuries.
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CHAPTER 8: SUMMARY AND FUTURE DIRECTIONS

8.1

Summary

Repair of dense connective tissues throughout the musculoskeletal system is limited,
given the density of the matrix and the low cellularity of adult tissues. Like other fiberreinforced tissues, the knee meniscus is characterized by highly organized collagen
bundles that resist tensile stresses. Injuries disrupt this collagen architecture and
predispose the joint to cartilage erosion. While peripheral tears may be successfully
repaired, tears in the inner two-thirds of the meniscus have a poorer prognosis due to a
lack of vasculature and reparative cells. Efforts to biologically augment meniscal repair
have traditionally focused on increasing vascular supply and growth factors (Chapter 2),
overlooking the critical impact of extracellular matrix (ECM) properties in wound healing.
It is well recognized that matrix micromechanics and microstructure play a significant role
in regulating interstitial cell migration, an essential component of the intrinsic repair
process of dense connective tissues (Chapter 3). Using imaging and mechanical testing
modalities at the microscale, this work investigated how the biophysical properties of the
meniscal microenvironment regulate cell migration and tissue repair. Moreover, a novel
biomaterial was developed to reprogram the ECM of the meniscal wound interface to
generate a pro-healing microenvironment.

When limited connective tissue repair does occur, it does so through an orchestrated
series of events involving matrix breakdown, cellular division and migration, and eventually
new tissue formation to bridge the wound site. In Chapter 6, we found that cells were
unable to migrate through adult tissue, suggesting that the inability of the mature meniscus
to self-repair may be due in part to its dense, stiff, and highly structured ECM, which acts
as a steric barrier to interstitial cell migration. In contrast, cells were mobile within the more
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compliant and disorganized fetal ECM. Partially digesting the adult ECM with collagenase,
a matrix-degrading enzyme, produced a fetal-like environment that was permissible to cell
infiltration. Thus, the microenvironment of fibrous connective tissues may play a role in the
differential healing capacity of fetal and adult tissues, and may be modulated via
exogenous enzymatic degradation to promote cell migration and repair.

To generate a local microenvironment that facilitates the adult healing response, we pretreated the meniscal wound interface with collagenase so that the ECM resembled
immature tissue (Chapters 4 and 5). Through a series of in vitro and in vivo studies, we
demonstrated that reducing the local matrix stiffness and density at the injury site
increased cellular ingrowth, matrix remodeling, and tissue integration. Thus, a novel
strategy to promote meniscal repair may be to deliver a controlled, low dose of matrixdegrading enzyme to free the living native cells from the matrix and expedite migration
while allowing the production of new contiguous tissue spanning the defect.

Chapters 4 and 5 also document the development of a synthetic electrospun nanofibrous
scaffold that rapidly releases collagenase upon implantation into the defect site.
Electrospun nanofibrous scaffolds are a promising tool for soft tissue repair and tissue
engineering, given their ability to provide structural integrity and instruction for new tissue
formation. While they have been previously utilized for meniscal tissue engineering, this
is the first time, to the best of our knowledge, that nanofibers were used to localize delivery
of therapeutics to promote endogenous meniscal repair. In Chapter 4, we established the
retention of enzymatic bioactivity and tunable delivery from water-soluble poly(ethylene
oxide) (PEO) nanofibers. The technology was further functionalized by creating
collagenase-delivering fibrous composites containing both enzyme-releasing PEO fibers
and structural poly(ε-caprolactone) (PCL) fibers. This dual polymer scaffold provided a
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burst delivery of collagenase where the local enzyme activity enabled cell migration
through the partially digested wound interface, while the second, aligned fiber component
provided topographical instruction for ingressing cells. We found that these scaffolds
enhanced the integration strength of meniscal defects in vitro. In Chapter 5, we showed
that these scaffolds also increased cellularity and repair in vivo using a subcutaneous
xenotransplant model (rat) and an orthotopic meniscal injury model (sheep). Importantly,
matrix digestion was restricted to the wound interface and did not adversely affect
surrounding tissues.

In Chapter 7, we took the innovative approach of specifically directing the coordinated
phases of tissue repair. We designed a scaffold that would first enable repair by
modulating the matrix to permit migration, followed by recruitment of endogenous cells to
the wound site by providing a chemoattractant. We found that a soluble gradient of
platelet-derived growth factor-AB (PDGF-AB) stimulated cell migration through
biophysical barriers (porous membranes and meniscal tissue) in vitro. Next, we fabricated
a highly tunable scaffold, capable of delivering collagenase and/or PDGF-AB with varying
release profiles to the injury site to mediate wound repair. When the scaffold was inserted
into a meniscal defect and placed subcutaneously in vivo, the sequential delivery of
collagenase and PDGF-AB led to the highest interfacial cellularity compared to delivery of
either biofactor alone. This versatile platform will allow us to maximize cell recruitment
while minimizing damage to the tissue microenvironment, as well as deliver additional
therapeutics, such as anabolic growth factors and anti-inflammatories, to promote matrix
synthesis and inhibit matrix catabolism in the long-term. By combining multiple bioactive
components that expedite cell colonization and wound integration in a spatiotemporal
manner, these novel scaffolds will bring us closer to repairing the meniscus and other
dense connective tissues.
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8.2

Limitations and Future Directions

While much was accomplished in this dissertation, there are of course limitations and
additional considerations and new experiments to be performed based on these findings.

8.2.1

Cellular and Extracellular Matrix Changes with Age

To determine whether aging affects interstitial migration in the meniscus, we compared
fetal and adult meniscal cellular and ECM properties in Chapters 7 and 6, respectively.
However, using primary cells and tissues limits the degree of control over our studies.
Since the exact age of donors were unknown (fetal tissues range from late 2nd–3rd trimester
and adult tissues from 20–30 months), changes during fetal development were not
considered in the scope of this work. Although experiments were restricted to cells and
tissues from the middle zone of the medial meniscus, isolated cells and tissue substrates
were likely heterogeneous. Also, it is unclear whether a specific cell type (e.g., progenitor
cells) was disproportionately represented due to an intrinsic propensity to migrate out of
explants, attach to substrates, and/or proliferate.
The effect of cell passage also warrants further investigation. We found that adult P1 cells
were more contractile than P0 cells on fibronectin-coated gels, but that fetal cells were
largely unaffected (Chapter 7). Interestingly, attempts to seed P1 cells onto tissue
substrates were consistently unsuccessful, most likely due to trypsin-mediated cleavage
of cell surface receptors. P0 and P2 cells were able to attach and spread, indicating that
cell adhesion may also depend on passage number. However, fetal and adult P0 cells
were smaller and more spindle-shaped than P2 cells, whose well-spread morphologies,
independent of ECM age, suggest mechanical memory (Talele et al. 2015, Yang et al.
2014) (Figure 8-1). Furthermore, while P0 cells showed signs of matrix invasion, P2 cells
remained predominantly on the tissue surface. Recent studies indicate cell culture on stiff,
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planar surfaces (e.g., tissue culture plastic) increases cell stiffness and leads to a
contractile, myofibroblastic phenotype (LeBlon et al. 2015, Talele et al. 2015). As such,
future experiments should use minimally passaged cells whenever possible, although
expanding cells on softer substrates may delay dedifferentiation (Majd et al. 2009, Wu et
al. 2015). Furthermore, integrin-blocking antibodies and contractility inhibitors (e.g.,
blebbistatin and Y27632 to block nonmuscle myosin II and ROCK) may provide insight to
how cell and ECM age, as well as cell expansion, affect the mechanosensing machinery.

Figure 8-1: Cell morphology is dependent on ECM age, cell age, and cell passage. (A)
Representative binarized images of fetal and adult meniscal cells spread on fetal and (B)
adult meniscal tissue substrates. Cells on adult tissues are more elongated than cells on
fetal tissues. Fetal cells are smaller and more spindle-shaped than adult cells at Passage 0.
However, there is no difference between fetal and adult cells at Passage 2, indicating that
cell-intrinsic differences are attenuated with expansion on tissue culture plastic.

An important cellular determinant of 3D mobility is nuclear size and stiffness. In Chapter
7, we showed that the nuclear volume of meniscal cells (P0) scaled with age. While a large
nucleus is associated with reduced migration speed (Lautscham et al. 2015), this
relationship was not directly confirmed in our study. In addition, we did not quantify nuclear
stiffness or lamin A/C content, although unpublished work suggests that they both
increase with age in meniscal cells. Future studies will investigate whether interstitial
migration could be improved by reducing nuclear stiffness, either by virus-mediated lamin
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knockdown, interrupting lamin processing (farnesyltransferase inhibitors) (Glynn et al.
2005), or by relaxing heterochromatin condensation (histone deacetylase inhibitors)
(Gerlitz et al. 2011).

Figure 8-2: Fetal and adult meniscal ECM imaged with different SHG systems. SHG signal
of interpenetrating fibers in the perpendicular plane are attenuated on the Zeiss microscope
(top). The Leica microscope (bottom) produces superior images in which individual collagen
fibrils are visible in all planes. Asterisks indicate orthogonal fibers (‘inter-fibrillar’ regions).
Scale = 50 µm.

To quantify age-related changes in the meniscal microenvironment, Chapter 6
characterized the microstructure of fetal and adult meniscus using second harmonic
generation (SHG) imaging. Although the microscope used in the study (Zeiss LSM 510)
can detect collagen fibers, the signal is highly attenuated when the fibers are oriented in
the Z plane (Figure 8-2). When imaged on a newer microscope with both forward and
backward detectors (Leica TCS SP8), the signal and resolution is greatly improved,
allowing detailed visualization of not only fiber bundles, but individual collagen fibrils in all
planes. Preliminary images support the idea that inter-fibrillar regions are not void spaces,
but rather discontinuities in the matrix (Figure 8-2, asterisk), and that fetal ECM is more
disorganized than adult ECM. Efforts to visualize the meniscal microstructure as a function
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of anatomical location and age are ongoing under the direction of Dr. Miltiadis Zgonis, and
will be aided by a recently acquired multiphoton microscope capable of this higher
resolution SHG imaging.

Figure 8-3: Micromechanical heterogeneity and anisotropy of fetal and adult meniscal
tissues. (A) Schematic of horizontal and (B) vertical sectioning planes and collagen fiber
units within each plane. (C) Indentation modulus (E ind) of different fiber units in the
horizontal and (D) vertical planes, as measured by AFM (tip radius ≈ 5 µm). Outer and inner
zones of fetal and adult tissues are tested for each sectioning plane (n=≥20 positions/group
for 2 donors per age, mean ± standard error of the mean). * = p≤0.05 vs. all other groups.
Images and data courtesy of Qing Li and Dr. Lin Han.

To measure matrix micromechanics as a function of age, we utilized atomic force
microscopy (AFM) indentation. While the elastic moduli reported in this thesis (Chapters
5 and 6) represent average values, they do not reflect the heterogeneity and anisotropy
of meniscal tissue. In a collaboration with Qing Li and Dr. Lin Han from Drexel University,
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we systemically mapped the micromechanical properties of fetal, juvenile, and adult
bovine menisci. While the overall matrix stiffness increased with age, the sectioning plane
(horizontal vs. vertical), anatomical location (inner vs. outer zone), and structural fiber unit
(superficial, circumferential, or radial fibers) influenced the measured modulus (Figure
8-3). For example, circumferential collagen fibers in the outer zone are more densely
packed and interdigitated with radial ‘tie’ fibers than in the inner zone, resulting in higher
matrix stiffness (Figure 8-4).

Figure 8-4: Collagen ultrastructure of the adult bovine meniscus is anisotropic and zonedependent. (A) SEM and AFM height images of vertical sections showing circumferential
fiber cross-section and radial ‘tie’ fibers. (B) SEM and AFM height images of horizontal
sections showing circumferential fiber alignment in the outer and inner regions.
Arrowheads indicate individual fibrils crossing to adjacent fibers. Images courtesy of Qing
Li and Dr. Lin Han.

These early results illustrate the inextricable link between ECM structure and mechanics
on the microscale, which may generate new fundamental knowledge about the
microenvironment of dense connective tissues. In addition to biophysical properties of the
ECM, cell mobility depends on the type and distribution of integrin-binding proteins and
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growth factors. Therefore, to fully comprehend how the ECM changes with age and
disease to affect migration, future studies should also characterize ECM composition via
nuclear magnetic resonance imaging or mass spectroscopy (Schiller et al. 2012).
To integrate our findings, we are building a computational model of 3D migration in a
collaboration with Drs. Xiao Wang and Vivek Shenoy. This model determines the force
required for the nucleus of a cell to navigate through a gap in the matrix, taking into
account the nuclear stiffness and radius, as well as the matrix stiffness and gap width
(Figure 8-5). Two distinct matrix regions were included in this preliminary model to mimic
tissue degradation: a soft region at the gap (degraded matrix) and a stiff surrounding
region (original matrix).

Figure 8-5: Computational model for cell migration through dense connective tissues. (A)
Schematic showing a nucleus above a narrow slot with an infinitely long distance (similar
to the organized collagen fibers in the meniscus). The slot width is much smaller than the
nuclear radius. The wall of the slot consists of a layer of digested ECM (red) that is softer
than the undigested ECM outside. (B) Simulation of cell nucleus moving through a narrow
and long slot in the ECM. Contour plots show the von-Mises stress at the initial, critical, and
migrated phases. (C) The resistance force on the nucleus is plotted as a function of the
vertical displacement of the nucleus. Model parameters are: shear modulus of the
undigested ECM (Em=20 kPa), the digested ECM (Em=10 kPa), and the nucleus (En=20 kPa);
nuclear radius (Rn = 10 µm); and width of the slot wall (L = 20 µm). Images and data courtesy
of Drs. Xiao Wang and Vivek Shenoy.
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Importantly, we simulated topographic anisotropy by constraining cell migration to a long
and narrow ‘inter-fibrillar’ slot, thus obliging the cell to deform and elongate as it enters the
matrix. In agreement with our observations, the model predicts that the force required for
a cell to penetrate a long slot is significantly lower than for a round hole with the minimum
diameter, and that the force is further reduced with matrix degradation. By modeling the
various biophysical parameters that influence cell migration, we may be able to identify an
optimal wound microenvironment for fibrous tissue repair.

8.2.2

Multiple Biofactor Delivery In Vivo

Electrospinning is a versatile platform that offers tunable control over the combinatorial
delivery of therapeutics, including their dose, bioactivity (via emulsion and sonification
techniques (Briggs et al. 2013)), temporal release profile (via material degradation and
fiber modification (Ionescu et al. 2010, Liao et al. 2009, Purcell et al. 2014)), and spatial
localization (via patterns or gradients within the scaffold (Hahn et al. 2006,
Sundararaghavan et al. 2011, Wade et al. 2015a)). While scaffold-mediated collagenase
delivery expedited meniscal repair in our proof-of-concept studies (Chapters 4, 5, and 7),
there are limitations regarding its translation to the clinic. First, a burst release of a matrixdegrading enzyme might damage surrounding tissues and cells during surgical
implantation. To address this problem, release could be delayed by controlling the rate of
scaffold hydration, such as increasing hydrophobicity via an external layer of PCL fibers
(data not shown). Another option is to slow the rate of PEO fiber degradation by increasing
the polymer chain entanglement with a higher molecular weight polymer, although this is
less effective than the previous method (data not shown).
Second, over-digestion of the tissue may occur, which could result in extensive weakening
of the tissue’s bulk mechanical properties or might initiate a catabolic, inflammatory
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response. Despite enhanced interfacial cellularity, enzyme-treated tissues are more likely
to lose shape and structure over time due to internal cell-mediated contraction. While
reducing the enzyme dose may prevent this, our data suggest that a certain level of
digestion may be necessary to initiate cell mobility and matrix remodeling (Chapters 6 and
7). To maximize cell migration while minimizing the amount of matrix degradation, a
chemotactic factor (PDGF-AB) could be released into the wound site after collagenase.
While PDGF-AB enhanced 3D cell migration in vitro, it did not significantly affect migration
in vivo when delivered alone (compared to control scaffolds) or following collagenase
(compared to collagenase-only scaffolds). However, only a single biofactor dose and
delivery profile was investigated in this preliminary study. While these parameters were
chosen based on scaling results from in vitro experiments, the bioactivity, release kinetics,
and diffusivity in vivo may be significantly different, due to protein adsorption, pH,
mechanical

forces,

tissue

permeability,

and

biofactor

inactivation/degradation.

Furthermore, cell response to PDGF depends on a myriad of factors that were not
considered in vitro, including cellular expression of ligand receptors, competing
chemoattractants and/or cell signaling pathways, and growth factor-matrix binding
(Vanden Berg-Foels 2013). Since PDGF-AB also has mitogenic and pro-matrix effects
(Bhargava et al. 1999, Tumia et al. 2009), ancillary anabolic stimulation may have
occurred from sustained delivery in vivo (unlike the transient exposure of in vitro migration
studies). Indeed, PDGF-AB delivery alone increased cellularity immediate to the wound
margin compared to control scaffolds, most likely by promoting cell proliferation.
Interestingly, this did not translate to increased cell invasion of the scaffold, as most cells
remained at the scaffold periphery. An effective chemotactic signal is difficult to establish
because it is unclear on what time and length scale to institute the gradient. For example,
delivering a high dose of PDGF-AB may stimulate migration at far distances, but
oversaturate cell receptors close to the wound margin (Vorotnikov et al. 2014). Despite
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these limitations, we demonstrated the capability to sequentially deliver bioactive factors
from a composite scaffold, which can be easily modified to optimize PDGF-AB loading
and release rate. Several in vitro studies may elucidate the bioactivity of PDGF-AB
released over time, including 1) Transwell or ‘tissue Boyden’ migration assays, with the
scaffold eluant in the bottom chamber, 2) BrdU proliferation assays to assess mitotic
activity, and 3) long-term culture of cell pellets or cells on scaffolds to evaluate matrix
deposition. To investigate the release profile in vivo, we may remove implanted scaffolds
at set time intervals to determine the amount of remaining drug. If PDGF-AB proves
ineffective in vivo, an alternative candidate is stromal-cell derived factor-1α (SDF-1α), a
chemokine that recruits mesenchymal stem cells to sites of injury (Lau et al. 2011).
In addition to the rapid and sustained release above, the third scaffold fiber fraction can
likewise be functionalized to deliver other molecules, such as a pro-chondrogenic growth
factor (TGF-β3 (Ionescu et al. 2012b)) to promote cell differentiation and matrix production
in the weeks to months after the initial phase of proliferative repair (Kim et al. 2015, Park
et al. 2010) (Figure 8-6). Additionally, to boost the maturation of de novo matrix, lysyl
oxidase, an enzyme that catalyzes collagen crosslinking, could be introduced alongside
TGF-β3 (Makris et al. 2014). Complementary delivery of anti-inflammatory agents (e.g.,
interleukin-1 receptor antagonist (McNulty et al. 2007)) and/or tissue inhibitors of
metalloproteinases (TIMPs) (Eckhouse et al. 2014)) could reduce undesired catabolic
degradation after the initial migratory process is completed. Strategies to achieve a
delayed, sustained release include drug encapsulation within hollow fibers or
microparticles (Ionescu et al. 2010, Liao et al. 2009), addition of surface affinity-binding
motifs (Purcell et al. 2014), or covalent immobilization to the scaffold (Choi et al. 2008). It
is paramount that the dosage, spatial distribution, and temporal sequence of multifactor
delivery systems be confirmed in an appropriate in vivo setting. For example, interfacial
matrix accumulation early in the proliferative phase may contribute to fibrous capsule
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formation and restrict scaffold colonization. Inhibiting macrophage function during the
inflammatory phase may also hinder tissue regeneration (Godwin et al. 2013).

Figure 8-6: Biomaterial design strategy for a third-generation electrospun scaffold to
enhance meniscal repair. (A) Schematic of tri-component electrospinning with three
discrete bioactive fiber populations. (B) Schematic illustrating fiber cross-sections with or
without drug loading for PEO, HA, and PCL fibers delivering collagenase, PDGF, and TGFβ3, respectively. While short- to medium-term release may be accomplished by
homogeneous blending within the material, long-term delivery may require entrapment
within a slow-degrading polymer shell. (C) Schematic showing the proposed biological role
of each biofactor and their time course of delivery.

Besides delivering soluble factors, the scaffold may provide instruction via mechanical
cues (fiber stiffness, density, and organization) and insoluble signals (e.g., adhesion
ligands). While these parameters were not extensively probed in this work, our in vitro
findings reflect the general consensus in the literature that 1) a dense scaffold with small
pores inhibits cellular ingress and 2) incorporation of RGD facilitates adhesion. While the
tri-component scaffolds that were compared, PCL/PEO/PEO and PCL/PEO/HA, contain
different polymer constituents and were randomly aligned (resulting in lower fiber packing
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than the aligned scaffolds used in vivo), it was clear that cellular ingress was inhibited by
the physical addition of a HA component in vitro. Cell infiltration into scaffolds after variable
periods of hydration may shed light on how scaffold density changes with HA mass loss
to affect migration. Enzymatic removal of HA via hyaluronidase digestion would also
provide a means to control scaffold density. Incorporating protease-sensitive crosslinkers
to HA macromers (Wade et al. 2015b) may increase the rate of cell infiltration by permitting
cell-mediated widening of small pores and formation of migratory tracks through which
other cells can follow, although this formulation will need to account for the initial burst of
collagenase. Lastly, while it is difficult to increase the ‘sacrificial’ PEO content via our
current tri-component electrospinning system, it is certainly feasible to introduce another
fast-degrading component by increasing number of discrete electrospinning jets.
The contribution of RGD to fibrous scaffold invasion is more difficult to interpret in vivo
(Bellis 2011). Although RGD proved necessary for cell adhesion to HA-only scaffolds in
vitro, the addition of a PCL fiber fraction rescued cell attachment and spreading (data not
shown), likely due to adsorption of integrin-binding proteins from serum-containing media,
such as fibronectin and vitronectin, onto this fiber fraction. As such, adsorption of serum
or blood proteins in vivo will alter the effects of synthetic RGD. Indeed, a pilot
subcutaneous study found that native cells were able to invade PCL/PEO/HA scaffolds
without RGD (data not shown). In fact, the competition between synthetic RGD and native
proteins for binding to integrin receptors may even attenuate the level of integrin signaling,
especially at high RGD concentrations (Sawyer et al. 2005). Taken together, future work
should look to optimize biomaterial-mediated delivery of instructive soluble signals while
simultaneously providing a microenvironment that facilitates cell infiltration and matrix
organization, all in the context of an in vivo setting. These experiments will be performed
in collaboration with Dr. Jason Burdick and the members of his laboratory (the PDGFdelivering fibers described in Chapter 7 were developed by Dr. Julianne Holloway).
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8.2.3

Translational Animal Models

While in vitro studies are suitable for probing basic mechanisms, they lack the biological
complexity of in vivo environments, in which the biochemical milieu, mechanical forces,
and cell-cell and cell-matrix interactions act in concert to affect outcomes. To move our
work towards in vivo translation, we first utilized a small animal subcutaneous model
(Chapters 5 and 7), where adult bovine meniscal repair constructs are implanted in the
dorsum of athymic rats. This allowed us to evaluate the biocompatibility and bioactivity of
our scaffold formulations in a physiologic setting that included vasculature, exogenous
cells (fibroblasts), and an innate immune response (athymic rats lack a humoral immune
response). While using this system allowed us to discern differences in cellularity and
tissue integration between experimental groups, there are drawbacks to this approach.
First, we could not mechanically evaluate the wound interface, as it was too weak to test
after removing the surrounding fibrous capsule. This could be accomplished in future
studies
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tissue

cryosections,

which

may

detect

micromechanical changes at the wound interface. Second, rat fibroblasts from the host
appeared to infiltrate the explants at longer time points. However, increased
immunohistochemical staining for type II collagen at the interface suggests that native
meniscal cells synthesized the matrix. To definitively differentiate between rat and bovine
cells, we may need to utilize fluorescence in situ hybridization (FISH) to identify speciesspecific DNA. Third, it has been reported that a delayed xenograft rejection may occur,
even in nude rats (Candinas et al. 1996). It may therefore be useful to assess immune cell
infiltration by immunohistochemical staining for CD45, a pan leukocyte marker, as well as
specific markers for neutrophils and macrophages (Hoemann et al. 2010). Early results
indicate that the majority of cells within the tissue were not CD45+ at the 4 week time
point. Lastly, the subcutaneous space is not reflective of the synovial knee joint, which is
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characterized by viscous synovial fluid, a lack of vasculature and lymphatics, and dynamic
loading of the connective tissues within. Nonetheless, these subcutaneous experiments
provided essential data on the feasibility and efficacy of this technology before
implementation in an orthotopic large animal model.
After the scaffold was optimized in the small animal model, we assessed its potential to
heal a bucket handle tear in an ovine injury model (Chapter 5). The 4 week pilot study
revealed that collagenase-releasing scaffolds may enhance tissue integration without
adversely affecting the surrounding cartilage, although the sample sizes were too small to
make statistical comparisons (n=2–3/group). The large animal study had its own set of
limitations. First, the sterilization method required for in vivo implantation may compromise
scaffold bioactivity, and should be considered early in device development. Using the
cartilage-based incubation assay documented in Chapter 4, we confirmed that gamma
irradiation preserved collagenase activity, whereas ethylene oxide did not. Second,
visualizing the medial meniscus, creating a standard-sized defect, and inserting the
scaffold proved to be extremely challenging from a surgical perspective. For the purposes
of clinical translation, a customized arthroscopic tool should be developed to facilitate
implantation, similar to those that insert ultra-thin cells sheets under the retina (Nazari et
al. 2015). Third, the initial bucket handle defect that we created had a tendency to
propagate over time, resulting in secondary radial tears by 12 weeks in specimens across
all experimental groups (data not shown). It is possible that long-term unrestricted pasture
exercise contributed to this deterioration. Unfortunately, as a consequence, it was difficult
to locate the scaffolds at this later time point, as many had extruded from the defect and
became embedded in the synovium. In future studies, a controlled rehabilitation regimen
should be employed, with radiopaque scaffolds to longitudinally track scaffold position
(Martin et al. 2015). Finally, functional outcomes at either the tissue-level (mechanical
properties of the meniscal wound interface and underlying cartilage) or organism-level
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(joint range of motion, gait, and activity level) were not assessed due to the pilot nature of
this work. For example, microindentation testing of both cartilage and repaired meniscus
may be a viable method to evaluate the mechanical integrity of tissues prior to processing
for histology (Kim et al. 2015). Ongoing efforts to quantify animal activity and joint function
are described in the following section.

8.2.4

Method to Assess Joint Kinematics in Humans and Large Animals

8.2.4.1 Introduction
Functional outcomes such as joint kinematics and gait are important indicators of efficacy
in musculoskeletal research (Keegan 2007). Traditional technologies that objectively
assess these parameters, such as visual tracking systems and/or force plates (Barrey
1999, Clayton et al. 2001, Zumwalt et al. 2006), are challenging to deploy in long-term
translational and clinical studies. To address this limitation in our large animal work, we
developed a low-cost, multi-sensor device that detects animal activity and joint angle, and
hypothesized that it could quantify post-operative functional recovery. To date, we have
used the device to establish longitudinal changes in animal activity after a bilateral
arthrotomy, and have demonstrated the feasibility of measuring joint kinematics in both
large animals and humans using a magnet-based detection system.

8.2.4.2 Methods
The device consists of a plastic enclosure containing a 3.7 V polymer lithium ion battery,
microcontroller board (Arduino Fio), radio board (XBee), sensor board (9 Degrees of
Freedom Sensor Stick), and data logger (OpenLog). The sensor board integrates a tripleaxis accelerometer, triple-axis gyroscope, and triple-axis magnetometer (Godwin et al.
2009) and was calibrated prior to use via a custom software tool. A computer with a radio
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peripheral receives transmitted data to plot it in real time. To measure changes in joint
angle, the device and a neodymium magnet (1" diameter, 1/4" thick) were affixed 4" distal
and 4" proximal to a human knee joint on the posterior surface, respectively. The knee
was moved to flexion angles of 0º, 30º, 60º, and 70º. Position was held for 5 s at each
angle (n=3-4/group) and the magnetic field strength was recorded at 40 Hz. An equation
relating sensor-magnet angle as a function of magnetic field magnitude was derived to
predict flexion angle. To validate that the device could capture dynamic range of motion
of the knee during normal gait, a human subject (n=1) walked at a step frequency of ~1
Hz, and the magnetic field strength and angular velocity were recorded. Individual steps
(n=10) were used to obtain the range of motion (ROM) during the gait cycle.
To evaluate general activity in a large animal, the device was attached to a harness worn
by a castrated male Yucatan minipig pre- and post-surgery (n=1, 26 kg pre-op) in an
unrelated study involving bilateral arthrotomy of the stifle (Fisher et al. 2014), with
analgesics given for the first 5 days after surgery. Data was collected at 8 Hz for 30 min
of unsupervised activity in a 4' x 6' pen pre-operatively on Day -1 (Baseline) and postoperatively on Day 1 and weekly thereafter until euthanasia at Week 12. Angular velocity
(º/s) parallel to the dorsal plane (animal turning left or right) was recorded and the absolute
values binned into four activity intensity levels: 0–5 (Rest), 5–50 (Low), 50–100
(Moderate), and >100 (High). On Week 11, the sensor and magnet were laterally attached
to the left hindlimb 4" proximal and 5" distal to the stifle joint, respectively. The stifle was
manually flexed to angles of 20º (maximum extension), 30º, 60º, and 90º. Position was
held for 5 s at each angle (n=3–4/group) and the magnetic field strength was recorded at
8 Hz. The animal was allowed to freely ambulate within the pen and the magnetic field
strength was recorded. Individual steps (n=10) were used to obtain the ROM and were
visually confirmed with synchronized high-speed video. Significance was assessed by
one-way ANOVA with Tukey’s post-hoc tests to compare magnetic field strength between
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groups (p≤0.05). Data are presented as the mean ± standard deviation unless specified
otherwise.

8.2.4.3 Results
A wearable device capable of sensing motion and quantifying joint kinematics was
fabricated with off-the-shelf electronics for <$200. Knee flexion angle was predicted via
changes in the magnetic field strength, which increased exponentially with flexion (Figure
8-7B, p≤0.05). Using this method, we measured the range of motion (ROM) of a human
knee during a normal gait cycle. Flexion angle and angular velocity of the tibia appeared
as repetitive and predictable patterns during ambulation (Figure 8-7C and Figure 8-7D).
The average ROM of the human knee during the gait cycle was 54±4º, with a peak flexion
angle of 55±3º.

Figure 8-7. Magnet-based system for quantifying joint kinematics. (A) Experimental
schematic. (B) Magnetic field strength as a function of flexion angle (n=3–4/group, mean ±
standard deviation). * = p≤0.05 vs. all other angles. (C) Average flexion angle and (D) angular
velocity for a human knee during a gait cycle (n=10 steps, mean ± standard error of the
mean).
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Next, the device was used to monitor unsupervised large animal activity pre- and postsurgery, and to quantify stifle joint kinematics. The device was worn by a Yucatan minipig
and angular velocity in the dorsal plane was recorded over 12 weeks (Figure 8-8). On
Day -1 (Baseline), the animal had full ROM and activity was characterized by Rest and
Low intensity activity, with short periods of Moderate and High intensity activity (Figure
8-8A). Immediately post-operative on Day 1, the animal was predominately sedentary and
ambulated with a stiff, limping gait. The animal regained 50% of its pre-operative NonRest activity level by Week 1, and was fully recovered by Week 3. Non-Rest activity levels
were maintained until Week 10, when it slightly declined (Figure 8-8B). The average
ROM of the porcine stifle during the gait cycle was 55±13º at Week 11, with a peak flexion
angle of 101±4º (Figure 8-9).

Figure 8-8: Unsupervised activity monitoring demonstrates time course of recovery in a
porcine model. (A) Distribution of activity intensity pre- and post-surgery. (B) Non-Rest
Activity normalized to the pre-operative Baseline value (red dashed line) and animal weight
over 12 weeks.
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Figure 8-9: Dynamic range of motion during unprovoked ambulation. (A) Image of animal
wearing the device. (B) Sensor and magnet positions during gait cycle. (C) Magnetic field as
a function of flexion angle (n=3–4/group, mean ± standard deviation). * = p≤0.05 vs. all other
angles. (D) Average flexion angle during a gait cycle at Week 11 (n=10 steps, mean ±
standard error of the mean). Red line indicates neutral stance.

8.2.4.4 Discussion
Objective quantification of joint function is crucial for evaluating experimental treatments
in translational models. Wearable motion sensors have the potential to provide objective,
individualized data on physical activity and locomotion for animal models. However, basic
accelerometer-based monitors cannot assess the type or quality of movement (Brown et
al. 2010), whereas more complicated analytical systems are costly and often require the
use of multiple sensor components in a supervised environment (Keegan et al. 2012,
Roepstorff et al. 2013). To that end, we developed a low-cost device using a single
integrated sensor that quantifies both joint kinematics and activity. When worn by the
research subject, the device wirelessly transmits data on acceleration, angular velocity,
and magnetic field in 3D space, allowing for remote, real time visualization and analysis
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of unprovoked and unsupervised movement. Using this system, we tracked the time
course of recovery of a pig after arthrotomy and found that return to baseline activity
occurred 3 weeks after surgery. Monitoring also revealed a slight decline in activity in the
long term, which may indicate behavioral changes due to increasing weight or age. By
placing a magnet opposite the articulating joint, we identified discrete steps and calculated
the dynamic ROM during unprovoked ambulation in both the human knee and the porcine
stifle. Importantly, the measured ROM for the porcine stifle was consistent with previously
reported values for healthy swine (Stavrakakis et al. 2014), indicating functional joint
recovery by 3 months. This method allows for species-independent, individualized
assessment of joint kinematics using a single sensor. While magnetometers have
previously been used for this purpose, the Earth’s magnetic field was utilized as a
reference, limiting the system to quasi-static measurements (Bonnet et al. 2007,
O’Donovan et al. 2007). Experiments to validate our method as well as algorithms to
distinguish standard gait parameters, such as cadence and swing/stance phase ratio, are
ongoing. Simple and inexpensive, this magnet-based system will facilitate the longitudinal
assessment of joint abnormalities and functional recovery for animal and human subjects
in orthopaedic research.
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8.3

Conclusion

Orthopaedic injuries are prevalent and poor intrinsic healing of fibrous connective tissues,
especially in avascular regions, can lead to altered joint biomechanics, inflammation, and
early degenerative osteoarthritis. The ability of tissues to self-repair depends on the
availability of reparative cells at the injury site, but steric impediments posed by the dense
and stiff extracellular matrix of adult dense connective tissues hinder interstitial migration
of native cells to the wound margin. Targeted reprogramming of the wound interface
through biomaterial-mediated delivery of a matrix-degrading enzyme can remove the
natural biophysical barriers to cell migration, generating a microenvironment that favors
endogenous cell-mediated healing. Likewise, additional functionalization of the delivery
system to promote and enhance cell migration speed, or to reduce intrinsic barriers to
migration (such as nuclear stiffness) may likewise improve repair outcomes. Taken
together, these findings will define a new paradigm for fibrous tissue repair and
regeneration.
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